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The activation and reduction of dioxygen are the most important process in 
biological respiration and in energy conversion systems such as fuel cells which harness 
clean and effective electrical power generated from chemical fuels that use O2 as an 
electron/cation acceptor. The stepwise reduction of dioxygen to water is highly exothermic 
transformation which is substantial for aerobic respiration. The metal-bound reduced-O2 
intermediates are formed in the course of reductive O‒O bond activation. Establishing 
redox and thermodynamic relationships between metal-oxy species and its reduced (and 
protonated) derivatives is critically important for a full understanding of (bio)chemical 
processes involving metalloenzyme mediated dioxygen processing. Biomimetic synthetic 
model chemistry is a powerful tool to better understand fundamental elements of 
metalloprotein electronics, functions, and selectivity/reactivity. 
In chapter 1, an overview of reductive dioxygen activation by heme and heme-
peroxide-copper based systems is provided. It also includes important intermediates in the 
catalytic reduction of dioxygen by metalloenzymes. 
Chapter 2 presents a new iron-porphyrinate complex, which employs a tridentate 
ligand that incorporated a histamine moiety appended to the periphery of a fluorinated 
tetraphenylporphyrin and the reactivity of various reduced heme compounds, toward 2,6-
dimethyl-phenyl isocyanide (DIMPI) and nitric oxide (NO). The generated DIMPI-FeII and 
NO-FeII complexes were characterized by UV-vis, IR, NMR, and EPR spectroscopies. 
In chapter 3, the dioxygen reactivity of reduced heme, which is an advanced 
cytochrome c oxidase (CcO) active site model system as a binucleating ligand, is reported 
in the absence and the presence of copper ion. This work represents that the process of 
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oxygenation of the iron complex in the absence and presence of copper ion matches well 
with proposed CcO catalytic cycle, i.e., Cu-independent generation of heme superoxide 
and subsequent formation of peroxide moiety with copper ion. 
Chapter 4 discusses the stepwise reduction and protonation of a ferric heme 
superoxide complex and the first example of experimentally determined thermodynamics 
(reduction potential and pKa). With these measure thermodynamic parameters, the OO–H 
bond dissociation free energy (BDFE) was calculated employing thermodynamic square 
scheme and Bordwell equation. The determined BDFE value was confirmed by the 
oxidizing capability of ferric heme superoxide species via hydrogen atom transfer (HAT). 
In chapter 5, thermodynamic comparisons for O2-derived iron-porphyrinate 
interrelated ferric superoxide, peroxide and hydroperoxide complexes in the presence and 
absence of an appended imidazolyl axial base are described. Also, the reactivity results of 
superoxide species with/without axial ligand with external substrates reveal their oxidizing 
capability, and these observations corroborate the new thermodynamic results presented 
here.  
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1.1 Fundamental properties and activation/reduction of dioxygen 
Dioxygen (O2) is the most abundant and a critical constituent of the earth’s 
atmosphere, which is paramagnetic with a triplet ground state resulting from the presence 
of two unpaired electrons in degenerate molecular orbitals.1 Although molecular dioxygen 
in its triplet ground state is a kinetically inert under ambient conditions, it is a 
thermodynamically powerful oxidant due to the inherent reactivity of its double bond. 
However, in order to utilize the high oxidizing power, the O=O double bond needs to be 
reductively activated.2 The activation/reduction of dioxygen is the most important process 
in biological respiration and in energy conversion systems such as fuel cells which harness 
clean and effective electrical power generated from chemical fuels that use O2 as an 
electron/cation acceptor.3,4 Such processes convert chemical to electrical energies via the 
oxygen reduction reaction (ORR).5,6 The first prerequisite for the broad application of fuel 
cells is catalysts that use H2/O2 on the anode and cathode, respectively. At the anode, H2 is 
oxidized, releasing protons and at the cathode, the protons/electrons are used to reduce 
dioxygen.7 
2H2 → 4H+ + 4e–                   Anode 
O2 + 4H
+ + 4e– → 2H2O        Cathode 
This oxygen reduction reaction (ORR) occurs mainly by two pathways: the two-
proton/ two-electron (2H+/2e–) reduction to hydrogen peroxide (H2O2) or the four-proton/ 
four-electron (4H+/4e–) reduction to water (H2O) in aqueous solutions.
8–12 The first one 
electron reduction of O2 to superoxide ion is thermodynamically unfavorable, as shown in 
Figure 1.1. However, stepwise one electron reduction from superoxide to peroxide species 
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and direct the two-electron reduction of dioxygen are thermodynamically favorable 
reactions (Figure 1.1).  
 
Figure 1.1 Thermodynamics of the stepwise reduction of dioxygen. Reduction potentials 
shown are versus normal hydrogen electrode (NHE) at 25 ℃. 
 
 
The oxygen reduction reaction (ORR) at the cathode is much slower than the 
hydrogen oxidation reaction occurring at the anode. In order to speed up the ORR kinetics, 
nature uses terminal oxidases in the respiratory chain where O2 is reduced to H2O in a four-
electron process and the energy harvested from this reduction is converted into a proton 
gradient to drive the synthesis of ATP. Thus, the most common type of ORR is catalyzed 
by the heme a3/CuB site with an iron porphyrin core structure in cytochrome c oxidase 
(CcO) (vide infra).8  
The reactions between triplet state O2 (S = 1) with organic substrates where most 
of the organic molecules have spin-paired singlet spin state (S = 0), are spin-forbidden.13 
To overcome this spin-barrier which makes a direct O2 mediated substrate oxidation 
kinetically sluggish, nature has utilized metalloenzymes which contain metal ions such as 
iron, copper, and manganese.14 These enzyme cofactors can be classified into two types, 
oxygenases and oxidases based on the role of O2 in the reaction.
15 Oxygenases incorporate 
one (monooxygenase) or both (dioxygenase) oxygen atoms into organic substrates (eq 1and 
eq 2, and Figure 1.2a), whereas oxidases utilize O2 to oxidize the organic substrates while 




Monooxygenases:            R‒H + O2 + 2H
+ + 2e– → R‒OH + H2O               (1) 
          Dioxygenases:                  R‒H + O2 → R(O)OH                                          (2)  
          Oxidases:                          O2 + 4H
+ + 4e– → 2H2O                                       (3)  
                                                    O2 + 2H




Figure 1.2 Catalytic cycles for copper-based (a) oxygenase (b) oxidase (adapted from ref 
16). 
 
1.2 Dioxygen activation/reduction by metalloenzymes 
Metalloenzymes activate dioxygen to carry out a variety of biological reactions. 
These enzymes use diverse active sites, such as heme and nonheme iron, copper and other 
metal sites. Herein, this chapter focuses on dioxygen activating heme enzymes. 
 
1.2.1 Heme enzymes 
Heme-containing proteins are of particular importance for living organisms and the 
interaction of iron of hemes with dioxygen plays a variety of biological roles such as 
transport and storage of dioxygen (hemoglobin and myoglobin: Figure 1.3), electron 
transfer (cytochromes), one-electron oxidation (peroxidases) and monooxygenation of 
foreign substrates (cytochrome P450s), dismutation of H2O2 (catalases), NO synthesis 
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(NOS) and four-electron reduction of O2 (oxidases). In this regard, myoglobin (Mb) and 
hemoglobin (Hb) are biological dioxygen carriers and are responsible for the storage and 
transport of O2 in most aerobic organisms. Myoglobin contains one heme prosthetic group, 
while hemoglobin which transports O2 is a tetramer where four O2 molecules bind 
cooperatively (Figure 1.3).17,18 
 
 
Figure 1.3 Crystal structures of human myoglobin (Left, PDB: 2DN2) and hemoglobin 




Figure 1.4 Schematic drawing of the interaction of dioxygen with heme enzymes. L is an 
axial ligand.  
 
The reduction sequence of dioxygen activation by metalloenzymes proceeds by 
electron and proton transfer reactions as shown in Figure 1.4. In all of the above systems 
the common mechanistic process is the stepwise oxidation of FeII or FeIII and then on to 
the FeIV oxidation state. The initial reduction step of O2 activation mechanism is the 
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binding of dioxygen to the heme iron, forming a low-spin ferric superoxide (oxy ferrous) 
intermediate. The subsequent reduction of the oxygenated species, [(P)FeIII–(O2˙ˉ)] or 
[(P)FeII–(O2)], forms a ferric peroxide complex, [(P)Fe
II–(O2
2‒)], which is followed by 
protonation at the distal oxygen to generate a ferric hydroperoxide, [(P)FeIII-(OOH)], also 
known as compound 0 (Cmpd 0). A second protonation on the distal oxygen of 
hydroperoxide species causes heterolytic O−O bond cleavage to produce a highly reactive 
high-valent ferryl-oxo π-cation porphyrinate radical ((P•+)FeIV=O, compound I, Cmpd I), 
releasing a molecule of water.20 
Cmpd I, which is an oxidation state two-electron equiv higher than the resting state, 
was first discovered in horseradish peroxidase (HRP)21 and is formed by O‒O bond 
activation of O2 or H2O2 depending on the class of enzymes. This species is identified as 
key reactive intermediates in the catalytic cycles of heme-containing peroxidases, catalases, 
and cytochrome P450s (CYP450s). The radical of Cmpd I resides generally on the 
porphyrin or the axial ligand. The electronic structure is described as S = 3/2 due to the 
ferromagnetic coupling between S =1 ferryl species and S = ½ porphyrin π cation radical, 
as in most peroxidases and catalases, while for chloroperoxidase (CPO) and CYP450s, 
strong antiferromagnetic coupling is observed, resulting in an overall S = ½ state.14,22 The 
reactivity of Cmpd I differs from enzyme to enzyme. In peroxidases, the high-valent oxo 
iron porphyrin oxidizes amines, phenols, and other aromatic substrates, whereas the species 
oxidizes hydrogen peroxide to oxygen molecule in catalases.23 For CYP450s the high-





1.2.1.1 Cytochrome P450s  
Cytochrome P450s (CYP450s) were discovered in the early 1960s,24 and they are 
thiolate-ligated heme-containing monooxygenases (Figure 1.5), present in almost every 
aerobic species and play a key role in a wide variety of oxidative reactions in biology, 
including hydroxylation, epoxidation, heteroatom oxidation, and heteroatom 
dealkylation.25–34 They are primarily responsible for oxygen transfer from dioxygen into 
biological substrates, with the second oxygen atom being reduced by two electrons 
provided by nicotinamide adenine dinucleotide phosphate, NAD(P)H via a reductase 
protein to a water molecule (Scheme 1.1). These processes are of essential importance in 
biosystems, where the enzyme participates in detoxification and biosynthesis of steroids, 
terpenoids, alkaloids, antibiotics, pigments, antioxidants, etc.35 
 
 
Figure 1.5 The active site of cytochrome P450 (adapted from ref 36) containing a 
prosthetic heme IX complex coordinated by a thiolate ligand from a cysteine residue. 
 





In hydroxylation reactions catalyzed by cytochrome P450s, the hydrogen 
abstraction oxygen “rebound” mechanism shown in Figure 1.6 (see below in Chapter 4 for 
more details) was proposed by Groves et al.37 In this pathway, the high-valent ferryl-oxo 
π-cation porphyrinate radical species (Cmpd I) abstracts a hydrogen atom from the 
substrate (R‒H) to form a carbon radical (R•) with the iron(IV) hydroxide complex. The 
incipient radical then reacts with the FeIV‒OH species (compound II, Cmpd II) i.e., 




Figure 1.6 The hydrogen abstraction/oxygen “rebound” mechanism for cytochrome P450 
(adapted from ref 15).  
 
1.2.1.2 Peroxidases and catalases 
Peroxidases and catalases which contain protoporphyrin IX as the heme prosthetic 
group are ubiquitous oxidoreductase heme enzymes. The heme structure is similar to 
CYP450s (Figure 1.5), and the difference is that peroxidases have a proximal axially 
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coordinated histidine residue while catalases accommodate a tyrosinate residue as an axial 
ligand (Figure 1.7).38,39 Also, the structural differences between peroxidases and catalases 
are the distal side residues, in peroxidases His/Arg (H42/R38) and in catalases His/Asn 




Figure 1.7 (a) Active site of peroxidases (PDB entry: 1ATJ). (b) active site of catalases 
(PDB entry: 2IQF ) (adapted from ref 40). 
 
Peroxidases and catalases catalyze the removal of hydrogen peroxide (H2O2) which 
is deleterious intermediate from the cells. Their catalysis reaction is initiated by the 
reduction of H2O2 to H2O by heterolytic cleavage of the peroxide (HO‒OH) bond, forming 
a (P•+)FeIV=O, Cmpd I species (eq 5).41 The main difference between peroxidases and 
catalases about catalytic reaction is the reactivity of Cmpd I. In peroxidases Cmpd I 
oxidizes one electron donating substrates forming high-valent iron(IV)-oxo ((P)FeIV‒OH, 
compound II, Cmpd II) (eq 6). Subsequent reduction of Cmpd II by one electron reforms 
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(P)FeIII resting state enzyme giving water (eq 7). Catalases use Cmpd I to oxidize a second 
molecule of H2O2, forming dioxygen and water (eq 8). In other words, Cmpd I in 
peroxidases mediates substrate dehydrogenative oxidations, while for the catalases a 




1.2.2 Heme-copper oxidases 
More than 90% of O2 consumption by living organisms is processed by heme-
copper oxidases (HCOs) which are a large superfamily of integral membrane proteins that 
exist in eukaryotic mitochondria and some bacteria.42 One subset of the HCOs superfamily 
includes Cytochrome c oxidase (CcO), which serves as a trans-membrane enzyme involved 
as the terminal oxidase of cell respiration.18,43,44 CcO catalyzes the reduction of O2 to H2O 
(eq 9) in the respiratory chain of aerobic organisms using reduced cytochrome c as an 
electron donor. As shown in eq 9, a single molecule of dioxygen interacts with eight 
protons, four of which are taken up from the inner side of the membrane to form two water 
molecules, while the remaining four protons are diffused to the outer side of the membrane 
(Figure 1.8). The exergonic electron transfers are coupled to endergonic proton 
translocation processes across the membrane, thus creating an electrochemical proton 
gradient that drives ATP generation.45–49 
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                                     8H+in + 4e
– + O2 → 4H
+
out + 2H2O                                          (9) 
 
 





Figure 1.9 (a) X-ray structures of the redox-active metal sites of bovine heart cytochrome 
c oxidase.51 (b) active site of cytochrome c oxidase from bovine heart in the reduced state 
(adapted from ref 49). 
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As shown in Figure 1.9a, cytochrome c oxidase has four redox centers; CuA, heme 
a and heme a3/CuB. In subunit II CuA which is a homodinuclear Cu dimer, acts as a one-
electron redox center at the membrane surface. This center transfers electrons supplied 
from cytochrome c to heme a which is a low-spin bis-imidazole-ligated heme of subunit I. 
The six-coordinate heme a then passes the electrons to the high-spin heme a3 center axially 
ligated by a proximal histidine. The two hemes (heme a and heme a3) are linked through 
their axial histidine ligands: His(Fea)–Phe–His(Fea3). Heme a3 is magnetically coupled to 
the CuB center, thus comprising of a binuclear active site where O2 binds and is 
subsequently reduced. In the highest resolution crystal structure to-date,50 the distance 
between the heme a3 and CuB is 4.8 Å. The CuB ion is coordinated by three histidine 
residues (His-291, His-290, and His-240) one of which (His-240) is covalently cross-linked 
to a tyrosine residue (Tyr-244), likely a result of a post-translational modification (Figure 
1.9b).52–56  
During or subsequent to the process of synthesis, proteins undergo a variety of post-
translational modifications (PTMs), which may involve covalent modification between 
amino acid side chains at protein active sites.57 For example, a well-known and widely 
prevalent side chain cross-link is disulfide bond formation giving Cystine which is the 
oxidized dimer form of the amino acid. As such, the unique post-translationally modified 
covalent cross-link between nitrogen atom (Nε) of a nearby histidine residue and carbon 
atom (Cβ) of a tyrosine residue in CcO has been revealed by crystallographic studies of the 
active site. The crystal structure (Figure 1.9b) shows that one of the CuB ligands, His-240, 
is cross-linked to Tyr-244 and that cross-linked tyrosyl is optimally positioned to 
participate in dioxygen activation. During O2 reduction catalysis, three of the electrons are 
13 
 
clearly provided by heme a3/CuB binuclear center (BNC), where one additional electron 
must originate from elsewhere. In peroxidases and catalases, the source of a similar 
electron is often the heme macrocycle, but in CcO neither optical nor resonance Raman 
spectroscopy support the formation of porphyrin π-cation radical resulting from heme iron 
oxidation.58 Thus, the most likely possibility of this additional electron source is an amino 
acid residue. On the basis of the proximity of the cross-linked tyrosine, it has been 
speculated that this residue could be the source of the fourth electron required for O–O 
bond cleavage. This post-translational linkage is postulated to play a critical functional role 
during the reduction of the heme-copper center. It is believed that the cross-link His-Tyr 
unit results in decreased pKa value of the tyrosine‒OH, facilitating the proton delivery and 
tyrosyl radical formation and increase the redox potential, based on model studies.59–62 
Also, it is proposed that the tyrosine-histidine cross-link stabilizes the precise geometry of 
the binuclear active site. In other words, in the absence of the His-Tyr cross-link, one of 
the histidines that is bound to CuB coordinates to the heme a3, leaving the binuclear center 
severely disrupted, and rendering the enzyme inactive. Recently, it is proposed that Tyr is 
the source for both the proton and the electron to cleave O–O bond during the catalytic 
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Heme proteins participate in critical and diverse biological functions which include 
electron-transfer, catalysis and signaling. For the latter two subjects, small molecule 
diatomic gases are often involved, such as O2, NO and CO.
1,2 There exist classes of proteins 
which serve to discriminate between these molecules for purposes including detection, 
signaling and/or function.3,4 For molecular oxygen, roles include storage-transfer, or 
activation of O2 for substrate oxidation or oxygenation chemistries.
5 Nitric oxide (nitrogen 
monoxide) is a signaling molecule6 such as in its interaction with the heme center in 
guanylate cyclase, wherein binding leads to a signaling cascade resulting in smooth muscle 
relaxation.7–14 Carbon monoxide is also a diatomic gas which is biosynthesized through 
heme O2-activation chemistry (i.e., in heme oxygenases);
15–17 CO can also act in biological 
signaling via heme protein binding.18 
In the history of the study of O2 interactions with hemoproteins, the investigation 
of the binding of diatomic surrogate ligands, mainly CO and NO, has received considerable 
attention. These have been utilized as structural models, but also are useful in the study of 
ligand binding dynamics and electronic structure of the ligated reduced hemes.19–23 For 
example, CO bound hemes are amenable to vibrational spectroscopic analyses, along with 
CO-photoejection and CO re-binding study.21–24 As well, reduced hemes with NO bound 
are active for EPR spectroscopic interrogation. The replacement of CO with isocyanide 
(RNC:) ligands has also been found to be a useful probe to investigate vibrational 
spectroscopy and binding kinetics or heme-ligand photodissociation and time resolved 
rebinding. The strong isocyanide N‒C triple-bond stretching vibration can be monitored, 
whereas variation in the size or nature of the isocyanide R-group, e.g., R = aryl vs –Me or 
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–tBu, provides insights concerning steric effects or issues of small ligand binding to iron 
relative to the size or shape of a protein active-site pocket.25–30 
One of our research group’s major foci has been and continues to be the study of 
dioxygen binding and reduction at heme-copper heterobinuclear metal ion centers.31 We 
seek to determine how neighboring copper-ligand moieties influence the binding of O2 to 
hemes, and in a complementary manner see how hemes affect O2 binding to copper ion in 
varying ligand environments. Then, as such synthetic heme-O2-Cu assemblies can be 
compared and related to the active-site chemistry of heme-copper oxidases which bind and 
reduce O2 to two water molecules (while also translocating protons through a 
mitochondrial membrane which downstream facilitates ATP biosynthesis), we are 
interested in elucidating detailed insights into the O–O reductive cleavage process, as a 
function of the exact nature (structure and electronics/bonding behavior) of the heme, the 
copper-ligand and the source of electrons (E° value) and protons (pKa). Additional factors 
include heme or copper-ligand electron-donating ability (and thus the FeIII/FeII and/or 
CuII/CuI E° value), nature of porphyrinate peripheral groups and/or copper-ligand denticity 
and their possible steric influences or affects upon the entire heme-O2-Cu(ligand) structure, 
for example the Fe…Cu distance in the heme-O2-Cu assembly.
31–35 
A specific example of such a synthetic construct is shown in Figure 2.1, where also 
an added heme axial ‘base’, dicyclohexylimidazole (DCHIm), is present.35,36 As 
anticipated, the structural, spectroscopic properties and reactivity of this and other such 
assemblies significantly depend on the detailed nature of the heme, the copper ligand, the 





Figure 2.1 Synthetic steps involved in generation of a low-spin heme-peroxo-copper 
complex. 
 
As such, it is critical that complementary investigations be carried out on surrogate 
ligand binding to the various components of our assemblies. One such aspect is the 
investigation of O2, CO, NO and/or RNC binding to varying designed porphyrinoids, 
wherein the axial base ligand is varied between a weak O-donor (as solvent) such as 
tetrahydrofuran (THF), or N-donor ligands such as DCHIm (Figure 2.2) or a covalently 
linked imidazolyl or pyridyl ligand. To better our understanding of the chemistry of full 
heme-O2-Cu assemblies, it is very useful to understand the structural aspects, physical 
properties and reactivity patterns of just these heme-containing moieties with varying axial 
ligand base, with O2, CO, NO and RNC’s. In fact, some of this information has been 
obtained and previously published, in particular for heme-O2 (Fe
III-superoxide) complexes, 
for four of the five species shown in Figure 2.2.37,38 Also, some of the related (heme)FeII-
CO and (heme)FeII-NO compounds have also been described.37 Here, we report on 
advances made from the study of new (heme)FeII derived adducts with 2,6-dimethylphe- 
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nyl isocyanide (DIMPI) along with nitric oxide, using the F8, P
Im, PPy and a brand new 
heme PImH possessing a covalently linked histamine moiety, see Figure 2.2 and equations 
3 & 4. New insights have been obtained based on the X-ray structures and physical 
properties which are described and also compared with corresponding adducts using F8, 






Figure 2.2 Ferric heme-superoxide complexes previously characterized and a new five-
coordinate ferrous species.  
 
2.2 Results and discussion 
2.2.1 Stable heme-isocyanide complex formation 
DIMPI reacts immediately with the reduced synthetic ferrous-heme complexes, 
[(F8)Fe
II], [(PPy)FeII], [(PIm)FeII] and [(PImH)FeII] (Scheme 2.1) to yield six-coordinate low-
























2.2.1.1 Generation of bis-isocyanide-porphyrin complex [(F8)FeII-(DIMPI)2] 
 
When one equivalent DIMPI is added to a THF solution of [(F8)Fe
II] at room 
temperature, a new UV-Vis peak at 430 nm is observed, but the absorption at 422 nm 
characteristic of the starting complex still remains. However, addition of another equivalent 
of DIMPI leads to the full formation of the 430 nm peak in the Soret region (Figure 2.3 and 
Scheme 2.2). Additional DIMPI added to the solution does not change the UV-Vis spectral 
features. Based on these observations, we postulate that two DIMPI molecules are bound 
to the FeII center, as also confirmed by integration of peaks in the 1H-NMR spectrum of 
[(F8)Fe
II-(DIMPI)2]. Similar UV-Vis spectral features were observed for a structurally 




39 The reactivity of DIMPI with reduced synthetic hemes is similar 
to that in general and previously observed for carbon monoxide (CO) as the heme 
ligand.37,40 Complex (1)-DIMPI was further characterized by FT-IR spectroscopy where a 
single ν(C≡N) stretch is observed at 2124 cm
‒1 (vide infra, Figure 2.4, Table 2.1), as would 
be expected for this highly symmetric compound, even with the presence of two DIMPI 
ligands per molecule. Also, the 19F-NMR spectrum of (1)-DIMPI shows one sharp 




Figure 2.3 UV-Vis spectroscopic data for the ferrous DIMPI and NO complexes of (1), 
(2), (3), and (4) in THF at room temperature. Black-reduced FeII species; Red-FeII-DIMPI 





Figure 2.4 Solid state FT-IR spectra for FeII-DIMPI complexes of (1), (2), (3), and (4).   
 





ν(C≡N) / ν(N–O) 























[(PPy)FeII-NO] 417 1648 2.08/2.00/1.97 
[(PIm)FeII-NO] 423 1650 2.07/2.00/1.97 
[(PImH)FeII-NO] 425 1650 2.07/1.99/1.95 
 
 
2.2.1.2 Generation of six-coordinate (PPy/PIm/PImH) iron(II)-DIMPI complexes 
 
[(PPy)FeII] and [(PIm)FeII] in THF solution at RT exhibit different structures in this 
solvent, as previously deduced by observation of the positions of NMR spectroscopic 
pyrrole resonances. [(PPy)FeII] and [(PIm)FeII] are both five-coordinate high-spin, the 
former at all temperatures between RT and ‒90 °C. However, at low temperature [(PIm)FeII] 
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is six-coordinate low-spin (S = 0), with the pyrrole resonances appearing in the diamagnetic 
region, indicating that both the imidazolyl group and a THF solvent molecule act as axial 
ligands.37 The new complex [(PImH)FeII] behaves similarly, at room temperature it is 5-
coordinate high spin where the tethered imidazolyl is axially bound to the FeII center. This 
results in an asymmetry and four different pyrrole resonances appear in a ratio of 4 (δppm 
57.0) :2 (δppm 49.0) :1 (δppm 19.0, 15.7):1 (δppm 8.30), see Figure 2.5. By contrast, at lower 
temperatures [(PImH)FeII] forms a six-coordinate low spin (S = 0) species, again postulated 
to have both a THF and imidazole bound to the FeII center, as δpyrrole = 9.80 ppm, Figure 




Figure 2.5 (top) 2H-NMR spectra of heme FeII complex d8-[(P
ImH)FeII] in THF (δpyrrole = 
57.0, 49.0, 19.0, 15.7, 8.30 ppm) at 293 K, (ratio of pyrrole-H is 1:1:2:4). (bottom) 2H-
NMR spectra of heme iron(II) complex d8-[(P
ImH)FeII] in THF (δpyrrole = 9.80 ppm) at 183 
K. See main text for detail. (*) corresponds to solvent molecule THF. 
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Addition of one equivalent of DIMPI solution to each of the reduced FeII 
porphyrinates ([(PPy)FeII], [(PIm)FeII] and [(PImH)FeII]) in THF at room temperature leads 
to a substantial change in the UV-Vis Soret region, with the formation of a band at 430 nm 
in all three cases. Additional equivalents of DIMPI do not yield any change in the UV-Vis 
spectra (Figure 2.3, Scheme 2.3). This may indicate that only one DIMPI molecule is bound 
to the iron(II) center axially while the covalently linked axial base imidazole/pyridine is 
coordinated to the FeII center giving an overall six-coordinate low-spin ferrous-DIMPI 
complex. These conclusions are borne out by the X-ray structures determined for 
complexes (3)-DIMPI and (4)-DIMPI (see below, Figure 2.6).  
We have also carried out experiments to determine binding constants of DIMPI 
with the ferrous hemes with covalently attached axial ligand bases. Titrations with DIMPI 
were performed using (PPy)FeII (2), (PIm)FeII (3) and (PImH)FeII (4), and isosbestic behavior 
was seen for all the titrations (Figure 2.7). A plot of the absorbance at 430 nm versus 
[DIMPI] (Figure 2.7) reaches a maximum at ∼1 equiv of DIMPI, and no further spectral 
changes are observed with the addition of more DIMPI. Assuming that DIMPI reversibly 
binds to the ferrous heme complexes (PPy)FeII (2), (PIm)FeII (3) and (PImH)FeII (4) under 
equilibrium conditions, a good fit of the data can be obtained with a model for a one-to-
one binding isotherm. This fit gives association constants (Ka) of 2.29 × 10
7 M−1, 1.19 × 
107 M−1, and 1.29 × 107 M−1, for (2), (3), and (4), respectively. These values are comparable 
to those measured for DIMPI binding to hemoglobin (Hb) and myoglobin (Mb) [Ka = 1.0 
× 108 M-1]. The binding constant for complex (2)-DIMPI is 2-fold greater than (3)-DIMPI 
and (4)-DIMPI, which is consistent with a less strong binding of the pyridine axial base in 





Figure 2.6 Displacement ellipsoid plots (50% probability level) of [(PIm)FeII-(DIMPI)] 
(left; 3-DIMPI) and [(PImH)FeII-(DIMPI)] (right; 4-DIMPI), in both cases showing the 
imidazolyl and 2,6-dimethylphenyl isocyanide ligands bound to Fe(II) center. Lattice 
solvent molecules and H atoms have been omitted for the sake of clarity. Selected bond 





Figure 2.7 Binding isotherm at 430 nm resulting from the reaction of (a) (PPy)FeII (12 μM 
in 2.5 mL Tetrahydrofuran, THF, black) and DIMPI (red, (PPy)FeII-DIMPI). Ka = 2.29 x 
107 M‒1; (b) (PIm)FeII (12 μM in 2.5 mL Tetrahydrofuran, THF, black) and DIMPI (red, 
(PIm)FeII-DIMPI). Ka = 1.19 x 10
7 M‒1; (c) (PImH)FeII (12 μM in 2.5 mL Tetrahydrofuran, 
THF, black) and DIMPI (red, (PImH)FeII-DIMPI). Ka = 1.29 x 10




UV-vis Spectral Titrations for (P)FeII + DIMPI. To a solution of (P)FeII (12 μM, THF; 
P = PPy, PIm, PImH) was added 0.1 – 2.5 equiv of DIMPI in 0.1 equiv increments from a 
stock solution in THF. UV-vis spectrum was taken after each addition of DIMPI, showing 
isosbestic conversion of (P)FeII to (P)FeII-DIMPI. The reaction mixture was allowed to 
equilibrate fully until no further spectral change was observed prior to the next equivalent 
of DIMPI. A plot of the change in absorbance at 430 nm vs DIMPI resulted in the binding 
curve shown in Fig. S9 – S11 and could be well fit by a 1:1 binding model, eq 1–4. Using 
this equation, the best fit of the plot for PPy, PIm and PImH system gives Ka = 2.29 x 10
7 M‒













2.2.2 Crystal structure of Isocyanide Complexes 
In order to understand the similarities and differences in the coordination geometry 
of these FeII-DIMPI complexes, crystal structures of (3)-DIMPI and (4)-DIMPI were 
determined. The structures are depicted in Figure 2.6 and important structural parameters 
are listed in Tables 2.2 and 2.3. In both structures, the geometry around the iron is 
octahedral, where the 5th ligand is the covalently linked imidazole (or pyridine), while the 
6th ligand is the isocyanide (DIMPI). The metal center lies in the porphyrinate plane. The 
observed bond distances and angles for both indicate very little strain within the linker arm. 
A slight perturbation from the expected linear Fe–C–N bond angle is seen for complex (3)-
DIMPI, with a Fe–C–N value of 173.8(4). This is notably less linear when compared 
with (4)-DIMPI where, Fe–C–N, 179.3(3) is nearly linear. This difference could arise 
due to crystal packing effects. The Fe–C(DIMPI) bond distances are ca. 1.82 Å for both 
(3)-DIMPI, and (4)-DIMPI. The Fe–N(imidazole) bond distances are ca. 2.02 Å, while the 
average Fe–N(porphyrin) bond distances are 1.99 Å, similar to our previously reported 
[(F8)Fe
II]•2THF complex.42 Both structures are well ordered except the difluorophenyl 
group and toluene solvent molecule in complex (4)-DIMPI, see Materials and Methods. 
These appear to be disordered over two orientations and can rotate slightly from 
perpendicularity with respect to the porphyrin plane. Lehnert and co-workers have 
previously published on a crystal structure of the ZnII analogue, a five-coordinate complex 







Table 2.2 Crystallographic data for complex [(PIm)FeII-(DIMPI)] and [(PImH)FeII-(DIMPI)] 
 
Compounds (3)-DIMPI (4)-DIMPI • Toluene 
FormulaWeight (g/mol) 1106.89 1271.13 
T (K) 110(2) 110(2) 
Crystal shape small dark red plate 
(0.11  0.05  0.02 mm3) 
dark red plate  
(0.15  0.08  0.03 mm3) 
Space group triclinic, P-1 (no. 2) monoclinic, P21/c (no. 14) 
a (Å) 12.3852(6) 12.4643(2) 
b (Å) 12.5816(6) 12.3010(2) 
c (Å) 19.3657(12) 39.9319(8) 
α (⁰) 104.424(5) 90 
β (⁰) 95.293(4) 93.9552(18) 
γ (⁰) 111.823(5) 90 
V (Å3) 2655.1(3) 6107.91(19) 
Z 2 4 
Dx (g cm
−3) 1.385 1.382 




(sin /)max (Å−1) 0.60  0.60 
Total, Unique, and 
Observed Reflections 
24276, 9448, 6441 40278, 11998, 8909 
Rint 0.0467 0.0597 
GOF 1.041 1.021 
R1/wR2 [I > 2(I)] 0.0703/0.1902 0.0501/0.1089 
R1/wR2 0.1038/0.2151 0.0760/0.1220 















Table 2.3 Selected bond lengths (Å) and bond angles () for (3)-DIMPI and (4)-DIMPI. 
Proposed H-bonds are also listed 
 
Compound (3)-DIMPI 
Bond length (Å) 
Compound (4)-DIMPI•Toluene 
Bond length (Å) 
Fe – N1 1.998 (4) Fe – N1 1.994 (2) 
Fe – N2 2.000 (3) Fe – N2 1.991 (2) 
Fe – N3 1.990 (4) Fe – N3 1.995 (2) 
Fe – N4 2.001 (3) Fe – N4 1.985 (2) 
Fe – N5 2.034 (4) Fe – N8 2.024 (2) 
Fe – C56 1.824 (4) Fe – C59 1.835 (3) 








Bond angle (⁰) 
N1 – Fe – N5 91.38 (15) N1 – Fe – N8 85.99 (8) 
N2 – Fe – N5 89.77 (15) N2 – Fe – N8 89.90 (9) 
N3 – Fe – N5 88.85 (15) N3 – Fe – N8 91.10 (8) 
N4 – Fe – N5 88.58 (14) N4 – Fe – N8 89.03 (9) 
N5 – Fe – C56 176.03 (16) N8 – Fe – C59 177.61 (9) 








Bond Angles (⁰) 
F1…H64methyl (C64) 2.731/ (133.93) F1
…H35py (C35) 3.089/ (129.88) 
F2…H7pyrrole (C7)  3.490 / (95.04) F1
…H40imid (C40) 2.914 / (135.45) 
F3…H8pyrrole (C8) 
F4…H39imid (C39) 
F5…H2pyrrole (C2)         
2.966 / (95.57) 
3.117 / (153.44) 




3.148 / (146.75) 
3.163 / (91.25) 
2.883 / (101.78) 
F6…H41imid (C41) 2.991/ (166.53) F5
…H17pyrrole (C17) 2.903 / (100.89) 
  F6…H66methyl(C66) 
N9H…N7pyridine 
2.539 / (176.34) 
1.986/ (173.74) 
 
Other potentially important (from a structural perspective) observations obtained 
from the crystal structures of both complexes are that weak but noticeable intramolecular 
CH…F interactions occur, as shown in Figure 2.8 and listed in Table 2.3. The observed 
range of C–H…F interactions for our new structures lie between 2.73–3.08 Å, which is 
greater than the sum of reported Van der Waals radii for hydrogen and fluorine 
(approximately 2.3–2.5 Å). Based on reported structural observations and DFT 
calculations,44 the very strong H-bonding ability of fluorine gives rise to such C–H…F 
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interactions which vary between ~ 2.7 to 3.1 Å , similar to what is observed for (3)-DIMPI, 
and (4)-DIMPI. Such literature examples of organic compounds with longer distance H…F 
interactions occur even where the CH…F angle lies in the range between 130 and 145 
and even in some cases it is close to 100.44 Further comparisons may be made to examples 
of non-bonded CH…O contacts made between an O-atom in an FeIV-oxo complex with 
surrounding ligand methyl group H-atoms; there, short CH…O distances are observed (2.3 





Figure 2.8 Crystal structures showing weak intramolecular CH…F interaction identified 










With these precedents in mind, we postulate that in the solid state structure of (3)-
DIMPI, a CH…F interaction occurs between the methyl group on the DIMPI ligand (H64C) 
and F1 from the proximate o-F aryl porphyrinate substituent, see the green line in the 
middle top of the (3)-DIMPI structure in Figure 2.8-left, and Figure 2.9(a); here the CH…F 
distance and angle are 2.73 Å and 134°, respectively (Table 2.3). A far closer to linear 
interaction occurs between F6 and H41 from the ligated imidazolyl group with a bond 
distance and angle of 2.99 Å and 167°, respectively (Table 2.3 and Figure 2.8, bottom right). 
Notice F6 and F5, on the same porphyrinate aryl group both H-bond, the latter to the pyrrole 
hydrogen atom (H2), this F5…H2C interaction is likely synergistic with F6…H41 
interaction. Envisioning the iron atom as a kind-of pseudo center of symmetry, the F3 and 
F4 atoms on the left-hand o-F2-phenyl ring forms two H-bonds, between F3
…H8pyrrole (C8) 
and F4…H39imid (C39) (Table 2.3). The overall result is that the H-bonding interactions 
formed by the four F-atoms just described fixes the orientation of the imidazolyl axial 
ligand, which is already close to perpendicular to the porphyrinate plane, to be nearly 
coplanar with both of the aryl rings containing these F3, F4, F5 and F6 atoms {Notice how 
in viewing the structure of (3)-DIMPI (Figure 2.8, Left) that these two aryl rings and the 
imidazolyl ring seem to lie in the plane of the sheet.} This imidazole orientation could also 
lead to a close interaction of F2…H7pyrrole (C7) in the solution state (see 
19F-NMR 
spectroscopy, below), whereas in solid state structure this distance seems too long for this 




Figure 2.9 Crystal structure of (a) (3)-DIMPI and (b) (4)-DIMPI showing weak 
intramolecular CH…F interactions identified by the dotted green lines. See main text for 
detailed discussion. 
 
Similarly, for (4)-DIMPI we observe close to linear CH…F interaction between a 
methyl group H-atom on the DIMPI ligand (H66) and F6 from the o-F porphyrinate aryl 
substituent, shown by the green dotted line on the lower left side of Figure 2.8-Right; here 
the CH…F distance and angle are 2.54 Å and 176°, respectively (Table 2.3 and Figure 2.8-
right, also see Figure 2.9(b). The other methyl group on the DIMPI ligand likewise forms 
an H-bond, with the F2 atom on the aryl group to the lower right side of (4)-DIMPI, as 
shown in Figure 2.8, Right. To the left side (Figure 2.8, Right), the F5 atom, that on the 
same ring as F6, is involved in H-bonding to a pyrrole H-atom (H17) (Table 2.3). For F1, 
on the right hand aryl group, we postulate that multiple H…F interactions occur, to H40 
from the ligated imidazolyl group as well as H35 from the dangling free pyridyl group, see 
the green lines to the upper right of the (4)-DIMPI structure in Figure 2.8-Right; here the 
CH…F distances and angles are 2.91 Å and 135° (F1…H40), and 3.08 Å and 130° (F1…H35), 
respectively. Tilting of the o-F2-aryl group containing F3 and F4, allows for two H-bonds 
to form to pyrrole H-atoms (Table 2.3). Thus, all six fluorine atoms in (4)-DIMPI may 
participate in H-bonding. In part, we postulate that these solid-state interactions persist in 
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solution, as indicated by 19F-NMR spectroscopy where almost all of the fluorine resonances 
exist as doublets due to H-atom coupling, as described below. 
Another H-bond observed in this X-ray structure of (4)-DIMPI is a very strong one, 
between the H-atom on the uncoordinated N-atom of the imidazolyl group, to the N-atom 
of the dangling pyridine (Figure 2.8-Right). Here, the N9H…N7pyridine angle is near linear 
(173.7 °) with a N9H…N7 distance of 1.986 Å (and where N9…N7 = 2.863 Å) (Table 2.3). 
Complexes (2)-DIMPI, (3)-DIMPI and (4)-DIMPI were also characterized by FT-
IR spectroscopy (Figure 2.4, Table 2.1). The IR spectrum for (1)-DIMPI shows a single 
sharp ν(C≡N) band (2124 cm
-1), corresponding to the absorption for both isonitrile ligands in 
[(F8)Fe
II-(DIMPI)2], which is shifted 4 cm
‒1 higher in energy relative to the stretching 
frequency of the uncomplexed ligand. The shift to higher energy is relatively small and 
could be attributed to a ligand (σNC) to metal (dσ) interaction, consistent with the expected 
behavior for an isonitrile ligand acting as a σ-donor to a metal center. [(TPP)FeII-
(tBuNC)2],
39 as mentioned above, was structurally characterized but no IR data were given.  
On the other hand, for all three porphyrin FeII-DIMPI complexes with covalently 
attached axial bases (pyridine/imidazole/histamine moieties), we observe a shift in the C≡N 
bond stretch of the isonitrile ligand to lower energy with respect to the uncomplexed ligand. 
The ν(C≡N) band for (2)-DIMPI is 2104 cm
‒1, 16 cm‒1 lower in energy compared to that of 
free DIMPI, and also 20 cm‒1 lower in energy with respect to (1)-DIMPI. For (3)-DIMPI, 
the value of ν(C≡N) is 2098 cm
‒1, which is 23 cm‒1 lower in energy with free ligand. In (4)-
DIMPI [ν(C≡N) band (2112 cm
‒1)], we again observe a lower energy C≡N bond stretch 
compared to free DIMPI, but only by a small amount (ν(C≡N) = ‒8 cm
‒1). The shift to lower 
energy in all these cases could be due to the presence of a more strongly donating axial 
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base trans to the isonitrile ligand. This will most likely decrease the σ-donation to the FeII 
from the isocyanide ligand, while increasing backbonding to the ligand C≡N * orbitals 
from the FeII d orbitals.  
Diamagnetic 1H-NMR spectra were observed for all FeII-DIMPI (S=0, d6) 
complexes. The pyrrole hydrogens of the FeII-DIMPI porphyrinates resonate between 8.5‒
9.5 ppm compared with the starting reduced high-spin five-coordinated paramagnetic FeII 
(d6) species ranging in δpyrrole = 12 to 58 ppm.
37 We also observed a singlet δ 2.65 ppm for 
the DIMPI o-methyl protons and a multiplet for the aromatic protons of bound DIMPI at δ 
7.2‒7.5 ppm, both sets of peaks are slightly shifted downfield from what is observed for 
free DIMPI. 
In the 19F-NMR for bis-isocyanide complex, [(F8)Fe
II-(DIMPI)2] / (1)-DIMPI, we 
observe one sharp singlet peak at ‒109.0 ppm, as shown in Figure 2.10. Therefore, unlike 
what we have suggested (and described above) for what is observed in the X-ray crystal 
structures for the supers-structured hemes ((3)-DIMPI, and (4)-DIMPI), there are no 
observed F-atom interactions or coupling to porphyrin or isocyanide H atoms.  
 
Figure 2.10 19F-NMR of (1)-DIMPI (top), (3)-DIMPI (middle) and (4)-DIMPI (bottom) 
complexes in THF at room temperature.  
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On the other hand, we observed CH…F coupling for, (3)-DIMPI and (4)-DIMPI, 
(Figure 2.10) with peaks for the ortho F-atom resonances on the porphyrinate aryl groups 
occurring between ‒110 to ‒112 ppm.41 In the case of (3)-DIMPI, doublet peaks, proposed 
to be due to 19F resonances coupled to a S = ½ H-atom, are observed at ‒111.7 and ‒111.0 
ppm and both of these appear to integrate to two F-atoms. Our suggested assignments are 
as follows: (a) One of the two upfield (more negative delta value) doublets corresponds to 
F4 and F6 coupling to imidazole H-atoms H39 and H41, which spatially line up rather well, 
see Table 2.3, Figure 2.8. (b) The other upfield doublet represents 2 o-fluorine H-bonds 
with pyrrole H-atoms, possibly F3 and F5 with pyrrole H-atoms H8 and H2, and these also 
seem to be in very closely matching chemical environments. (c) One of the two absorptions, 
‒110.8 or ‒110.6 corresponds to a single o-fluorine atom (F2) also coupling to a pyrrole 
CH7 atom, but by symmetry this is in a different chemical environment then for the 
interactions discussed just above for F5 and F3. (d) Then, the other upfield absorption is a 
unique interaction of F1 with the DIMPI methyl group H-atoms (CH64…F1).   
Similarly, for (4)-DIMPI we observe four ortho F-atom resonances, three doublets 
and one multiplet in 19F-NMR spectroscopy, Figure 2.10. The peaks at ‒111.6 and ‒110.8 
ppm both integrate to two fluorine atoms, which we propose are due to (a) fluorine atom 
F6 and F2 coupling with the DIMPI methyl H-atoms H66A and H67C, see Table 2.3, 
Figure 2.8, (b) while the other generally upfield doublet represents two fluorine atom being 
in same chemical environments due to the coupling of F-atoms F3 and F4 from the same 
porphyrinate phenyl ring, forming H-bonds with the pyrrole H atoms H8 and H12. If (or 
probably when) the aryl ring with F3 and F4 tilts the other way, then symmetry related 
switching of H-bonding to pyrrole H-atoms may (or probably does) occur, but the result is 
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the same type of CH…F H-bonding. Further, the doublet resonance at ‒110.5 ppm should 
correspond to F5 coupling to the pyrrole H-atom H17. This leaves the multiplet peak at ‒
110.9 ppm which likely arises due to the H-bonding interaction and magnetic coupling of 
F1 to two H-atoms, the imidazole H-atom H40 and the dangling pyridine H-atom H35, see 
Table 2.3 and Figure 2.8. During the dynamic behavior expected in solution, the dangling 
pyridyl ring may break its H35…F1 interaction, and twist over to the other side (to the left 
in Figure 2.8-Right), as the imidazole bound to Fe also twists in order to maintain the very 
strong imidazole N-H to pyridine nitrogen hydrogen bond); the pyridyl H35 would now H-
bond to F5 (instead of F1); further, F5 may then gain an H-bond to H40.  All of these 
motions would leave the 19F-NMR shifts and couplings unchanged.  
As mentioned, for (1)-DIMPI, we do not observe any DIMPI ligand H-atom 
coupling to F-atoms of the F8 heme.  Also, we do not observe any such couplings for the 
compound (THF)(F8)Fe
II-CO (unpublished observation). We suggest that when there is a 
tethered axial ligand such as in PIm or PImH, there are constraints in the movement or rotation 
of the axial ligand, which thereby allow for these weaker imidazole-H…F interactions to 
be observed. Further studies may be warranted. 
 
 
2.2.3 Stable Heme–Fe–Nitrosyl formation 
 
In this study, we have also investigated the reactivity of [(F8)Fe
II], [(PPy)FeII], 
[(PIm)FeII], and the newly synthesized [(PImH)FeII] towards nitric oxide (NO). All iron (II) 
complexes form a NO-adduct at room temperature by bubbling NO(g) through the solution 
of each of the reduced iron complexes, as shown in Scheme 2.4. We have systematically 
characterized FeII–NO complexes by using UV-Vis, FT-IR, 1H-NMR, 19F-NMR 
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spectroscopy and low temperature EPR spectroscopy, to access the binding properties of 
our covalently tethered N-donor ligands. 
In-depth studies have been done by Lehnert and coworkers8,43 using synthetic heme 
porphyrins with tethered N-donor ligands which indicate a direct correlation between the 
coordination geometry of the iron center and the observed spectroscopic properties 
obtained from UV-Vis, IR, and EPR. For five-coordinate (5C) heme nitrosyls, the Soret 
band (UV-Vis) is typically about 405 nm, whereas in six-coordinate (6C) porphyrinoids, 
where the proximal ligand (N-donor) is bound to the Fe center, the Soret λmax shifts to 
~426 nm. Similarly, in IR spectroscopy, 5C and 6C ferrous-heme mononitrosyl species 
have distinct N–O stretching modes. For 5C complexes, the N–O stretch typically lies 
between 1675 and 1700 cm−1, whereas for 6C complexes, the N–O stretch occurs at ~1630 
cm−1. Low temperature EPR spectroscopy studies conducted by several authors reveal 
interesting differences between the 5C and 6C iron(II) porphyrin NO adducts.47 Hyperfine 
lines resulting from the bound nitrogen of NO are observed at the lowest g value (g min) 
in 5C ferrous-heme nitrosyls. The coordination of the proximal nitrogen atom in 6C 
ferrous-heme nitrosyls causes a broadening in the EPR spectrum at g-mid resulting from 
the hyperfine lines of the bound NO and the trans-N donor ligand. Based on spectroscopic 
data available from the literature, our [(F8)Fe
II-NO] complex forms a typical 5C ferrous-
heme mono-nitrosyl complex with a Soret band λmax at 408 nm in the UV-vis region at 
room temperature (Figure 2.3), along with a characteristic N–O stretching band ν(N–O) at 
1680 cm−1 in its IR spectrum.48,49 Additional evidence for the 5C nitrosyl complex can be 
seen in its EPR spectrum, which displays g values at 2.09, 2.02, and 1.99, with three 
45 
 
hyperfine splittings at g(min) (Figure 2.11).48,49 In the 19F-NMR, a broad o-phenyl fluorine 
signal is observed at −106.0 ppm. 
 
Scheme 2.4 Six coordinate ferrous heme mono nitrosyl complexes of (PPy)FeII, (PIm)FeII 







Figure 2.11 X-band EPR at 8 K in THF for ferrous heme-NO complexes. [(F8)Fe
II-NO] 
(Red, 5C species), while (2), (3), and (4) form 6C species. [(PPy)FeII-NO] (Orange, 6C), 
[(PIm)FeII-NO] (Green, 6C) and [(PImH)FeII-NO] (Blue, 6C). These spectra were analyzed 
further using an EPR simulation computer program, and the results of those fits, giving g-




Figure 2.12 X-band EPR spectroscopy of ferrous heme-NO complexes recorded at 8K in 
frozen THF (red) and fit of the spectrum using the program Easy Spin (blue). Fit 
parameters:  
(a) (1)–NO (g1 = 2.0918, g2 = 2.0074, g3 = 2.0052; N hyperfine: 
NOA1 = 48.78, 
NOA2 = 
67.63, NOA3 = 35.68) 
(b) (2)–NO (g1 = 2.0746, g2 = 2.0081, g3 = 1.9904; N hyperfine: 
NOA1 = 4.0, 
NOA2 = 60.4, 
NOA3 = 35.8; 
PyA1 = 18.1, 
PyA2 = 20.1, 
PyA3 = 19.1) 
(c) (3)–NO (g1 = 2.0686, g2 = 2.002, g3 = 1.9662; N hyperfine: 
NOA1 = 44.10, 
NOA2 = 63.18, 
NOA3 = 47.45; 
ImA1 = 22.94, 
ImA2 = 1.29, 
ImA3 = 16.84) 
(d) (4)–NO (g1 = 2.0690, g2 = 2.0050, g3 = 1.9643; N hyperfine: 
NOA1 = 14.68, 
NOA2 = 
23.97, NOA3 = 71.75; 
ImHA1 = 2.0, 
ImHA2 = 4.3, 
ImHA3 = 10.2)   
 
In the case of [(PPy)FeII-NO], the Soret band absorption is observed at 417 nm 
(Figure 2.3), which lies in between that known for 5C and 6C iron-nitrosyl complexes. This 
indicates that in solution at room temperature, the proximal pyridine is weakly bound to 
the iron center to give 6C species. Further evidence comes from the low temperature EPR 
spectrum of [(PPy)FeII-NO], shown in Figure 2.11, Figure 2.12 and Table 2.1, which clearly 
resembles the spectra of other 6C low-spin heme-Fe(II)-nitrosyl complexes;43 lowering the 
temperature allows for stronger binding of the pyridyl group, as would be expected. The 
spectrum shows small, unresolved hyperfine splitting at g(mid) due to the presence of the 
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proximal pyridine ligand (g = 2.07, 2.01, 1.98).  The lack of UV-Vis spectral features at 
400, and 470 nm, as well as EPR data for [(PPy)FeII-NO] confirms that in solution it forms 
a 6C species, but where the pyridyl group is weakly bound to the iron center at room 
temperature.  
On the other hand complexes [(PIm)FeII-NO] and [(PImH)FeII-NO] form very stable 
6C iron(II) nitrosyl species. In the UV-vis region, the observed Soret bands shift to 423 nm 
for (3)-NO, and 425 nm for (4)-NO (Figure 2.3) which match very well with reported 6C 
iron(II) nitrosyl complexes.43 To further investigate the strength of the proximal (imidazole) 
ligand binding to the iron center in (3)-NO and (4)-NO, the EPR spectra of both complexes 
were recorded. The observed g values are 2.07, 2.00, and 1.97 for (3)-NO and 2.06, 1.99 
and 1.96 for (4)-NO (Figure 2.11, Figure 2.12, Table 2.1). For both species, the hyperfine 
pattern is on g(mid) and the hyperfine lines are not well resolved. Also, the stretching 
frequency, ν(N–O) for complexes (3)-NO and (4)-NO are the same, at 1650 cm
‒1. This lower 
stretching frequency is due to the binding of the N-donor ligand (Imidazole) trans to the 
NO, which weakens the Fe–NO σ-bond.50 Interestingly, these frequencies are higher in 
energy compared to a similar ferrous heme nitrosyl with a free axial base, [Fe(To-
F2PP)(MI)(NO)] (MI = methylimidazole; ν(N–O) = 1624 cm
‒1). The trend observed is in line 
with a previous study by Scheidt,14 further suggesting that the tethered axial ligand bases 
bind to the heme more weakly that would or does a freely added (or present) base. The IR 
data matches closely with reported work by Lehnert and co-workers43 and indicates that 
the benzyl-imidazole linker and the histamine linker impede the binding of the proximal 
N-donor ligand when compared to the free base, but still allow for the formation of very 




Figure 2.13 19F-NMR of (1)-NO (top), (3)-NO (middle) and (4)-NO (bottom) complexes 
in THF at room temperature. 
 
In 1H-NMR, the pyrrole hydrogen atoms resonate at 8.8 and 9.65 ppm for (3)-NO 
and (4)-NO, respectively. While in 19F-NMR, the o-fluorine atoms resonate at ‒106, ‒107, 
‒110 ppm for (3)-NO, and ‒105, ‒108 ppm, for (4)-NO, as seen in Figure 2.13. Here peaks 
are very broad compared with all the FeII-DIMPI complexes, where peaks were very sharp, 
and displayed visible H‒F coupling interactions. 
 
2.3 Conclusions 
we have described the synthesis of a new porphyrin with a covalently tethered 
histamine type ligand, which binds to the iron center. These new ferric [(PImH)FeIII-Cl] and 
ferrous [(PImH)FeII] hemes have been thoroughly characterized by various spectroscopic 
methods. Using this newly designed heme and a family of other covalently tethered axial 
ligands (pyridine/imidazole) synthesized in our lab, we have explored their reactivity 
towards 2,6-dimethylphenyl isocyanide (DIMPI), and nitric oxide (NO). Towards this aim, 
we have generated and characterized the six coordinate ferrous heme complexes; 
[(PPy)FeII(DIMPI)], [(PIm)FeII(DIMPI)] and [(PImH)FeII(DIMPI)], which have UV-Vis, IR, 
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and EPR properties that are clearly distinguishable from those of [(F8)Fe
II(DIMPI)2]. The 
X-ray structures reveal a significant contribution from H-bonding between porphyrinate 
meso-phenyl ortho-fluorine atoms, and these have been described. These are emphasized 
in large part because 19F-NMR spectroscopy clearly indicates that most if not all of these 
interactions are maintained in solution. We have also characterized several ferrous heme 
mono-nitrosyl complexes by multinuclear NMR, UV-Vis, EPR and solid FT-IR 
spectroscopy. At room temperature, [(PIm)FeII] and [(PImH)FeII] form very stable six-
coordinate ferrous iron-NO complexes. [(F8)Fe
II] forms a five-coordinate ferrous heme 
nitrosyl complex, while [(PPy)FeII] appears to be somewhere between 5-coordinate, and 6-
coordinate due to its weakly binding axial pyridyl ligand.  
As mentioned, the impetus for synthesizing ferrous heme porphyrinates using the 
(PPy), (PIm) and (PImH) ligand systems is to utilize these porphyrins in our ongoing research 
into modeling the active site chemistry of cytochrome c oxidase. An understanding of the 
nature of reactions and structures, i.e., coordination numbers, ligation preferences (e.g., 
pyridyl vs imidazolyl vs solvent THF), and other bonding or structural aspects can help to 
better understand the types of structures obtained in heme-O2-copper chemistry, and also 
inform the design of hemes utilized for such studies. 
 
2.4 Experimental section 
2.4.1 Materials and methods 
All chemicals and solvents were purchased as commercially available analytical 
grade unless otherwise specified. Tetrahydrofuran (THF, inhibitor free) was dried over 
sodium/benzophenone ketyl, and purified by distillation under argon. Pentane was dried 
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by distillation over calcium hydride. Toluene was used after passing through a 60 cm long 
column of activated alumina (Innovative Technologies), under argon. 2,6-Dimethylphenyl 
isocyanide (DIMPI) was purchased from Sigma Aldrich. •NO gas was obtained from 
Matheson Gases and purified following methods previously described in the literature.51 A 
three-way syringe was used for the addition of •NO gas to all metal complex solutions. 
Preparation and handling of air-sensitive compounds were performed under an argon 
atmosphere using standard Schlenk techniques or in an MBraun Labmaster 130 inert 
atmosphere (less than 1 ppm O2, less than 1 ppm H2O) drybox filled with nitrogen. 
Deoxygenation of all solvents was accomplished by either repeated freeze/pump/thaw 
cycles or bubbling with argon for 45–60 min.  
Instrumentation: Benchtop UV-Vis measurements were carried out by using a 
Hewlett Packard 8453 diode array spectrophotometer equipped with HP Chemstation 
software and a Unisoku thermostated cell holder for low temperature experiments. A 10 
mm path length quartz cell cuvette modified with an extended glass neck with a female 
14/19 joint, and stopcock was used to perform all UV-Vis experiments. ESI-MS were 
acquired using a Finnigan LCQ Duo ion-trap mass spectrometer equipped with an 
electrospray ionization source (Thermo Finnigan, San Jose, CA). The heated capillary 
temperature was 250 ⁰C and the spray voltage was 5 keV. Spectra were recorded 
continuously after injection. Infrared (IR) spectra were obtained on solid samples using a 
Thermo Scientific Nicolet Nexus 670 Fourier transform IR (FT-IR) spectrophotometer 
with ATR attachment. 1H-NMR and 19F-NMR spectra were acquired using a Bruker 300-
MHz NMR spectrometer. Chemical shifts were reported as δ (ppm) values relative to an 
internal standard (tetramethylsilane) and the residual solvent proton peak. Electron 
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paramagnetic resonance (EPR) spectra were recorded with a Bruker EMX spectrometer 
equipped with a Bruker ER 041 X G microwave bridge and a continuous-flow liquid 
helium cryostat (ESR900) coupled to an Oxford Instruments TC503 temperature controller. 
Spectra were obtained at 8 K under nonsaturating microwave power conditions (ν = 9.428 
GHz, microwave power = 0.201 mW, modulation amplitude = 10 G, microwave frequency 
= 100 kHz, receiver gain = 5.02 × 103). EPR spectra were simulated by using the Easy Spin 
(see Figure 2.12). The compounds (F8)Fe
II (1),35,52,53 (PPy)FeII (2)37,38 and (PIm)FeII (3)37,54 
were synthesized as previously described. 
 
2.4.2 Synthesis of (PImH)FeII (4) 
The synthesis of complex (PImH)FeII (4) involves multiple steps as shown in Scheme 
2.1, where F6(NHCOCH2CH2Br)TPPH2
55 and LN3Tr56 were synthesized as previously 
described. 
 
2.4.2.1 Synthesis of PImTr ligand 
To a 50 mL round bottom flask containing 1.8 g (2.0 mmol) of 
F6(NHC(O)CH2CH2Br)TPPH2 and 0.7 mL of diisopropylethyl amine was added to 1.7 g 
(4 mmol) of LN3Tr in 15 mL of THF. The resulting mixture was heated to reflux overnight. 
After cooling to room temperature, the solvent was removed under vacuum. The solid 
residue was re-dissolved in dichloromethane and washed several times with distilled water, 
from which the organic layer was dried over anhydrous sodium sulfate. Column 
chromatography of the crude material on alumina (ethyl acetate : hexane = 97:3, Rf = 0.4) 
yielded 2.3 g (1.9 mmol, 65 %) of the desired product as a purple solid. ESI-MS (m/z): 
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1236.11 (M + H)+ (Figure 2.14); 1H-NMR (CD3CN, 300 MHz; δ, ppm, RT): 8.88-8.78 (m, 
8H, pyrrole-H), 8.73 (s, 1H, pyridine-H), 8.29 (d, 1H, pyridine-H), 8.02 (d, 1H, pyridine-
H), 7.91-7.73 (m, 4H, Ar-H, pyridine-H), 7.47-7.19 (m, 20H, Ar-H, Tr-H), 6.94-6.92 (m, 
6H, Ar-H), 6.87 (s, 1H, Imidazole-H), 6.04 (s, 1H, Imidazole-H), 1.68 (t, 2H, (-CH2-)), 
1.49 (t, 2H, (-CH2-)), 1.32 (t, 2H, (-CH2-)), 1.20 (t, 2H, (-CH2-)), 1.04 (s, 2H, (-CH2-)py), -
2.87 (s, 2H, NHpyrrole) (Figure 2.15). 
 
 
Figure 2.14 ESI-MS of the porphyrin ligand PImTr, corresponding to M+H+ and M+Na+ 
(1258.35) in CH2Cl2 at 293 K. 
 
 
Figure 2.15 1H-NMR spectra of covalently linked histamine containing porphyrin PImTr in 
CD3CN at 293 K. (*) corresponds to solvent molecules, residual NMR solvent CH3CN and 
ethyl acetate (used as an eluent for column chromatography. 
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2.4.2.2 Synthesis of PImTr-d8 ligand 
The pyrrole deuterated porphyrin ligand PImTr-d8 was prepared using a procedure 
identical to that described above for PImTr, but employing the pyrrole deuterated porphyrin 
F6(NH2)-d8
36 instead of F6(NH2).  
 
2.4.2.3 Synthesis of [(PImH)FeIII-Cl] 
The ligand PImTr (1.3 g, 1.05 mmol) was dissolved in 20 mL THF under an argon 
atmosphere. FeII chloride tetrahydrate (7 g, 55.2 mmol) was added and the solution was 
heated to reflux at 60 ºC under argon for 3 h. After cooling to room temperature, the 
solution was exposed to air and stirred for 3 h. The solvent was removed by rotary 
evaporation and the residue obtained was re-dissolved in 100 mL CH2Cl2 followed by 
filtering the insoluble solid present. The solution was stirred with HCl (1 M, 100 mL) for 
3 h and then neutralized using solid NaHCO3. The organic layer was washed with 100 mL 
saturated NaHCO3 then brine solution and dried over anhydrous MgSO4. The desired 
product was purified by column chromatography (silica, CH2Cl2: MeOH = 95:5, Rf = 0.4). 
Yield: 0.8 g, 72%. UV-Vis spectrum [λmax, nm] in THF: 419, 527, 553 (Figure 2.16). ESI-
MS (m/z): 1047.01 (M–Cl‒)+ (Figure 2.17) 1H-NMR (300 MHz, THF, δ, ppm, RT): 82 (s, 
br, pyrrole-H). EPR spectra (X-band spectrometer, ν = 9.428 GHz): g = 6.0, 1.98 in THF 





Figure 2.16 UV-Vis spectra of heme iron(III) porphyrin, [(PImH)FeIII-Cl] complex in 




Figure 2.17 ESI-MS of [(PImH)FeIII-Cl] in CH2Cl2 at 293 K; the peak at 1047.01 
corresponds to M-Cl‒. 
 
2.4.2.4 Synthesis of [(PImH)FeIII-Cl]-d8 
The pyrrole deuterated heme–FeIII [(PImH)FeIII-Cl]-d8 was prepared using an 
identical procedure to that described above for [(PImH)FeIII-Cl], but employing pyrrole 
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deuterated porphyrin PImTr-d8 instead of P
ImTr. 2H NMR (THF, 300 MHz, δ, ppm, RT): 82 
(s, br, pyrrole-D) and (δ, ppm, ‒90 ⁰C): 126.0 (s, br, pyrrole-D), shown in Figure 2.18. 
 
 
Figure 2.18 (top) 2H-NMR spectra of heme iron(III) complex d8-[(P
ImH)FeIII-Cl] in THF 
(δpyrrole = 82.0 ppm) at 293 K. (bottom) 
2H-NMR spectra of heme iron(III) complex d8-
[(PImH)FeIII-Cl] in THF (δpyrrole = 126 ppm) at 183 K. (*) corresponds to solvent molecule 
THF. 
 
2.4.2.5 Synthesis of (PImH)FeII 
The degassed solution of [(PImH)FeIII-Cl] (500 mg, 0.5 mmol) in 120 mL CH2Cl2 
was added to a degassed 50 mL saturated Na2S2O4 (aq) solution under an argon atmosphere. 
The two solutions were mixed using argon bubbling for 30 min in an additional funnel. 
The reaction mixture was allowed to sit for 20 min until the two layers separated. The 
organic layer was separated and passed through anhydrous Na2SO4 powder loaded in a 
filter tube (one end connecting to the additional funnel and the other end connecting to a 
Schlenk flask) under an argon atmosphere. Then the solvent was removed and dried in 
vacuo for 3 h. The resulting solid was kept in glove box. Yield: 437.1 mg, 93%. UV–Vis 
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spectrum [λmax, nm] in THF: 419, 525, 552. 
19F-NMR (THF-d8, 282 MHz; δ, ppm): ‒109.7, 
‒110.3, ‒111.0, ‒111.6, ‒112.4.  
 
2.4.2.6 Synthesis of (PImH)FeII-d8 
The pyrrole deuterated heme–FeII (PImH)FeII-d8 was prepared using an identical 
procedure to that described above for (PImH)FeII, but employing pyrrole deuterated 
porphyrin [(PImH)FeIII-Cl]-d8 instead of [(P
ImH)FeIII-Cl]. 2H NMR (300 MHz, THF): δ 57.0 
(s, 1H, pyrrole-D), 49.0 (s, 1H, pyrrole-D), 19.0 (s, 1H, pyrrole-D), 15.7 (s, 1H, pyrrole-
D), 8.3 (s, 4H, (pyrrole-D). 2H-NMR (THF, 300 MHz; δ, ppm, ‒90⁰C): 9.80 (Figure 2.5).  
 
2.4.3 Synthesis of DIMPI complex  
2.4.3.1 Synthesis of [(F8)FeII-(DIMPI)2], (1)-DIMPI 
In the drybox, to a solution of (F8)Fe
II (1) (10.0 mg, 0.024 mmol) in THF (5 mL) 
was added 2,6-dimethylphenyl isocyanide (6.3 mg, 0.048 mmol). After stirring the reaction 
mixture for 30 min, the solvent was removed under vacuum to yield a red solid. The crude 
solid obtained was further dissolved in THF and layered with pentane to obtain a very fine 
crystalline material. UV-Vis spectrum [λmax, nm] in THF: 430, 527. 
1H-NMR (THF-d8, 300 
MHz; δ, ppm): 10.45 (pyrrole-H), 2.43 (s, -CH3 (DIMPI)), 7.2 (m, ArH (DIMPI)); 
19F-
NMR (THF-d8, 282 MHz; δ, ppm): ‒109 (d). FT-IR spectrum (solid): νCN = 2124 cm
‒1.  
 
2.4.3.2 Synthesis of [(PPy)FeII-(DIMPI)], (2)-DIMPI 
[(PPy)FeII-(DIMPI)], (2)-DIMPI: In the dry box, to the THF solution of (PPy)FeII, (2) 
(10.0 mg, 0.011 mmol) in a 10 mL Schlenk flask, we added one equivalent of DIMPI (1.5 
57 
 
mg, 0.012 mmol) and the reaction mixture was stirred for half an hour. The solvent was 
removed under vacuum to yield a deep red colored solid, which was further recrystallized 
by dissolving in a minimal amount of THF and layering it with pentane to obtain the fine 
crystalline material. UV-Vis spectrum [λmax, nm] in THF: 430, 534. FT-IR spectrum (solid): 
νCN = 2104 cm
‒1. 
 
2.4.3.3 Synthesis of [(PIm)FeII-(DIMPI)], (3)-DIMPI  
This complex was synthesized in a similar manner to complex (2)-DIMPI. X-ray 
quality crystals were obtained from the solution of MeTHF/pentane. UV-Vis spectrum 
[λmax, nm] in THF: 430, 532. 
1H-NMR (THF-d8, 300 MHz; δ, ppm): 9.1 (pyrrole-H), 7.2 
(m, ArH (DIMPI)), 2.43 (s, -CH3 (DIMPI)); 
19F-NMR (THF-d8, 282 MHz; δ, ppm): ‒110.6 
(d), ‒110.8 (d), ‒111.0 (d), ‒111.7 (d). FT-IR spectrum (solid): νCN = 2098 cm
‒1. 
 
2.4.3.4 Synthesis of [(PImH)FeII-(DIMPI)], (4)-DIMPI 
This complex was also synthesized in a similar manner as the afore-mentioned 
complexes, (2)-DIMPI and (3)-DIMPI. X-ray quality crystals were obtained from a 
solution of Toluene/pentane. UV-Vis spectrum [λmax, nm] in THF: 430, 533. 
1H-NMR 
(THF-d8, 300 MHz; δ, ppm): 9.78 (pyrrole-H), 7.2 (m, ArH (DIMPI)), 2.27 (m, -CH3 
(DIMPI)); 19F-NMR (THF-d8, 282 MHz; δ, ppm): ‒110.55 (d), ‒110.8 (d), ‒110.9 (m), ‒







2.4.4 Synthesis of NO complex  
2.4.4.1 Synthesis of [(F8)FeII-NO], (1)-NO48 
The ferrous mono-nitrosyl complex (1)-NO was generated by bubbling excess NO 
gas through the THF solution of (F8)Fe
II (1) (2 mM) under argon atmosphere at room 
temperature. After the reaction mixture stirred for 2 hours, the solvent was removed under 
vacuum to obtain a dark red solid. A highly pure material was obtained by dissolving red 
solid in the minimum amount of THF and layering it with pentane inside the dry box. UV-
Vis spectrum [λmax, nm] in THF: 408, 547. 
1H-NMR (THF-d8, 300 MHz; δ, ppm): 6.9 (br, 
pyrrole-H); 19F-NMR (THF-d8, 282 MHz; δ, ppm): ‒106 (br). FT-IR spectrum (solid): νNO 
= 1688 cm‒1. EPR spectra (X-band spectrometer, ν = 9.428 GHz): g = 2.09, 2.02, 1.99 
(hyperfine) in THF at 7 K. 
 
2.4.4.2 Synthesis of [(PPy)FeII-NO], (2)-NO46   
A method similar to that used to synthesize complex (1)-NO was used to make 
complex (2)-NO. Excess of NO gas was bubbled through the 2 mM THF solution of 
(PPy)FeII (2). UV-Vis spectrum [λmax, nm] in THF: 417, 543. 
1H-NMR (THF-d8, 300 MHz; 
δ, ppm): 8.0 (pyrrole-H). FT-IR spectrum (solid): νNO = 1648 cm
‒1. EPR spectra (X-band 
spectrometer, ν = 9.428 GHz): g = 2.07, 2.01 (br-hyperfine), 1.98 in THF at 7 K. 
 
2.4.4.3 Synthesis of [(PIm)FeII-NO], (3)-NO46 
This complex was prepared in the same manner as complexes (1)-NO and (2)-NO. 
UV-Vis spectrum [λmax, nm] in THF: 423, 542. 
1H-NMR (THF-d8, 300 MHz; δ, ppm): 8.8 
(pyrrole-H); 19F-NMR (THF-d8, 282 MHz; δ, ppm): ‒106.2 (br), ‒107.9 (br), ‒110.9 (br). 
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FT-IR spectrum (solid): νNO = 1650 cm
‒1. EPR spectra (X-band spectrometer, ν = 9.428 
GHz): g = 2.07, 2.00 (hyperfine), 1.97 in THF at 7 K. 
 
2.4.4.4 Synthesis of [(PImH)FeII-NO], (4)-NO 
Synthesis of this complex was accomplished as mentioned above for the 
preparation of (1)-NO. UV-Vis spectrum [λmax, nm] in THF: 425, 541. 
1H-NMR (THF-d8, 
300 MHz; δ, ppm): 9.65 (pyrrole-H); 19F-NMR (THF-d8, 282 MHz; δ, ppm): ‒104.9 (br), 
‒108.1 (br). FT-IR spectrum (solid): νNO = 1650 cm
‒1. EPR spectra (X-band spectrometer, 
ν = 9.428 GHz): g = 2.06, 1.99 (hyperfine), 1.96 in THF at 7 K. 
 
2.4.5 X-Ray Structure Determination 
X-ray structure determination of (3)-DIMPI and (4)-DIMPI was performed at the 
X-ray diffraction facility at Johns Hopkins University. CIF files have been deposited with 
the Cambridge Crystallographic Data Centre (CCDC). CCDC 1455862 and 1455863 
contain the supplementary crystallographic data for this article. These data can be obtained 
free of charge from the CCDC via http://www.ccdc.cam.ac.uk/data_request/cif.  
All reflection intensities were measured at 110(2) K using a SuperNova diffractometer 
(equipped with Atlas detector) with Cu Kα radiation (λ = 1.54178 Å) under the program 
CrysAlisPro (Version 1.171.36.32 Agilent Technologies, 2013). The program CrysAlisPro 
(Version 1.171.36.32 Agilent Technologies, 2013) was used to refine the cell dimensions 
and for data reduction. The structures were solved with the program SHELXS-2013 
(Sheldrick, 2013) and was refined on F2 with SHELXL-2013 (Sheldrick, 2013). Analytical 
numeric absorption correction based on a multifaceted crystal model was applied using 
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CrysAlisPro (Version 1.171.36.32 Agilent Technologies, 2013). The temperature of the 
data collection was controlled using the system Cryojet (manufactured by Oxford 
Instruments). The H atoms were placed at calculated positions using the instructions AFIX 
23, AFIX 43 or AFIX 137 with isotropic displacement parameters having values 1.2 or 1.5 
times Ueq of the attached C or N atoms. 
Crystals of (3)-DIMPI were obtained from a MeTHF solution of complex and 
layered with pentane, while crystals of (4)-DIMPI were obtained from saturated solution 
of toluene. The structure of (3)-DIMPI is partly disordered. Some unresolved electron 
density − i.e., a very disordered lattice methyl THF solvent molecule − has been taken out 
in the final refinement (SQUEEZE details are provided in the CIF file, Spek, 2009). In 
addition, the imidazole / amide arm may be slightly disordered, but the disorder is not 
significant enough to model it in the final refinement.  The structure (4)-DIMPI is partly 
disordered.  One difluorophenyl group and the lattice toluene solvent molecule are found 
to be disordered over two orientations, and the occupancy factors of the major components 
of the disorder refine to 0.561(16) and 0.722(4), respectively; see the Electronic 
Supplementary Material, i.e., the appropriate CIF file. 
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Heme-copper oxidases (HCOs), the terminal enzyme of the respiratory chain in the 
mitochondrial inner membrane from mammalian and bacterial sources, reduces dioxygen 
to water, coupling the redox energy to membrane proton translocation utilized for ATP 
synthesis.1–10 The enzyme possesses five key redox-active metal ion centers, dicopper 
complex CuA, which is a binuclear electron-transfer center, a low-spin heme a (cytochrome 
a), and the heterobinuclear (Fea3/CuB) active site, where dioxygen binding and reduction 
occurs.1–10 The latter (Scheme 3.1) consists of a high-spin heme and a neighboring (~ 4.5–
5.0 Å) copper ion possessing three histidine imidazole nitrogen ligands, one of which is 
cross-linked to a tyrosine (Tyr) residue biosynthesized via a post-translational 
modification.11–16 With a focus on the heme/Cu active site in varying redox or ligation 
states, structural aspects and the O2-reduction mechanism have been studied extensively, 
utilizing many spectroscopic methods,1–10 X-ray crystallography17,18 and computational 
approaches.19  
The current state of our understanding of early stages in the CcO O2-binding and 
reduction are given in Scheme 3.1. Molecular oxygen reacts with a fully reduced FeII···CuI 
binuclear active site, initially forming a detectable, transient, Fe–O2 (“oxy-heme”) adduct, 
formally a FeIII–(O2˙ˉ) (A) species possessing end-on superoxide binding. This assignment 
is consistent with resonance Raman (rR) spectroscopic properties, as being similar to those 
found in oxy-hemoglobin (νFe−O = 567 cm
−1) and oxy-myoglobin (νFe−O = 570 cm
−1).20,21 
Intermediate A rapidly undergoes O–O cleavage to yield PM.22 A total of four 
electrons are required to fully reductively cleave the  O–O bond of dioxygen. Three 
electrons are provided by the binuclear site (two from iron (FeII → FeIV) and one from CuB 
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(CuI → CuII)). It is now accepted that the fourth electron derives from the phenol residue 
of the nearby His-Tyr cross-link. This phenol residue serves as an overall hydrogen atom 
donor (H•), leaving PM formulated as a FeIV=O/CuII–OH/Tyr• moiety, i.e., thus with a 
ferryl-oxo (Fea3
IV=O; ν(Fe–O) = 804 cm–1), cupric-hydroxide (CuB
II–OH) and  a tyrosyl 
radical (Scheme 3.1).6,8,10 Also, evidence suggests that the His-Tyr cross-link enables 
enzyme CuB incorporation and stabilizes the precise geometry of the binuclear active 
site.11,16 
On the basis of biochemical experiments,23 computational studies24–27 and synthetic 
modeling,5,10 a peroxo-bridged heterobinuclear FeIII–(O2
2–)–CuII (Ip) has been predicted as 
an intermediate species occurring on the pathway from A to PM. This peroxo moiety 
critically precedes O–O bond cleavage via initial H-bonding or protonation,19 possibly 
through a water molecule bridge, as shown in Scheme 3.1. 
 
Scheme 3.1 Proposed O−O Reductive Cleavage Mechanism by Heme-Copper Oxidases 




Design and construction of heme/copper synthetic models provide critical 
information about structure, spectroscopy and reactivity relevant to CcO enzyme 
mechanism, in the usual manner that models contribute to scientific advances, allowing a 
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breakdown and attention to particular aspects of the protein structure/function. With 
respect to dioxygen reactivity, reduced heme-copper assemblies (or components) have 
been shown to generate heme-FeIII-superoxide entities (like intermediate A, Scheme 3.1), 
see complexes from Collman28 and Naruta29 and their co-workers, Figure 3.1. Other studies 
from Naruta30 and our laboratories31,32 have revealed that peroxo-bridged heme-FeIII–
(O2
2–)–CuII(ligand) complexes can be generated possessing three structural types10 (high-
spin (HS) µ-η2:η1-peroxo (C, D),30,31,33 HS µ-η2:η2-peroxo (E)31,32 and low-spin (LS) µ-
1,2-peroxo (F))10,34 (Figure 3.1). Collman’s investigations involving elegant binucleating 
(for Fe and Cu) ligands, demonstrated efficient electrocatalytic four-electron four-proton 
O2-reduction to water (ORR),
35 and stoichiometric studies where a phenol H-atom donor 
could reductively cleave the O–O bond of a heme-O2-Cu construct.
36 We have developed 
similar model systems with simpler compounds, i.e., complex D, (Figure 3.1) which effect 
efficient electrocatalytic ORR chemistry.37,38 
In stoichiometric reactivity studies, detailed synthetic and theoretical/computation 
insights have been obtained concerning elements critical for reductive cleavage of heme-
Cu bound O2 (as peroxide) intermediate. However, many details and fundamental aspects 
have not been elucidated or fully understood. These include the exact structural 
requirements for the Fe–O–O–Cu moiety, tridentate versus tetradentate Cu-chelation, 
factors such as H-bonding to a peroxide O-atoms (which one?) versus actual protonation, 
the origin and pKa of the proton-donor, the timing of electron versus proton injection, and 
so on. Thus far, for heme-Cu–O2 constructs, very small changes in the local (ligand) 
environment may lead to absolutely varying chemistry, and there is a need to understand 
these effects in obtaining fundamental insights.  For example, LS-3DCHIm (F) and LS-
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4DCHIm (G) (Figure 3.1), which differ by only one DCHIm Cu-ligand, behave completely 
differently toward proton-electron sources. The former is completely unreactive, while the 
latter, in the presence of an H-bonding phenol, undergoes clean peroxide O–O reductive 
cleavage to give water.10,19,34,39 
 
 
Figure 3.1 Various complexes of heme/copper synthetic models: superoxide heme-FeIII–
(O2
•‒)···CuI(ligand) complexes, (A, Collman’s group; B, Naruta’s group). Heme-FeIII–
(O2
2–)–CuII(ligand) complexes: X-ray crystal structure of Naruta’s HS µ-η2:η1-peroxo-
bridged complex (C: adapted from ref 26); Karlin group analog (D);  µ-η2:η2-peroxo 
compound (E); LS heme peroxo adducts with a µ-1,2-peroxo structure type, LS-3DCHIm 




From these perspectives, considerable further studies and advancements are needed. 
These include a continued effort to define the dioxygen reactivity of reduced heme-copper 
assemblies, while also if possible, elucidating the heme only and (ligand)-Cu O2-chemistry. 
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For further elaborated/new heme-O2–Cu species, subsequent defining of O–O reductive 
cleavage chemistry is a longer-term goal, in the contexts mentioned above.  
In the present study, we report on an advanced CcO active site model system with 
binucleating ligand PImH; this employs a new tridentate ligand which includes a histamine 
moiety appended to the periphery of a fluorinated tetraphenylporphyrin. The FeII-
porphyrinate complex (PImH)FeII (1), is shown in Chart 3.1.40 Herein, we report the 
oxygenation chemistry of 1, whose chemistry mimics the initial O2 binding in CcO, as well 
as (of course) formation of oxy-hemoglobin and -myoglobin. The generation of a heme-
copper derivative of 1 has been accomplished and oxygenation of the reduced FeII–CuI 
form gives a high-spin heme-peroxo-copper product. Lastly, addition of DCHIm as a heme 
axial ligand to the high-spin solution leads to low-spin complex. All complexes have been 
spectroscopically characterized by UV-vis, 2H-NMR and EPR spectroscopies; for the O2 
derived complexes, vibrational data has been obtained using rR.  
 






3.2 Results and discussion 
3.2.1 Dioxygen reactivity of (PImH)FeII (1) 
Complex 1 reacted with dioxygen to form a low-temperature stable superoxide 
level intermediate, which was characterized by UV-vis, 2H NMR, rR and EPR 
spectroscopies. Bubbling dry O2 through a solution of (P
ImH)FeII (1) {λmax = 419, 526 and 
552(sh) nm} in THF at –80 °C led to new features at 424 and 541 nm which were ascribed 
to a (PImH)FeIII–(O2
•‒) (2), Figure 3.2. Further characterization of the 1/O2 reaction product 
comes from low temperature 2H-NMR spectroscopic investigation, employing a deuterated 
(β-pyrrolic hydrogens) analog of 2 (2-d8) in THF solvent (Figure 3.3). It confirms the 
proposed formation of a myoglobin-like FeIII-superoxide complex. Complex 2 gives rise 
to a diamagnetic spectrum (δ = 9.12 ppm), consistent with the formation of (PImH)FeIII–
(O2
•‒) (2-d8) and suggesting a low-spin (S = 0) six-coordinate iron.
41 As expected for a 
diamagnetic species, complex 2 is EPR silent. The literature on hemoglobin and model 
compounds has generally proposed that the unpaired electron of the low-spin FeIII ion is 
antiferromagnetically coupled with the unpaired electron of the superoxide radical anion, 
making the complex diamagnetic.41 It should be noted, however, that recent X-ray 
spectroscopic data have shown the electronic structure to more closely resemble FeII–(O2) 
in a similar model system, while oxy-hemoglobin has more FeIII–(O2
•‒) character (although 







Figure 3.2 (A) Reaction scheme showing reversible ferric heme superoxide (2) formation 
by bubbling O2(g) into a solution of fully reduced complex 1. (B) UV-vis spectra (THF at –





Figure 3.3 2H NMR spectra of (A) d8-(P
ImH)FeII (1-d8) and (B) d8-(THF)(P
ImH)FeIII–(O2
•‒) 




We postulate that the sixth axial ligand present in 2 is the imidazolyl group of the 
tridentate tether in PImH (see Chart 3.1). We base this conclusion on our previous X-ray 
crystallographic finding that in a six-coordinate iron(II) complex with PImH, also containing 
a strong isocyanide donor ligand DIMPI (2,6-dimethylphenyl isocyanide), [(PImH)FeII–
DIMPI], the free imidazole group binds strongly (Fe-NIm = 2.024 Å) as the axial ligand 




The O2-binding to 1 was reversible, as we have found for some other heme-Fe(II) 
O2-adducts with porphyrinates possessing electron-withdrawing fluorine-substituents,
43 
where warming a solution of 2 to room temperature in a closed system allows for release 
of dioxygen and regeneration of (PImH)FeII (1), to the extent of ~ 80%. Cooling of this 
solution (without further addition of O2) to –80 °C leads to close to full regeneration of 
(PImH)FeIII–(O2
•‒) (2). Dioxygen binding cycling in this manner illustrated in the Figure 3.4. 





Figure 3.4 Reversible dioxygen binding to (PImH)FeII (1) (black) yielding (PImH)FeIII–(O2
•‒) 
(2) (red) in THF. Spectra shown in grey are generated during the transformation. It was 






Figure 3.5 Resonance Raman spectra of ferric superoxide complex (PImH)FeIII–(O2
•‒) (2) 
in frozen THF obtained at 77 K with 413 nm excitation: Fe–O and O–O stretching 
frequencies for the complex generated with 16O2 (blue) or 
18O2 (orange). The 
16O2–
18O2 
difference spectrum is shown in green. 
 
Complex (PImH)FeIII–(O2
•‒) (2) was further characterized by rR spectroscopy 
(Figure 3.5). In the lower-frequency region, a νFe−O stretch is detected at 575 cm
–1 which is 
similar to that of other known “oxy-heme” FeIII–(O2
•‒) synthetic models with a nitrogen 
axial ligand.10,41,44  This Fe–O stretch shifts down by 24 cm–1 upon 18O2 substitution. An 
oxygen isotope-sensitive feature corresponding to the O–O stretch was detected at νO−O = 
1171 cm–1, which shifted to 1110 cm–1 with 18O2. With the hemes that our research group 
has utilized, having 3 or 4 of the meso-aryl groups possessing 2,6-difluoro substituents, we 
have observed O–O stretches at similar frequencies (Table 3.1). Also consistent with the 
assignments is our finding that the νFe−O and νO−O of 
16O/18O isotope shifts (vide supra) 
closely match those calculated using the harmonic oscillator model: Δcalcd Fe−O (
16O2/
18O2) 
= –26 cm‒1, Δcalcd O−O (
16O2/
18O2) = –67 cm
‒1. However, it is quite common that this 
vibrational mode of dioxygen-bound heme complexes is not observable.10,28,45 Table 3.1 
lists examples from our own investigations, along with several protein and synthetic oxy-
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heme (FeIII-superoxide) complexes, where  νO−O is observed. A more complete listing can 
be found elsewhere.10 





Mb WT 1103 578 (−29) 46 
Cyt P450 WT 1139 (−66) 546 (−31) 47 
Cyt P450 D251N 1136 (−66) 537 (−30) 48 
(THF)(F8)Fe
III−(O2
•−) 1178 (−64) 568 (−24) 49 
(6L)FeIII−(O2
•−) 1176 (−64) 572 (−24) 33 
(PIm)FeIII−(O2
•−) 1180 (−56) 575 (−23) 50 
(PImH)FeIII−(O2
•−) (2) 1171 (−61) 575 (−24) this work 
[(α4Fe(CO2Me)4)O2
•−] 1004(−53) 967 (−56) 581 (−22) 51 
[(FeIII(OPhP))−O2
•−] 1147 (−59) 570 (−22) 44 
aMb WT, wild-type myoglobin; Cyt P450 WT, wild-type cytochrome P-450 monooxygenase (P450); P450 




Figure 3.6 Diagrams of heme-FeIII-superoxide synthetic model systems.33,44,49–51 
 
3.2.2 Generation of a reduced Heme–Cu complex using PImH 
Addition of 1 equiv of [CuI(CH3CN)4](B(C6F5)4) to the reduced complex (P
ImH)FeII 
(1) led to the desired reduced heterobinuclear FeII/CuI compound [(PImH)FeIICuI]+ (3), 
which had prominent UV-vis absorptions at 423 and 542 nm at low temperature (Figure 
3.7). An asymmetry in pyrrole resonances of reduced complex 1 is observed in 1H-NMR 
spectroscopy, where different chemical shifts for inequivalent porphyrin phenyl 
substituents leads to observation of two peaks (at δ 50 and 59 ppm) (Figure 3.8). Addition 
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of the copper(I) ion leads to disappearance of upfield shifted resonances (< 0 ppm) which 
we assign as being derived from methylene hydrogen atoms of the tethered histamine group. 
Since the copper ion takes up (i.e., binds to) the tridentate chelate from this complex, the 
imidazolyl group of the histamine arm is no longer bound to the iron center. The pyrrolic 
protons in 2H-NMR spectroscopy at –80 °C resonate at δ 89.4 and 102.8 ppm, typical of a 





Figure 3.7 (A) Overall scheme for reactivity of [(PImH)FeIICuI]+ (3) toward O2(g) at –80 °C 
in THF to yield a HS peroxo species [(PImH)FeIII–(O2
2–)–CuII]+ (3a) and LS peroxo complex 
[(DCHIm)(PImH)FeIII–(O2
2–)–CuII]+ (3b) following addition of DCHIm. (B) UV-vis spectra 
(–80 °C) for in situ generated HS 3a (red) and LS 3b (blue) starting following oxygenation 





Figure 3.8 1H-NMR spectrum of (top) complex (PImH)FeII (1) and (bottom) (PImH)FeIICuI 




Figure 3.9 2H-NMR spectra of (A) in situ generation of d8-[(P
ImH)FeIICuI]+ (3-d8); (B) d8-
[(PImH)FeIII–(O2
2–)–CuII]+ (3a-d8) generated by bubbling O2; (C) d8-[(DCHIm)(P
ImH)FeIII–
(O2
2–)–CuII]+ (3b-d8) generated by the reaction of 3a-d8 with DCHIm. The strong sharp 
peaks at δ 1.73 and 3.58 ppm correspond to solvent THF.  
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3.2.3 Generation of the high-spin heme–peroxo–Cu complex 
 
Addition of dry O2(g) to the THF solution of fully reduced heterobinuclear heme-
copper complex [(PImH)FeIICuI]+ (3) at low-temperature resulted in the formation of new 
species [(PImH)FeIII–(O2
2–)–CuII]+ (3a) with UV-vis spectral features at 420, 545 and 565 
nm (Figure 3.7B), notably with two Q-band features. These characteristics are the same as 
those known for other previously well-characterized high-spin heme–peroxo–Cu 
complexes also with tridentate ligands on the copper ion. (Figure 3.7A).10,31,32,49,52,53 
To provide more detail concerning the structure of [(PImH)FeIII–(O2
2–)–CuII]+ (3a), 
we carried out rR spectroscopy (Figure 3.10) and found that the peroxo ligand νO−O 
vibration is observed at 799 cm–1; this shifts to 751 cm–1 upon 18O2 substitution. In addition, 
a band at 524 cm–1 (∆18O2 = –23 cm
–1) is assigned to νFe−O for this peroxide complex. Again, 
as discussed above for (PImH)FeIII−(O2
•‒) (2),  observed isotope frequency shifts when using 
18O2 match well with values calculated using the harmonic oscillator model (Δcalcd O−O 
(16O2/
18O2) = –46 cm
‒1, Δcalcd Fe−O (
16O2/
18O2) = –23 cm
‒1), corroborating our assignments. 
While the UV-vis features for 3a are most like high-spin heme-peroxo complexes with 
tridentate chelates bound to copper(II) (vide supra), we note that  the νO−O value observed 
for 3a (799 cm–1) is much higher in energy than that found for the three other examples we 
have previously studied, which have tridentate ligands on the Cu(II) ion and where side-on 
µ-η2:η2–O2
2– binding to both Fe(III) and Cu(II) occurs, νO−O = 747‒767 cm
–1.31,32,49,54 In 
copper-dioxygen coordination chemistry, ligand denticity induces different O2 (as peroxide, 
O2
2–) binding modes;55–57 CuI-chelates with tridentate ligands prefer a side-on binding 




complexes whereas with tetradentate ligands (L)CuI complexes react with O2 to give end-





Figure 3.10 rRaman data (16O2–
18O2 difference) collected at 413 nm excitation and 77 K 
for HS 3a and LS 3b. Complex 2 is present as an impurity, observed as a set of 16O2/
18O2 
peaks at 575/550 cm‒1 (marked with an asterisk). 
 
Chart 3.2 HS/LS-TMPA heme-peroxo-copper complexes 
 
However, these 3a vibrations (νFe−O = 524 cm
–1; νO−O = 799 cm
‒1; Figure 3.9) are 
very close to those previously reported for the HS-TMPA heme-peroxo-copper complex 
(Chart 3.2). For this complex with tetradentate chelate bound to copper, νO−O = 804 cm
–1, 
and the peroxo unit is bound side-on to the high-spin FeIII, but end-on to the CuII, for an 
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overall µ-η2:η1 coordination mode that has been supported by EXAFS spectroscopy and 
DFT calculations.39,58 We posit that the PImH tridentate chelate induces considerable 
geometric distortion in the Cu(II) coordination sphere, which results in the peroxo binding 
to Cu in an essentially η1 fashion. Thus, we postulate that 3a possesses a µ-η2:η1-peroxo 
coordination, formulated as [(PImH)FeIII–(µ-η2:η1-O2
2–)–CuII]+, as shown in Figure 3.7A.  
On the basis of past extensive NMR spectroscopic studies on 
[(F8)Fe
III−X−CuII(TMPA)]+ (X = O2–, OH–; TMPA = tris(2-pyridyl)methylamine),59 the 
peroxo analog (X = O2
2–),58,60 and [(2L)FeIII–(µ-η2:η2-O2
2–)–CuII]+ 32,61 (shown as E, Figure 
3.1), the further analog with tridentate chelates for Cu ion, 49,59,61,62 [(PImH)FeIII–(O2
2–)–
CuII]+ (3a) has an overall electronic structure where S = 2, derived from antiferromagnetic 
coupling of high-spin FeIII (S = 5/2) and CuII (S = 1/2) centers. This assignment is further 
supported by its EPR silent behavior (12 K, in THF frozen solution). Further supporting 
the S = 2 electronic structure assignment, 3a displays a pyrrole signal in the paramagnetic 
region at 93.0 ppm (−80 °C, THF; see Figure 3.9B), very similar to that observed for other 
HS complexes which are listed in Table 3.2.  The 93.0 ppm pyrrole resonance is in the 
range expected for HS ferric iron. 
 
Table 3.2 2H-NMR data and pyrrole chemical shifts of heme/copper dioxygen adducts or 
heme-peroxo-copper complexesa 
 
complex δpyrrole solvent temp(K) ref 
D 92 acetone 193 63 
(F8)Fe
IIIO2Cu
II(LMe2N) 105 CH2Cl2/6% EtCN 178 49 
E 106 THF 183 61 
(F8)Fe
IIIO2Cu
II(LN4OH) 83 THF 213 64 
HS-TMPA 68 MeCN 233 65 
HS-AN 95 acetone 193 53 
3a 93 THF 193 this work 
aSee the Figure 3.11 for figures of (F8)FeIIIO2CuII(LMe2N), (F8)FeIIIO2CuII(LN4−OH), and HS-AN and Chart 




Figure 3.11 Figures of high-spin heme-peroxo-copper synthetic model systems.49,53,64 
 
 
Figure 3.12 Diagrams of low-spin µ-1,2-peroxo configuration complexes.34,39,66 
 
3.2.4 Generation of a low-spin heme–peroxo–Cu complex with PImH 
A low-spin analog to [(PImH)FeIII–(O2
2–)–CuII]+ (3a) was generated by the addition 
of axial base DCHIm in THF at −80 °C (Figure 3.7A). This resulted in a drastic change in 
the UV-vis features (Figure 3.7B). Relatively intense low-energy features observed at ~ 
800-900 nm (assigned as peroxo-to-Fe LMCT bands) are characteristic of LS µ-1,2-peroxo 
species, as previously demonstrated for F and G (Figure 3.1) and in a number of other 
cases (see Figure 3.12 for 4-DCHIm and LS-AN, and Chart 3.2 for LS-TMPA).34,39,66 The 
addition of DCHIm resulted in clear Soret and Q-band shifts (from those observed in 3a) 
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to 425 and 538 nm, respectively (Figure 3.7B). 2H-NMR spectroscopy confirms the spin 
state change from high-spin 3a (pyrrole signal at 93.0 ppm) to low-spin 3b (pyrrole signal 
at 10.2 ppm, i.e., in the diamagnetic region; see Figure 3.9). This behavior suggests that in 
3b, there exists antiferromagnetic coupling between the low-spin (S = 1/2) six-coordinate 
FeIII and the d9 CuII (also S = 1/2) centers, through the peroxo bridge. Complex 3b is EPR 
silent (12K, THF), also consistent with antiferromagnetic coupling and a resulting S = 0 
electronic structure formulation. 
Resonance Raman spectroscopic interrogation of LS compound 
[(DCHIm)(PImH)FeIII–(O2
2–)–CuII]+ (3b) reveals the expected differences in νFe−O and νO−O 
stretching vibrations in comparison to HS complex [(PImH)FeIII–(O2
2–)–CuII]+ (3a) (Figure 
3.10). Coordination of DCHIm to generate 3b produced two isotope-sensitive peaks, an 
O−O vibration at 817 cm–1 (Δ18O2 = –55 cm
‒1) and an Fe−O stretch at 610 cm–1 (Δ18O2 = 
–26 cm‒1). This observed νFe−O (
16O2/
18O2) shift is close to expected value (Δcalcd Fe−O 
(16O2/
18O2) = –27 cm
‒1) in the harmonic oscillator approximation. The magnitude of the 
isotope shift for νO−O (= –55 cm
–1) is a bit larger than the calculated value (Δcalcd O−O 
(16O2/
18O2) = –47 cm
‒1), however it is still consistent with the assignment of this stretch to 
that of a peroxide ligand. Changing from HS (3a) to LS (3b) dramatically increases νFe−O 
by 86 cm–1 (Figure 3.7A), while a smaller increase (18 cm–1) is observed for νO−O. Similar 
effects have been observed recently39,67 for DCHIm binding and indicate a change in Fe 
spin state and Fe-peroxo coordination geometry. The relatively high νO−O stretch for the 
peroxo group in 3b (compared to that of 3a) indicates a LS µ-1,2-peroxo coordination 
mode in the former. Thus, 3b is formulated as [(DCHIm)(PImH)FeIII–(µ-1,2-peroxo–O2
2–)–
CuII]+ (shown in Figure 3.7A), based on our previous investigation and resulting 
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we investigated the dioxygen reactivity of reduced heme (PImH)FeII (1) in the 
absence and the presence of copper ion. Reaction of 1 and O2 results in O2-bound ferrous 
heme compound, (PImH)FeIII–(O2
•‒) (2), such as that found in oxygenated myoglobin and 
hemoglobin. 2H-NMR suggests that 2 is low-spin six-coordinate iron. The evidence points 
to the imidazolyl group of the appended tridentate chelate as serving as an axial ligand base. 
Addition of Cu(I) ion leads to a new reduced heme-copper complex (PImH)FeIICuI (3), an 
advanced CcO active site model system due to (i) its tridentate ligand CuI-binding and (ii) 
the imidazolyl ligand has a free N–H group (see below). At low temperature, dioxygen 
reaction with 3 gives a high-spin species [(PImH)FeIII–(µ-η2:η1-O2
2–)–CuII]+ (3a) and 
addition of DCHIm as an axial ligand changes the peroxo coordination to end-on, resulting 
in formation of LS species with end-on peroxo coordination, [(DCHIm)(PImH)FeIII–(µ-1,2-
O2
2–)–CuII]+  (3b). 
This oxygenation chemistry with (PImH)FeII (1) lays the groundwork for a better 
understanding of FeII/CuI/O2 reactions chemistry. Our ongoing studies are focused on 
investigating the reductive O–O cleavage relevant to CcO enzyme active site chemistry of 
heme-(O2
2−)-Cu complexes by employing systematically varied H+/e– sources. Also, since 
PImH has a built-in imidazole and tridentate system in copper chelation as occurs in CcO, 
another goal of our research is to mimic the post-translational modification which occurs 
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in CcO, that being formation of a histidine-tyrosine cross-link which is functionally 
critical16 (see the Introduction).  
 
3.4 Experimental section 
3.4.1 Materials and methods 
All reagents and solvents purchased and used were of commercially available 
quality except as noted. Inhibitor-free tetrahydrofuran (THF) was distilled over 
Na/benzophenone under argon and deoxygenated with argon before use. The preparation 
and handling of air-sensitive compounds were performed under a MBraun Labmaster 130 
inert atmosphere (< 1 ppm of O2 and < 1 ppm of H2O) glovebox filled with nitrogen. 
Dioxygen gas purchased from Airgas and dried by passing it through Drierite. 18O2 gas was 
purchased from ICON, Summit, NJ, and 16O2 gas was purchased from BOC gases, Murray 
Hill, NJ. 
All UV−vis measurements were carried out using a Hewlett-Packard 8453 diode 
array spectrophotometer with HP Chemstation software and a Unisoku thermostated cell 
holder for low-temperature experiments. A 10 mm path length quartz cell cuvette modified 
with an extended glass neck with a female 14/19 joint, and stopcock was used to perform 
all UV–vis experiments, as previously described.33,50,68 1H and 2H-NMR spectra were 
measured on a Bruker 300-MHz NMR spectrometer at ambient or low temperatures. 
Chemical shifts were reported as δ (ppm) values relative to an internal standard 
(tetramethylsilane) and the residual solvent proton peaks. Electron paramagnetic resonance 
(EPR) spectra were recorded with a Bruker EMX spectrometer equipped with a Bruker ER 
041 × G microwave bridge and a continuous flow liquid helium cryostat (ESR900) coupled 
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to an Oxford Instruments TC503 temperature controller. Spectra were obtained at 8 K 
under non-saturating microwave power conditions (ν = 9.428 GHz, microwave power = 
0.201 mW, modulation amplitude = 10 G, microwave frequency = 100 kHz, and receiver 
gain = 5.02 × 103). The compounds (PImH)FeII,30 the pyrrole deuterated derivative d8-
(PImH)FeII,30 and CuI(CH3CN)4(B(C6F5)4)
35 were synthesized as previously described.  
 
3.4.2 UV-vis spectroscopy  
3.4.2.1 UV-vis spectroscopy of [(PImH)FeIII–(O2•‒)] (2) 
Complex [(PImH)FeIII–(O2
•‒)] (2) was generated in THF solution, by preparing 0.01 
mM (for Soret band monitoring) or 0.1 mM solutions of (PImH)FeII (1) in a 10 mm path 
length quartz Schlenk cuvette, which was sealed with a rubber septum in the glovebox. The 
cuvette was then cooled to –80 ℃, and the solution was bubbled with O2 to generate the 
superoxide compound 2. UV-vis: λmax = 424, 541 nm. 
 
3.4.2.2 UV-vis spectroscopy of [(PImH)FeIICuI]+ (3), [(PImH)FeIII–(O22–)–CuII]+ (3a), and 
[(DCHIm)(PImH)FeIII–(O22–)–CuII]+ (3b) 
In a similar manner, in the glovebox, 1 equiv of [CuI(CH3CN)4](B(C6F5)4) (from a 
2 mM stock solution (THF)) was added to the 10 mm path length quartz Schlenk cuvette 
containing the reduced complex (PImH)FeII (1) (125 μL of a 2 mM solution) to generate 
complex [(PImH)FeIICuI]+ (3); the cuvette was then filled with THF up to a total volume of 
2.5 mL. This cuvette was then cooled to –80 ℃, and the solution was bubbled with O2 to 
generate the complex [(PImH)FeIII–(O2
2–)–CuII]+ (3a). Subsequently, addition of 1.5 equiv 




(3b). UV-vis: [(PImH)FeIICuI]+ (3) λmax = 423, 542 nm; [(P
ImH)FeIII–(O2
2–)–CuII]+ (3a) λmax 
= 420, 545, 565 nm; [(DCHIm)(PImH)FeIII–(O2
2–)–CuII]+ (3b) λmax = 425, 538 nm.   
 
3.4.3 EPR spectroscopy  
3.4.3.1 EPR spectroscopy of (PImH)FeII (1) and [(PImH)FeIII–(O2•‒)] (2) 
In a glovebox, 1.0 mg of (PImH)FeII (1) was dissolved in 0.5 mL of deoxygenated 
THF in an EPR tube. Outside the glovebox, the solution was cooled to –80 °C (acetone-
dry ice bath) and bubbled with O2 to generate the superoxide compound 2. Then, the EPR 
spectrum was recorded at 12 K. Both 1 and 2 were found to be EPR silent.       
 
3.4.3.2 EPR spectroscopy of [(PImH)FeIICuI]+ (3), [(PImH)FeIII–(O22–)–CuII]+ (3a) and 
[(DCHIm)(PImH)FeIII–(O22–)–CuII]+ (3b) 
In a glovebox, 1.0 mg of (PImH)FeII and 0.9 mg of CuI(CH3CN)4(B(C6F5)4) were 
dissolved in 0.5 mL of deoxygenated THF in an EPR tube and sealed properly. Outside the 
glovebox, the solution was cooled to –80 °C (acetone-dry ice bath) and dioxygen was 
bubbled into the solution using a syringe to generate the Heme–Peroxo–Cu complex, 
[(PImH)FeIII–(O2
2–)–CuII]+ (3a). A total of 1.5 equiv of DCHIm (3.5 mg of DCHIm in 0.5 
mL of THF) was added to the reaction mixture. Then, the EPR spectrum was recorded at 







3.4.4 2H-NMR spectroscopy 
3.4.4.1 2H-NMR spectroscopy of [d8-(PImH)FeIII–(O2•‒)] (2-d8) 
In the glovebox, 2.6 mg of d8-(P
ImH)FeII (1-d8) was dissolved in 0.5 mL of 
deoxygenated THF in a NMR tube. To the cold THF solution (at –80 °C, acetone-dry ice 
bath) of 1-d8 was bubbled with O2. 
2H-NMR (300 MHz, THF) 2-d8: δpyrr 9.12 ppm.  
 
3.4.4.2 2H-NMR spectroscopy of [d8-(PImH)FeIICuI]+ (3-d8), [d8-(PImH)FeIII–(O22–)–
CuII]+ (3a-d8) and [d8-(DCHIm)(PImH)FeIII–(O22–)–CuII]+ (3b-d8) 
In the glove box, a 1:1 mixture of 2.6 mg of d8-(P
ImH)FeII (1-d8) and 2.3 mg of 
[CuI(CH3CN)4](B(C6F5)4) was dissolved in 0.5 mL of deoxygenated THF in a NMR tube 
to generate complex [d8-(P
ImH)FeIICuI]+ (3-d8). To the cold THF solution (at –80 °C, 
acetone-dry ice bath) of 3-d8 was bubbled with O2. In the same NMR tube 1.5 equiv of 




2H-NMR (300 MHz, THF): Complex 3-d8, δpyrr 89.4, 102.8 ppm; 3a-d8, 93.0 ppm; 
3b-d8, 10.2 ppm.   
 
3.4.5 resonance Raman (rR) spectroscopy 
3.4.5.1 rR spectroscopy of [(PImH)FeIII–(O2•‒)] (2) 
In the glovebox, 2 mM solutions of an (PImH)FeII in THF were prepared and 
transferred to rR tube and capped with tightfitting septa. The sample tubes were placed in 
a cold bath (dry ice/acetone) and oxygenated using 16O2 or 
18O2 gases. The oxygenated 
samples were set in a cold bath for 10 min, after which the sample tubes were frozen in 
liquid N2 and sealed by flame. Resonance Raman samples were excited at 413 nm, using 
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either a Coherent I90C-K Kr+ ion laser while the sample was immersed in a liquid nitrogen 
cooled (77 K) EPR finger Dewar (Wilmad). Power was ~2 mW at the sample, which was 
continuously rotated to minimize photodecomposition. The spectra were recorded using a 
Spex 1877 CP triple monochromator, and detected by an Andor Newton CCD cooled to –
80 °C. rRaman [FeIII–(O2•‒)] (2): νO−O, 1171 cm
–1 (Δ18O2, –61 cm




3.4.5.2 rR spectroscopy of [(PImH)FeIICuI]+ (3), [(PImH)FeIII–(O22–)–CuII]+ (3a) and 
[(DCHIm)(PImH)FeIII–(O22–)–CuII]+ (3b) 
In the glovebox, 5 mM solutions of an equimolar mixture of (PImH)FeII and 
[CuI(CH3CN)4](B(C6F5)4) in THF were prepared and transferred to rR tube and capped 
with tightfitting septa. The sample tubes were placed in a cold bath (dry ice/acetone) and 
oxygenated using 16O2 and 
18O2. The labeled gases were cooled in dry ice for 5 min and 
injected through the solution by using a Hamilton gastight syringe. The oxygenated 
samples were set in a cold bath for 10 min, after which the sample tubes were frozen in 
liquid N2 and sealed by flame. To the cold THF solution (at –80 °C, acetone-dry ice bath) 
of 3a was added 1.5 equiv (3.5 mg of DCHIm in 0.5 mL of THF) of DCHIm for complex 
3b. rRaman [(PImH)FeIII–(O2
2–)–CuII]+ (3a): νO−O, 799 cm
–1 (Δ18O2,  –48 cm
–1); νFe−O, 524 
cm–1 (Δ18O2, –23 cm
–1), [(DCHIm)(PImH)FeIII–(O2
2–)–CuII]+ (3b): νO−O, 817 cm
–1 (Δ18O2, –
55 cm–1); νFe−O, 610 cm








(1) Wikström, M. K. F. Proton Pump Coupled to Cytochrome c Oxidase in Mitochondria. 
Nature 1977, 266, 271−273. 
(2) Ferguson-Miller, S.; Babcock, G. T. Heme/Copper Terminal Oxidases. Chem. Rev. 
1996, 96, 2889−2907. 
(3) Babcock, G. T. How Oxygen Is Activated and Reduced in Respiration. Proc. Natl. Acad. 
Sci. U. S. A. 1999, 96, 12971−12973. 
(4) Peterson, R. L.; Kim, S.; Karlin, K. D. Comprehensive Inorganic Chemistry II, 2nd ed.; 
Elsevier: Amsterdam, 2013; pp 149−177. 
(5) Solomon, E. I.; Heppner, D. E.; Johnston, E. M.; Ginsbach, J. W.; Cirera, J.; Qayyum, 
M.; Kieber-Emmons, M. T.; Kjaergaard, C. H.; Hadt, R. G.; Tian, L. Copper Active Sites 
in Biology. Chem. Rev. 2014, 114, 3659−3853. 
(6) Yoshikawa, S.; Shimada, A. Reaction Mechanism of Cytochrome c Oxidase. Chem. 
Rev. 2015, 115, 1936−1989. 
(7) Quist, D. A.; Diaz, D. E.; Liu, J. J.; Karlin, K. D. Activation of Dioxygen by Copper 
Metalloproteins and Insights from Model Complexes. JBIC, J. Biol. Inorg. Chem. 2017, 
22, 253−288. 
(8) Wikström, M.; Krab, K.; Sharma, V. Oxygen Activation and Energy Conservation by 
Cytochrome c Oxidase. Chem. Rev. 2018, 118, 2469−2490. 
(9) Huang, X.; Groves, J. T. Oxygen Activation and Radical Transformations in Heme 
Proteins and Metalloporphyrins. Chem. Rev. 2018, 118, 2491−2553. 
93 
 
(10) Adam, S. M.; Wijeratne, G. B.; Rogler, P. J.; Diaz, D. E.; Quist, D. A.; Liu, J. J.; 
Karlin, K. D. Synthetic Fe/Cu Complexes: Toward Understanding Heme-Copper Oxidase 
Structure and Function. Chem. Rev. 2018, 118, 10840−11022. 
(11) Das, T. K.; Pecoraro, C.; Tomson, F. L.; Gennis, R. B.; Rousseau, D. L. The Post-
Translational Modification in Cytochrome c Oxidase Is Required to Establish a Functional 
Environment of the Catalytic Site. Biochemistry 1998, 37, 14471−14476. 
(12) Liu, X.; Yu, Y.; Hu, C.; Zhang, W.; Lu, Y.; Wang, J. Significant Increase of Oxidase 
Activity through the Genetic Incorporation of a Tyrosine-Histidine Cross-Link in a 
Myoglobin Model of Heme-Copper Oxidase. Angew. Chem., Int. Ed. 2012, 51, 4312−4316. 
(13) Ravikiran, B.; Mahalakshmi, R. Unusual Post-Translational Protein Modifications: 
The Benefits of Sophistication. RSC Adv. 2014, 4, 33958−33974. 
(14) Davidson, V. L. Protein-Derived Cofactors Revisited: Empowering Amino Acid 
Residues with New Functions. Biochemistry 2018, 57, 3115−3125. 
(15) Lin, Y. W. Structure and Function of Heme Proteins Regulated by Diverse Post-
Translational Modifications. Arch. Biochem. Biophys. 2018, 641, 1−30. 
(16) Ehudin, M. A.; Senft, L.; Franke, A.; Ivanović-Burmazović, I.; Karlin, K. D. 
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Cytochrome P450 monooxygenases (CYP450s) catalyze the incorporation of one 
atom of molecular oxygen into biological substrates, i.e., they hydroxylate nonactivated 
C–H bonds in hydrocarbon and various other compounds.1–10 CYP450s are involved in 
critical biological processes, including the biosynthesis of steroid hormones, degradation 
of pharmaceutically derived drugs and detoxification of xenobiotics including 
carcinogens.11–14 Many excellent review articles concerning CYP450s exist, covering the 
relevant biochemistry, summarizing available protein X-ray structures15,16 and detailing 
aspects of the nature of intermediates and reaction mechanism. Theoretical/computational 
investigations and analyses have been part of the research efforts.1,3,5,10,17–21 
The CYP450 catalytic mechanism as currently accepted is depicted in Scheme 4.1. 
When the substrate (R–H) approaches the heme active-site, it displaces the distally bound 
axial water molecule from the six-coordinate low-spin ferric ion, converting it to a five-
coordinate, high-spin ferric-porphyrinate. The loss of the H2O causes an increase of the 
redox potential of the heme iron by approximately 300 mV,4 which enables electrons 
transfer from the biological reductase producing a five-coordinate ferrous porphyrinate. 
Note that in the resting state, the FeIII/FeII reduction potential ranges between –400 and –
170 mV, and thus is inactive to reduction.2 The ferrous heme binds dioxygen, giving rise 
to the initial ferric superoxide intermediate, often referred to as the oxy-heme or oxy ferrous 
intermediate. The addition of a second electron converts superoxide to a ferric peroxide 
intermediate, and this step is overall rate-determining in the CYP450 catalytic cycle.17,22 
Subsequently, the peroxide is protonated to form a low-spin ferric hydroperoxide 
intermediate, FeIII–OOH, which is known as Compound 0. A second protonation on the 
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distal oxygen of hydroperoxide species causes heterolytic O–O bond cleavage to produce 
a highly reactive high-valent ferryl–oxo π-cation porphyrinate radical (Cmpd I), releasing 
a molecule of water. Cmpd I is accepted as the active substrate oxidant for the normal 
CYP450 cycle.9,23 This species abstracts a hydrogen atom from the substrate to give a 
radical (R•) and the “OH” from the resulting iron(IV)-OH (Cmpd II) undergoes ‘rebound’24 
to the substrate radical, giving products R–OH plus the original (in the cycle) ferric heme. 
 





As shown in Scheme 4.1, superoxide/peroxide/hydroperoxide intermediates are 
involved in catalytic cycle of CYP450. These species also have been observed as 
intermediates in biological processes involving other O2 or H2O2 activating heme 
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enzymes.6 These include heme oxygenase (HO; oxidatively breaking down hemes while 
also effecting release of iron and CO (or other metabolite): superoxide (FeII-O2) and 
hydroperoxide),25–27 nitric oxide synthase (NOS; two-step reaction where hydroxylation of 
L-arginine to N-hydroxy-L-arginine (L-NHA) is followed by oxidation of L-NHA to 
citrulline and NO(g): superoxide, peroxide, and hydroperoxide),
28,29 steroid hormone 
multifunctional CYPs  (hydroxylation and lyase activities: superoxide, peroxide, and 
hydroperoxide),30–32 horseradish peroxidase (HRP; H2O2 mediated substrate oxidation: 
hydroperoxide),6,9,33,34 chloroperoxidase (CPO; H2O2 mediated substrate halogenation: 
hydroperoxide),9,35 aromatic peroxygenase (APO; oxygenation of aliphatic and aromatic 
hydrocarbons: hydroperoxide),9,36 and tryptophan 2,3-dioxygenase (TDO; transformation 
to formylkynurenine: superoxide).6,37 Any and all aspects of CYP or other O2/H2O2 
activating heme enzymes (vide supra) reaction mechanisms have been or are being 
investigated, including what key protonation events take place and how, and what the 
structures of all intermediates are such as atom-connectivity along with bonding (electronic 
structure). The initial oxy-heme, the O2-adduct with ferrous ion (i.e., the ferric 
superoxide),38 the subsequently reduced intermediate peroxide and protonated 
hydroperoxide (Cmpd 0) have not been detected in normal enzyme turnover. However, 
comprehensive radiolytic cryoreduction studies25,39–42 have provided many details 
concerning their structures and physical properties. Theoretical/computational 
investigations have also provided insights into the structures and thermodynamic inter-
relationships for intermediates in the CYP450 catalytic cycle (Scheme 4.1).5 
However, over the years and continuing on, generation of synthetic analogs of all 
the intermediates relevant to the CYP450 catalytic cycle has been of great interest (and 
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importance). In this regard, there are many known heme FeIII-superoxide synthetic 
compounds,8,43–52 O2-adducts of reduced ferrous hemes, including hemoglobin/myoglobin 
mimics such as the “Picket-Fence” porphyrin O2-adduct.
43 However, these do not possess 
thiolate axial ligation as in CYP450s. Ferric heme peroxide and ferric heme hydroperoxide 
complexes are relatively rare (and see discussions below) even though researchers have 
suggested that hydroperoxide species may serve as alternative oxidant, since it is a common 
intermediate in the catalytic cycles of monooxygenases.19,53–55  
Reviews emphasizing synthesis and reactivity of Mn+-(O2
•–) complexes are now 
available.56,57 Many Mn+-(O2
•–) complexes of the first row transition metals, for example 
Mn, Fe, Co, Ni, Cu and Zn have been synthesized via metal-complex + O2 or metal-
complex + superoxide reactions and their substrate reactivity investigated. Iron-superoxide 
species are considered to form in the first step of dioxygen activation as the reactive 
intermediates in heme (vide supra) and non-heme metalloenzymes (e.g., Myo-inositol 
oxygenase (MIOX) and isopenicillin-N-synthase (IPNS)).57  
In this report, we describe new synthetic analogues of those intermediates early in 
the cycle, prior to O–O cleavage, namely the ferric heme superoxide, peroxide and 
hydroperoxide species (S, P and HP, respectively (Figure 4.1)). We note that in CYP450, 
the superoxide, peroxide and hydroperoxide intermediates are thought to have an end-on 
structure,9,10,58 only binding to iron with one oxygen atom (the proximal O-atom), as 
depicted in Scheme 4.1. Utilizing the F8 (F8 = tetrakis(2,6-difluorophenyl)porphyrinate) 
heme framework, we have spectroscopically characterized corresponding S, P and HP 
complexes, with UV-vis, electron paramagnetic resonance (EPR) and resonance Raman 
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(rR) spectroscopies, and further chemically confirmed that P and HP are peroxidic (vide 
infra).  
More importantly, and the primary advance described in this report, is that we have 
experimentally established the thermodynamic relationships between these complexes: (1) 
The reduction of ferric superoxide compound S is reversible, using chemical reagents, and 
a reduction potential E°’ has been determined, (2) the ferric peroxo complex P, possessing 
an intermediate spin and side-on bound peroxide dianion ligand, can be reversibly 
protonated to give the low-spin ferric hydroperoxide HP. Thus, a pKa value for HP has 
been established. Further, another finding is that the ferric heme superoxide complex S can 
effect a hydrogen atom abstraction reaction, and directly produce ferric heme 
hydroperoxide complex HP (Figure 4.1). Only recently, Dey and co-workers45 
demonstrated for the first time that a ferric heme superoxide complex could effect a HAT 
reaction; removal of a hydrogen atom from a porphyrinate appended catechol, thus an intra-
molecular process, converted the superoxide complex to the hydroperoxide analog. Such a 
transformation represents the diagonal part of a thermodynamic square scheme, relating S, 
P and HP complexes (Figure 4.1). Now, with our measured reduction potential (E°’) and 
pKa values (as mentioned above), the O–H bond dissociation free energy (BDFE) of ferric 
heme hydroperoxide complex HP could be determined using the Bordwell relationship (eq. 
1) where CG,solv represents the H
+/H• standard reduction potential in a particular solvent 
(also see below).59 
 
BDFE = 1.37(pKa) + 23.06E
o + CG,solv                                (1) 
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Further, the calculated BDFE of complex HP, in fact is shown to be in-line 
(consistent) with the actual experimental reactivity of S toward a substrate with O–H bond 
(vide infra).  To the best of our knowledge, the present study reports the first example 
showing thermodynamics (reduction potential and pKa) involved and the generation of the 
ferric heme hydroperoxide species by ferric heme superoxide complex via HAT of an 




Figure 4.1 Sequential preparation of superoxide/peroxide/hydroperoxide heme analogs 
and thermodynamic square scheme of reduction (E° as determined vs Fc+/0) and 
protonation of a F8 ferric heme superoxide analog and O–H BDFE of ferric heme 





4.2 Results and discussion 
4.2.1 Generation and characterization of a ferric peroxide, [(F8)FeIII-(O22–)]– (P) 
As reported in previous work,60 addition of the outer sphere strong reductant CoCp2 
to the previously well-characterized ferric superoxide complex [(F8)Fe
III-(O2
•–)] (S) (λmax 
= 416 and 535 nm; rRaman, νO−O, 1178 cm
–1 (Δ18O2,  –64 cm
–1); νFe−O, 568 cm
–1 (Δ18O2, –
24 cm–1))61,62 at –80 ℃ in THF yields side-on ferric heme-peroxide complex [(F8)Fe
III-
(O2
2–)]– (P) with UV-vis spectral features at 434, 541 and 561 nm (Figure 4.2A). These 
electronic absorption spectra are the same as those known for other previously well-
characterized side-on ferric porphyrin peroxide complexes which have low energy Soret 
band and two peaks between 500 and 600 nm at α, β-region.11,49,63,64 Valentine and co-
workers63 originally discovered and characterized such species and synthesized them by 
the reaction of potassium superoxide solubilized with 18-crown-6 ether, where the first 
superoxide anion reduced a porphyrinate-FeIIICl (porphyrinate-H2 = TPP, OEP)
65 to the 
FeII form which then reacted with another equiv of superoxide anion to give the 
[(porphyrinate)FeIII(O2
2–)]– species with side-on bound peroxide ligand (see diagram 
below). These species do not possess an additional axial ligand, as deduced 
previously,11,49,63,64 and supported by the X-ray structure of a manganese analog 
[(TPP)Mn(η2-O2






Previously, our complex P was characterized by UV-vis, EPR (g = 4.2 (S = 3/2); 
see Figure 4.3) and 1H NMR  spectroscopies.60 Further characterization of P was carried 
out and 2H NMR and rR spectroscopies are presented here. The pyrrolic proton in 2H NMR 
spectroscopy at –80 °C resonates at δ 92.7 ppm (Figure 4.4), and this feature is consistent 
with the previously reported 1H NMR spectroscopic signature (90 ppm).60 Resonance 
Raman experiments confirmed peroxide formulation for P, with the observation of νO−O 
vibration (806 cm–1, ∆18O2 = –46 cm
–1) and νFe−O stretch (466 cm
–1, ∆18O2 = –19 cm
–1) as 
shown in Figure 4.2B. These observed stretching frequency values match those calculated 
using the harmonic oscillator model: ΔO−O,calc (
16O2/




= –21 cm–1. The relatively low Fe–O stretching frequency, which results from the 
symmetric stretching vibration of a side-on bound peroxide ligand, is similar to that in two 
other similarly structured heme peroxo compounds (vide infra, Table 4.1)49 as well as 
nonheme68–70 side-on peroxide complexes. It is notable that νFe−O in these compounds is 
considerably reduced compared to what is observed for oxy-heme (i.e., FeII-(O2)) species 
like oxy-myoglobin (νFe−O = 570 cm
–1),71 which we are referring to as ferric superoxide 
complexes. When strong acid, triflic acid (HOTf), is utilized to protonate peroxide species 
P, H2O2 is released as expected and a yield of 95.5% is obtained (see Figure 4.5 and 
Experimental Section). If no hydrogen peroxide had been released with the acidification, 
it would have likely meant that reductive O–O cleavage (to give water) had somehow 








Figure 4.2 (A) UV-vis spectra of [(F8)Fe
III-(O2
•–)] (S) (red) to [(F8)Fe
III-(O2
2–)]– (P) (blue) 
in THF at –80 ℃. (B) Resonance Raman spectra of ferric peroxide complex P in frozen 
THF obtained at 77 K with 413 nm excitation: Fe–O and O–O stretching frequencies for 
the complex generated with 16O2 (black) or 
18O2 (red). The 
16O2–
18O2 difference spectrum 
is shown in blue. The bands at 900 and 1000 cm–1 are vibrations within the porphyrin ring, 
which are generally observed for hemes and minimally impacted by O2 isotope substitution 




Figure 4.3 Frozen THF solution EPR (10K) spectrum of the side-on bound ferric heme 
peroxide complex [(F8)Fe
III-(O2






Figure 4.4 2H-NMR spectra of (a) d8-(F8)Fe
II, (b) d8-[(F8)Fe
III-(O2
•–)] and (c) d8-[(F8)Fe
III-
(O2
2–)]– (d) the reaction of superoxide d8-[(F8)Fe
III-(O2
•–)] with TEMPO–H in THF at –
80 ℃, indicating that a low-spin ferric-heme is formed (and see the text). The sharp peaks 













Table 4.1 Resonance Raman stretching frequencies (cm–1) of side-on ferric peroxide and 
end-on ferric hydroperoxide complexes 
complex νO–O (Δ18O2) νFe–O (Δ18O2) ref 
[(TMPIm)FeIII-(O2
2–)]– 807 (–49) 475 (–20) 48 
[(TMP)FeIII-(O2
2–)]– 809 (–45) 470 (–19) 48 
[(F8)Fe
III-(O2
2–)]– (P) 806 (–46) 466 (–19) this work 
Mb WT       –  617 (–15) 79 
Cyt P450 WT 799 (–40) 559 (–27) 81 
Cyt P450 D251N 774 (–37) 564 (–28) 82 
LPO       – 604 (–24) 117 
[(TMPIm)FeIII-(O2H)] 810 (–47) 570 (–26) 48 
[(TMPImXOMe)FeIII-(O2H)] 807 (–41) 575 (–25) 49 
[(TMPImOH)FeIII-(O2H)] 807 (–40) 579 (–28) 51 
[(TMPImOEt)FeIII-(O2H)] 811 (–42) 576 (–27) 51 
[(α4-FeEs4)-O2H] 830 (–47) 631 (–37) 80 
[FeIII-O2H(SQ)] 783 (–35) 531 (–20) 44 
[(F8)Fe




Figure 4.5 Calibration curve used for H2O2 quantification by the horseradish peroxidase 
(HRP) test. See experimental section for details. 
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4.2.2 Generation and characterization of [(F8)FeIII-(OOH)] (HP) 
The addition of one equiv 2,6-lutidinium triflate [(LutH+)](OTf) or 
[(H)DMF](OTf)74 to the solution of [(F8)Fe
III-(O2
2–)]– (P) at –80 ℃ in THF leads to 
protonation of this side-on ferric heme peroxide complex to form a corresponding ferric 
heme hydroperoxide species, [(F8)Fe
III-(OOH)] (HP). UV-vis spectra of HP exhibit 
absorptions at 418, 536 and 558 nm (Figure 4.6), while an EPR spectrum indicates 
distinctive changes from the side-on peroxide g = 4.2 signal observed in P, to a low-spin 
ferric hydroperoxide species characterized by g = 2.23, 2.14 and 1.96 signals (Figure 4.7A), 
very similar to published values for other ferric end-on hydroperoxide synthetically derived 
complexes,45,49,50,52,75–77 as well as for ferric heme hydroperoxides generated within 
hemoglobin and myoglobin.78,79 Consistent with our complex formulation as [(F8)Fe
III-
(OOH)] (HP), a high yield (93.3%) of H2O2 was detected when we acidified the complex 
solution with triflic acid (HOTf) and applied the a quantitative horseradish peroxidase 
assay (see Figure 4.5 and experimental section).72,73 
The characterization of [(F8)Fe
III-(OOH)] (HP) was further corroborated by rR 
spectroscopy. The rR spectra of HP are indicative of a clear change in the νFe−O vibrational 
stretch mode on protonation, shifting from 466 cm-1 (∆18O2 = –19 cm
–1) in side-on ferric 
peroxide species P to 576 cm-1 (∆18O2 = –25 cm
–1) in hydroperoxide complex HP, whereas 
the νO−O vibrational frequency remains the same, appearing at 806 cm
–1 (∆18O2 = –46 cm
–
1) as shown in Figure 4.7B. These νFe−O and νO−O vibrational stretching frequency 
downshifts when using 18O2 match well with values calculated using the harmonic 
oscillator model: ΔFe−O,calc (
16O2/
18O2) = –26 cm
–1, ΔO−O,calc (
16O2/
18O2) = –47 cm
–1. Also, 
these observed νFe−O and νO−O vibrational values are quite similar to those obtained in other 
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low-spin end-on ferric heme hydroperoxide model complexes (Table 4.1), those from the 
groups of Naruta49,50,52 and Dey80 and their co-workers. This also well matches data 
obtained from cryogenically ferric hydroperoxide species generated in CYP450’s,81,82 even 
though the latter have axial cysteinate ligands which makes the coordination environment 
very different as compared to those for the synthetic analogues (Table 4.1). The combined 
spectroscopic data (UV-vis, EPR and rRaman) support the formulation of HP as a low-
spin end-on (η1) ferric hydroperoxide species. We postulate that HP most likely possesses 
a solvent THF molecule (Figure 4.6), as we know this can confer low-spin character to six-
coordinate ferric hemes with F8;
61,62,83 there exists the possibility the axial ligand is 2,6-




Figure 4.6 UV-vis spectra of illustrating the conversion of [(F8)Fe
III-(O2
2–)]– (P) (blue) to 
form [(F8)Fe










Figure 4.7 (A) Frozen THF solution EPR (10K) spectrum of HP. (B) Resonance Raman 
spectra of ferric hydroperoxide complex HP in frozen THF obtained at 77 K with 413 nm 
excitation: Fe–O and O–O stretching frequencies for the complex generated with 16O2 
(black) or 18O2 (red). The 
16O2–
18O2 difference spectrum is shown in pink. Note that 
complex P is present as an impurity, observed as a set of 16O2/
18O2 peaks at 466/447 cm
–1 
(marked with an asterisk). 
 
4.2.3 Comparison of this work with previously reported hydroperoxide ferric hemes 
It has been generally difficult to cleanly synthesize ferric heme hydroperoxide 
compounds. Tajima and co-workers75,77,84 reported low-spin ferric hydroperoxide 
complexes which are in accord with a FeIII-heme(-OH)(-OOH) formulation, based on UV-
vis and EPR spectroscopies. Significant advances were made by Naruta and co-workers49 
who extensively characterized an end-on ferric hydroperoxide complex, that shown in 
Figure 4.8B.14,20 It was generated by protonation of the seven-coordinated side-on peroxide 
species [(TMPIm)FeIII-(O2
2–)] (Figure 4.8A) with ligated axial imidazole ligand from the 
covalently attached tether, wherein a spin state change from S = 3/2  (νFe−O = 470 cm
–1 
(∆18O2 = –19 cm
–1); νO−O = 809 cm
–1 (∆18O2 = –45 cm
–1)) to low-spin (νFe−O = 570 cm
–1 
(∆18O2 = –26 cm
–1); νO−O = 810 cm
–1 (∆18O2 = –47 cm
–1)) occurred (Table 4.1).49 Therein, 
a covalently appended axial imidazole ligand was critical to give a stable 6-coordinate 
ferric heme hydroperoxide complex. In the absence of the imidazolyl axial ligand (Figure 
117 
 
4.8), only decomposition occurred upon protonation. In other case, Anxolabéhère-Mallart 
and co-workers76 generated a ferric heme hydroperoxide complex in the presence of 1-
methylimidazole as sixth ligand by protonation of its side-on ferric peroxide precursor 
which is formed from the electrochemical reduction of an in situ formed ferric superoxide 
species. A significant difference in synthetic protocols occurs with our case (vide supra); 
while Naruta and co-workers postulated that methanol was the proton source converting 
peroxide to hydroperoxide complex, a stronger acid ([(LutH+)](OTf) or [(H)DMF](OTf)) 
was required in our case, but a strong  axial base ligand was not necessary. 
 




4.2.4 Reduction potential of the [(F8)FeIII-(O2•–)] (S)/ [(F8)FeIII-(O22–)]– (P) 
When we set out this study, one of the main goals was to see if we could determine 
a reduction potential for a superoxide [(F8)Fe
III-(O2
•–)] (S) conversion to side-on peroxide 
complex [(F8)Fe
III-(O2
2–)]– (P). In order to do this accurately it needed to be shown that 
reduction of S to P is a reversible reaction. In fact, we find this to be the case; [(F8)Fe
III-
(O2
•–)] (S) and peroxide [(F8)Fe
III-(O2
2–)]– (P) are interconvertible using redox reagents. 
Addition of the strong oxidant, [(4-BrC6H4)3N](SbCl6) (Tris(4-bromophenyl)ammoniumyl 
cation, known as Magic Blue because of its intense royal blue color; E1/2 = 0.67 V vs. Fc
+/0 
in MeCN)85 to the solution of P results in complete oxidative conversion of the peroxide 




Figure 4.9 UV-vis spectra demonstrating the oxidation of [(F8)Fe
III-(O2
2–)]– (P) (blue) to 
form [(F8)Fe
III-(O2
•–)] (S) (red) in THF at –80 ℃. A spectrum (gray lines) was recorded 
every ~2 min; the reaction goes to completion in ~ 20 min. Also, see the text.  
 
Observations supporting this conclusion are that the product solution containing 
[(F8)Fe
III-(O2
•–)] (S) is EPR silent (10 K, THF) as expected; the low-spin FeIII ion is 
antiferromagnetically coupled with the unpaired electron of the directly coordinated 
superoxide radical anion. Interestingly, the addition of the weaker reductant, Cr(η-C6H6)2 
(E1/2 = –1.15 V vs. Fc
+/0 in CH2Cl2),
85 to the solution of S leads to the formation of an 
equilibrium mixture of superoxide S and peroxide P, allowing the determination of the 
reduction potential for the superoxide (S)/peroxide (P) couple. A titration of superoxide S 
with varying amounts of Cr(η-C6H6)2 in THF at –80 ℃ was monitored by UV-vis 
spectroscopy (Figure 4.10), allowing the determination of an equilibrium constant value in 
each instance of added bis-benzene chromium(0) titrant (Table 4.2); the UV-vis 
absorptions for S and P gave direct determination of their concentrations, thus defining the 
amount/concentration of Cr(η-C6H6)2 reacted and of [Cr(η-C6H6)2]
+ formed. From the 
collection of calculated equilibrium constants, corresponding reduction potentials were 
determined by using the Nernst equation (E = E°’ – (RT/nF)ln(Q)). Thus, the reduction 




2–)]– (P) couple was calculated to be –
1.17 ±  0.01 V vs. Fc+/0 (for which E°’ = –0.39 V vs. SHE in THF). See Table 4.2 for further 
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details. A further demonstration of the reversibility of the reduction and oxidation of 
complex S/P was established; Peroxide species P generated by Cr(η-C6H6)2 could be fully 
oxidized back to superoxide S using Magic Blue and again, this resulting solution could be 




Figure 4.10 Conversion of [(F8)Fe
III-(O2
•–)] (S) (red) to [(F8)Fe
III-(O2
2–)]– (P) (blue) upon 
addition of Cr(η-C6H6)2 in THF at –80 ℃, resulting in the generation of equilibrium 
mixtures which allowed the determination of the reduction potential (–1.17 V vs. Fc+/0) of 
the S/P redox couple. Inset: monitoring the absorbance at 434 nm upon addition of various 






Table 4.2 Equilibrium concentrations and calculated Es values for the titration of Cr(η-
C6H6)2 into a solution of [(F8)Fe
III-(O2
•–)] (S) in THF at –80 °C 
 
[Cr(C6H6)2]added [Cr(C6H6)2]eq [Peroxide]eq [Superoxide]eq [Cr(C6H6)2]+eq Keq 
1.00 x 10-5 1.44 x 10-6 8.56 x 10-6 3.14 x 10-5 8.56 x 10-6 6.18 x 10-1 
3.91 x 10-5 1.64 x 10-5 2.33 x 10-5 1.67 x 10-5 2.33 x 10-5 5.01 x 10-1 
4.95 x 10-5 2.25 x 10-5 2.70 x 10-5 1.30 x 10-5 2.70 x 10-5 4.03 x 10-1 
5.92 x 10-5 2.49 x 10-5 3.44 x 10-5 5.62 x 10-6 3.44 x 10-5 1.18 x 10-1 









Figure 4.11 Addition of 1 equiv of magic blue to [(F8)Fe
III-(O2
2–)]– (P) (blue) generated 
by Cr(η-C6H6)2 from [(F8)Fe
III-(O2
•–)] (S), regenerates the formation of S (red) and again, 
upon addition of 5 equiv of Cr(η-C6H6)2, to this resulting solution, [(F8)Fe
III-(O2
2–)]– (P) 
(purple) is formed to the extent of ~85%. 
 
Keq Es (mV) 
6.18 x 10-1 –1.16 
5.01 x 10-1 –1.16 
4.03 x 10-1 –1.17 
1.18 x 10-1 –1.19 
1.08 x 10-1 –1.19 
121 
 
Recently, Naruta and co-workers52 reported the reduction potential (–0.67 V and –
1.1 V vs. SHE) of various ferric heme superoxide synthetic compounds, not experimentally 
but by employing density functional theory (DFT) calculations. Thus, these values are 





2–)]– (P) redox couple, E°’ = –0.39 V vs. SHE in THF at –80 °C. Anxolabéhère-Mallart, 
Fave and co-workers76 recently reported on the electrochemical generation of the side-on 
peroxide species [FeIII(F20TPP)(O2)]
− (EPR; g = 4.2) by applying a cathodic potential (Eapp 
= –0.60 V vs. SCE; –0.36 V vs. SHE) to the corresponding superoxide precursor in 
dimethylformamide at –30 °C. The electrochemical reduction was found to be irreversible, 
nevertheless the finding of ferric heme superoxide complex reduction at E°’ = –0.60 V vs. 
SCE (–0.36 V vs. SHE) is most interesting since it lies very close to our own result (vide 
supra). For Anxolabéhère-Mallart, Fave and co-workers, the superoxide and peroxide 
complexes employed the highly electron-withdrawing heme (F20TPP) with 20 aryl fluorine 
substituents; no axial base ligand was utilized. Roughly, the comparison of reduction 
potential of –0.36 V for the F20TPP containing ferric heme superoxide, as well as the –0.39 
V value for reversible reduction of  [(F8)Fe
III-(O2
•–)] with the far more negative potentials 
(vide supra) observed for the various [(P)FeIII-(O2
2–)] complexes from Naruta and co-
workers, possessing a more electron-rich porphyrinate with axial imidazole (TMPImOH,OEt; 
Figure 4.12), may make sense. (See Table 4.3 for comparison of reduction potential 
values.)86 Interestingly, computational chemists have estimated the reduction potential for 
the ferric heme superoxide species in CYP450 (Scheme 4.1); depending on “chosen model, 
QM region, and protonation state”, the values obtained range from –2.28 to –1.04 V vs. 
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SHE.5 Perhaps this is most reasonable, as the axial cysteinate ligand in CYP450’s is a 




Figure 4.12 Diagrams of hydroperoxide complexes from Naruta and coworkers, not shown 





Table 4.3 Thermodynamic information (reduction potential and pKa) and OO–H bond 
dissociation free energy (BDFE)s (kcal/mol) 
 
complex 












(TMPImOH)FeIII –1.32a 25.1a — — 51 
(TMPImOEt)FeIII –1.75a 32.3a — — 51 
(F20TPP)FeIII –1.09b — — — 76 
(por)(Im)FeIII — — 66.2c — 91 
(por)(SH)FeIII — — 63.9c — 91 
(F8)FeIII –1.17 28.8 — 73.5d  this work 
aCalculated in EtCN using DFT 
bMeasured in DMF by CV 
cCalculated in MeCN using DFT, BDE not BDFE 




4.2.5 Determination of the pKa Value of [(F8)FeIII-(OOH)] (HP) 
As mentioned in the Introduction, for the thermodynamic square scheme, the pKa 
value of hydroperoxide [(F8)Fe
III-(OOH)] (HP) has been determined in THF at –80 ℃. It 
was evaluated by spectral titration using the derivatized phosphazene base EtP2(dma) (pKa 
= 28.1 in THF, for the conjugate acid at room temperature, see diagram below).87  
 
As shown by a titration followed by UV-vis spectroscopy (Figure 4.13), the 
absorption band at 418 nm of HP decreased with increasing concentration of added 
EtP2(dma), and the absorption band shifted to 434 nm, with observation of an isosbestic 
point at 426 nm. Such additions gave rise to an equilibrium mixture of hydroperoxide HP 
and the side-on peroxide complex [(F8)Fe
III-(O2
2–)]– (P) (see Table 4.4). From this data, an 
equilibrium constant for this reaction was calculated in each instance and using the known 
pKa value of EtP2(dma), a pKa value for deprotonation of HP was determined to be 28.8 ± 
0.5 (THF, –80 °C). Following addition of excess base EtP2(dma), only the deprotonated 
complex P remained. As suggested by the data, the acid-base reaction interconversion of 
HP and P is reversible. This was further shown by adding [(LutH+)](OTf) to the solution 
generated in this titration (Figure 4.13), this gives the fully regenerated hydroperoxide 
complex HP (see Figure 4.14 for details). In order to corroborate the [(F8)Fe
III-(OOH)] 
(HP) pKa value determined experimentally, a complementary experiment was conducted 
employing the conjugate acid of EtP2(dma), i.e., as expected, based on relative pKa values, 
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the addition of EtP2(dma)H
+ (pKa = 28.1) to peroxide [(F8)Fe
III-(O2
2–)]– (P) results in the 
ready protonation and formation of HP (see Figure 4.15).  
 
Figure 4.13 UV-vis spectroscopic monitoring of the incremental addition of EtP2(dma) to 
a solution of [(F8)Fe
III-(OOH)] (HP) (pink) resulting in the formation of equilibrium 
mixtures of HP, EtP2(dma), [(F8)Fe
III-(O2
2–)]– (P) (blue) and protonated base EtP2(dma)H
+ 
which allowed the determination of the pKa value (28.8) of HP. Inset: monitoring of the 
absorbance at 434 nm (blue). 
 
Table 4.4 Equilibrium concentrations and calculated pKa values for the titration of 
EtP2(dma) into a solution of [(F8)Fe






[EtP2(dma)]added [Peroxide]eq [EtP2(dma)]eq [Hydroperoxide]eq [EtP2(dma)H+]eq Keq 
2.93 x 10-5 2.16x 10-5 7.71 x 10-6 1.63 x 10-5 2.16 x 10-5 3.68 
3.88 x 10-5 2.54 x 10-5 1.34 x 10-5 1.24 x 10-5 2.54 x 10-5 3.87 
4.83 x 10-5 2.96 x 10-5 1.86 x 10-5 8.30 x 10-6 2.96 x 10-5 5.64 
5.77 x 10-5 3.44 x 10-5 2.33 x 10-5 3.52 x 10-6 3.44 x 10-5 14.3 
7.62 x 10-5 3.68 x 10-5 3.94 x 10-5 1.14 x 10-6 3.68 x 10-5 29.8 
Keq pKeq pKa 
3.68 –0.56 28.6 
3.87 –0.58 28.6 
5.64 –0.75 28.8 
14.3 –1.15 29.2 





Figure 4.14 Addition of EtP2(dma) to the solution of [(F8)Fe
III-(OOH)] (HP) (pink), 
obtained via the protonation of [(F8)Fe
III-(O2
2–)]– (P) using [(LutH+)](OTf), regenerates 
complex P (blue). This resulting solution can (again) be protonated to give full formation 
of HP (purple) by adding 3 equiv of [(LutH+)](OTf); the small excess of acid was required 





Figure 4.15 Addition of 10 equiv. of [EtP2(dma)(Lu)H](OTf) (generated in situ from 
addition of 1equiv. of [(LutH+)](OTf) to EtP2(dma) in THF) to [(F8)Fe
III-(O2
2–)]– (P) (blue) 
leads to the formation of [(F8)Fe




As discussed above, Naruta and co-workers52 synthetically generated several ferric 
heme hydroperoxide complexes. They did address the question of pKa values, but only 
computationally. For two ferric hydroperoxide complexes they described, possessing 
modified superstructured synthetic hemes (see Figure 4.12), their DFT determined pKa 
values were 25.1 or 32.3 in EtCN as a solvent. In reality, these values are not so different 




4.2.6 Determination of the OO–H BDFE of [(F8)FeIII-(OOH)] (HP) 
The bond dissociation free energy (BDFE) is the thermodynamic parameter used to 
compare the energy, i.e., bond strength, for homolytic bond cleavage of a two atom-
centered unit. In order to determine the BDFE, we utilized the Bordwell equation (eq. 1)88 
which uses Hess’ law with the redox potential and acidity based on a thermodynamic cycle. 
Thus, using the measured thermodynamic parameters, E°’ (–1.17 V vs. Fc+/0, vide supra) 
and pKa (28.8, vide supra), a thermodynamic square scheme is completed as shown in 
Figure 4.1 and this leads to a BDFE of 73.5 ± 0.9 kcal/mol for the OO–H bond in 
hydroperoxide [(F8)Fe
III-(OOH)] (HP) according to eq. 2 where CG is 61 kcal/mol in 
THF.89  
 
BDFEO–H = 1.37(28.8) + 23.06(–1.17) + 61 = 73.5 kcal/mol             (2) 
 
As mentioned, this is to our knowledge the first case where a BDFE value has been 
reported using experimentally derived thermodynamics (reduction potential and pKa) for a 
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heme system, those involving O2 or its reduced derivatives.
90 Morokuma and co-workers91 
computationally evaluated aspects of other heme-superoxide (as well as other metal-
superoxide) species, and their findings are also in accord with the present results, i.e., that 
for [(F8)Fe
III-(OOH)], BDFE = 73.5 kcal/mol. For heme ferric superoxide complexes 
modeling protein active sites (e.g., hemoglobin, CYP450) where a proximal ligand is either 
an imidazole or an -SH group (the latter as a computational model for the cysteinate 
proximal ligand in CYP450’s), i.e., (B)(porphyrinate)FeIII-O2
•– (B = imidazole, SH) the 
ferric heme hydroperoxide complex OO–H BDE’s are calculated to be in the range 64–66 
kcal/mol. Lai and Shaik18 also computationally found that a CYP450 ferric heme 
superoxide is a “sluggish oxidant”. 
Corresponding OO–H BDFE (or BDE) values for a few product non-heme iron-
hydroperoxide complexes are known, but these tetramethylcyclam (TMC) ligand derived 
complex results come only through computational evaluation.91,92 These have recently 
been compared to experimental results on cobalt and other heavier metal-superoxide 
complexes.93 Dicopper(II)-μ-hydroperoxide complex OO–H BDFE’s have recently been 
determined.89,94 In one case, the BDFE is 72 kcal/mol, while in another example, the 
binucleating ligand utilized results in a hydroperoxide OO–H BDFE of 81 kcal/mol. Thus, 
the corresponding dicopper(II)-μ-superoxide complex is a quite strong oxidant for HAT 
reactivity. Experimentation and compilation of O–H bond thermodynamic parameters (i.e., 
BDE’s or BDFE’s) of dioxygen-derived species (M-OH, M-OOH or M-oxo species formed 
from O2-reduction/protonation) bound to metal complexes, is of considerable general 




4.2.7 Reactivity Studies of [(F8)FeIII-(O2•–)] (S) with O–H, C–H and N–H substrates  
One of the utilities of BDFE data is to determine or estimate the oxidative reactivity 
in this case of the ferric heme superoxide complex. Hydrogen atom transfer oxidation of 
substrates for [(F8)Fe
III-(O2
•–)] (S) would afford the corresponding hydroperoxide analog, 
[(F8)Fe
III-(OOH)] (HP). With an HP BDFE experimentally determined to be 73.5 kcal/mol, 
we can expect that S would only be capable of HAT reactions with substrates such as C–
H, N–H or O–H BDFE’s below or near this value.96 So, we have probed these possibilities. 
Addition of an excess of higher BDFE substrates than 73.5 kcal/mol (i.e., p-methoxyphenol, 
BDFE = 83.1 kcal/mol in THF; fluorene, 76.8 kcal/mol in THF; 9,10-dihydroanthracene, 
76 kcal/mol in DMSO; p-OMe-2,6-di-tert-butylphenol, 75.8 kcal/mol in THF)59,89 to 
solutions of [(F8)Fe
III-(O2
•–)] (S) at –80 ℃ in THF led to no reaction, as expected. Also, no 
reaction occurs with similar BDFE substrates for HP, such as 1,4-cyclohexadiene (72.9 
kcal/mol in MeCN) and xanthene (72.2 kcal/mol in THF).89 By contrast, BNAH (1-benzyl-
1,4-dihydronicotinamide, 70.7 kcal/mol in DMSO),97 phenylhydrazine (70.4 kcal/mol in 
MeCN) and diphenylhydrazine (67.1 kcal/mol in DMSO)59 do react rapidly with complex 
S, but we were not able to determine if the initial reaction is actually HAT; based on UV-
vis spectroscopic monitoring, the expected hydroperoxide product, [(F8)Fe
III-(OOH)] (HP), 
was not observed at the end of the reaction; probably HAT occurs, but side-reactions 
prevent clean formation of HP.  However, the addition of TEMPO–H (66.5 kcal/mol in 
THF)89 to a solution of S in THF at –80 ℃ led to shifting of the UV-vis spectrum (Figure 
4.16A), i.e., yielding an absorption at 418 nm, corresponding to HP, suggesting that 
substrate hydrogen atom abstraction reaction occurred. Note that this HAT reaction from 
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TEMPO–H to complex S is thermodynamically downhill by ca. 7 kcal/mol, thus predicted 
to be quite favorable. 
 
 
Figure 4.16 (A) UV-vis spectroscopic monitoring the reaction of [(F8)Fe
III-(O2
•–)] (S) (red) 
with TEMPO–H in THF at –80 ℃ to yield [(F8)Fe
III-(OOH)] (HP) (pink). (B) 10 K EPR 
spectrum of the final products of TEMPO–H HAT by S in frozen THF. The yield of 
hydroperoxide HP is 94.2 % based on the absorbance and known absorptivity of HP at 418 
nm. Spin quantification finds that the EPR signal corresponds to 92% of TEMPO radical. 
 
Complementary experiments were performed, confirming generation of 
hydroperoxide species from the reaction between [(F8)Fe
III-(O2
•–)] (S) and TEMPO–H. For 
one thing, addition of EtP2(dma) base to the product mixture led to the formation of 
peroxide species P based on UV-vis spectroscopy (Figure 4.17). Further, frozen solution 
EPR spectroscopy was also performed and this revealed a signal at g = 2 attributed to the 
TEMPO radical, appearing ‘on top of’ the signal expected for low-spin HP (Figure 4.16B), 
confirming H-atom abstraction by S from TEMPO–H. In addition, the final product 
exhibits upfield-shifted pyrrole resonance (δpyrr –0.63 ppm) in 
2H NMR spectroscopy, 
indicative of a six-coordinate ferric low-spin (S = 1/2) heme (Figure 4.4).98,99  
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For further insights into the nature of the hydrogen atom abstraction from TEMPO–
H by S, kinetic studies were carried out in THF at –80 ℃ via UV-vis spectroscopy (Figure 
4.16). The rate of formation of hydroperoxide HP obeyed pseudo-first-order kinetics 
(Figure 4.18) when the reaction was conducted with excess TEMPO–H, and the observed 
pseudo-first-order constants (kobs) are proportional to concentrations of TEMPO–H as 
shown in Figure 4.19 with an effectively zero intercept within error. According to this plot 
of kobs vs [TEMPO–H], the second order rate constant k2 was obtained to be 0.5 M
–1s–1 in 
THF at –80 ℃. When deuterated substrate, TEMPO–D, was treated to [(F8)Fe
III-(O2
•–)] (S), 
a significant slowing of the reaction occurred; k2 = 0.08 M
–1s–1 in THF at –80 ℃ (Figure 
4.20). The comparison of the rate constants for H vs. D provides for a significant kinetic 
deuterium isotope effect (KIE) of 6 in THF at –80 ℃ as shown in Figure 4.19, strongly 
suggesting that H-atom abstraction by S is the rate-determining step. 
There have been no prior reports of kinetic information to compare the reactivity 
of [(F8)Fe
III-(O2
•–)] (S) with other heme-superoxide complexes reacting with TEMPO–H. 
{Note: There is a study from Mayer and co-workers,100 where a heme FeIII-OH complex 
reacts with TEMPO–H, k2 = 76 M
−1s−1 at room temperature in toluene}. However, second 
order rate constants (k2) for non-heme metal-superoxide (i.e., M
n+-(O2
•–)) complexes (M = 
Cu, Mn, Co and Cr) involved in HAT reactions with TEMPO–H have been reported in a 






Figure 4.17 Addition of EtP2(dma) to product mixture of [(F8)Fe
III-(O2
•–)] (S) with 
TEMPO–H reaction (pink spectrum) leads to the formation of peroxide species [(F8)Fe
III-
(O2







Figure 4.18 Pseudo-first-order plots for the reactions of [(F8)Fe
III-(O2
•–)] (S) (0.04 mM) 
and (A) 0.4 (B) 1.2 (C) 2.0 (D) 2.8 (E) 3.6 mM of TEMPO–H to determine pseudo-first-





Figure 4.19 Plots of pseudo first order rate constants (kobs) plotted against various 
concentrations of TEMPO–H(D) to obtain the second order rate constant, kH = 5.0 x 10
–1 
M–1s–1 (black circle) and kD = 0.8 x 10








Figure 4.20 Pseudo-first-order plots for the reactions of [(F8)Fe
III-(O2
•–)] (S) (0.04 mM) 
and (A) 0.4 (B) 1.2 (C) 2.0 (D) 2.8 (E) 3.6 mM of TEMPO–D to determine pseudo-first-






Table 4.5 Kinetic studies for non-heme metal-superoxide (Mn+-(O2
•–)) complexes (M = Cu, 
Mn, Co and Cr) with TEMPO–H 
complex  k2 (M–1s–1)h temp, solvent ref 
[L1CuII(O2
•−)]PF6
a 2.4 −85 °C in acetone 101 
[L2CuII(μ-1,2-O2
•−)]BPh4
b 0.13 −20 °C in MeCN 94 
[K(Krypt)][L3Cu(O2
•−)]c 34.9 −80 °C in THF/MeCN 10:1 102 
[Mn(BDPBrP)(O2
•−)]d 500 −90 °C in THF 103 
[Co(BDPP)(O2
•−)]e 0.97 −90 °C in THF 103 
[Co(O2)(Me3TACN)(S2SiMe2)]
f 0.87 −105 °C in MeTHFi 93 
[iPrL2Cr]Li2O2(EtCN)4
g 306.6 −80 °C in EtCN 104 
aL1 = 1-(2-phenethyl)-5-[2-(2-pyridyl)ethyl]-1,5-diazacyclooctane 
bL2 = tacn/pyrazolate hybrid ligand 
cL3 = bis(arylcarboxamido)-pyridine ligand 
dH2BDPBrP = 2,6-bis((2-(S)-di(4-bromo)phenylhydroxyl-methyl-1-pyrrolidinyl)methyl)-pyridine 
eH2BDPP = 2,6-bis((2-(S)-diphenylhydroxylmethyl-1-pyrrolidinyl)methyl)pyridine 
freactivity with 4-OMe-TEMPO-H, deuterium-KIE = 8.8 
gL = −OiPr2SiOSiiPr2O− 
hsecond order rate constants 
i2-methyltetrahydrofuran 
 
As mentioned in the Introduction, recent review articles detail metal-superoxide 
complexes of the first row transition metals.56,57 Prior computationally derived 
generalizations concerning metal superoxide reactivity have been published;91,105 substrate 
reactivity depends on factors such as electrophilicity, reaction driving force, and coupling 
between the metal center and superoxide ligand. A CYP450 ferric superoxide is a weak 
oxidant for HAT, possessing  large activation energy barriers.18 These results are consistent 
with our findings where superoxide complex reacts by HAT with an exogenous weak O–
H (and perhaps N–H and C–H, vide supra) substrate. Also, a few potentially biologically 
relevant non-heme iron superoxide complexes are capable of abstracting hydrogen atom 
from weak X–H substrates such as 2,4-di-tert-butyl phenol,106 2-hydroxy-2-azaadamantane 
134 
 
(AZADOL), phenylhydrazine (X–H < 72.6 kcal/mol)107 and 9,10-dihydroanthracene 
(DHA; BDE = 76 kcal/mol).108,109 
 
4.3 Conclusions 
The side-on ferric peroxide species [(F8)Fe
III-(O2
2–)]– (P) generated from [(F8)Fe
III-
(O2
•–)] (S) by one electron reduction, is protonated by acids such as [(LutH+)](OTf) to form 
the end-on ferric hydroperoxide complex [(F8)Fe
III-(OOH)] (HP) which has been 
characterized by UV-vis, EPR and rR spectroscopies. Thus, the stepwise generation of 
superoxide (S), peroxide (P) and hydroperoxide (HP) analogs which are involved in 
catalytic cycle of CYP450 (Scheme 4.1) or many other heme enzymes (see the Introduction) 
are completed through reduction and protonation processes as outlined in Figure 4.1. More 
importantly, by direct experimentation, the reduction potential of the superoxide species 
[(F8)Fe
III-(O2
•–)] (S), and the pKa value for the hydroperoxide analog [(F8)Fe
III-(OOH)] (HP) 
have been established. With these parameters in hand, the O–H BDFE of HP could be 
calculated (73.5 kcal/mol). This work describes the first example of experimentally 
determined thermodynamics (reduction potential and pKa) interrelating S, P, and HP 
species while also demonstrating the generation of the ferric hydroperoxide complex (HP) 
using an exogenous substrate (TEMPO–H) for HAT by the ferric heme superoxide species 
(S). These results advance the literature concerning the thermodynamics of heme 
complexes while further showing the utility of synthetic model compounds to provide 
fundamental insights relevant to reaction cycles of heme enzymes. 
As mentioned in Introduction, the peroxide intermediate in catalytic cycle of 
CYP450 (Scheme 4.1) is thought to have an end-on (η1) geometry. Davydov, Sligar, 
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Hoffman, and co-workers42 detected this end-on bound peroxide intermediate by 
employing γ-irradiation at cryogenic temperature with P450cam. Thus, one future goal will 
be research relevant to thermodynamic analysis involving end-on ferric heme peroxide 
chemistry. We wish to also further assess whether heme or axial ligation modifications 
may lead to enhancement of the oxidizing capability of a heme-FeII/O2 derived adduct. 
 
4.4 Experimental section 
4.4.1 Materials and methods 
All reagents and solvents purchased and used were of commercially available 
quality except as noted. Inhibitor-free Tetrahydrofuran (THF) was distilled over 
Na/benzophenone under argon and deoxygenated with argon before use. Butyronitrile was 
distilled over sodium carbonate and potassium permanganate and deoxygenated with Ar 
before use. Cobaltocene was obtained from Sigma Aldrich, sublimed at 75°C, and stored 
under nitrogen in the glovebox freezer at –30 °C. The 2,6-lutidinium Triflate 
[(Lu)(H)](OTf) and TEMPO–H(D) were synthesized according to previously published 
literature procedures.110–112 
The preparation and handling of air-sensitive compounds were performed under a 
MBraun Labmaster 130 inert atmosphere (< 1 ppm O2 and < 1 ppm H2O) glovebox filled 
with nitrogen. Dioxygen gas purchased from Airgas and dried through Drierite. 18O2 gas 
was purchased from ICON, Summit, NJ, and 16O2 gas was purchased from BOC gases, 
Murray Hill, NJ. 
All UV−vis measurements were carried out using a Hewlett-Packard 8453 diode 
array spectrophotometer with HP Chemstation software and a Unisoku thermostated cell 
136 
 
holder for low-temperature experiments. A 10 mm path length quartz cell cuvette modified 
with an extended glass neck with a female 14/19 joint, and stopcock was used to perform 
all UV–vis experiments, as previously described.99,113,114 1H and 2H NMR spectra were 
measured on a Bruker 300-MHz NMR spectrometer at ambient or low temperatures. 
Chemical shifts were reported as δ (ppm) values relative to an internal standard 
(tetramethylsilane) and the residual solvent proton peaks. Electron paramagnetic resonance 
(EPR) spectra were recorded with a Bruker EMX spectrometer equipped with a Bruker ER 
041 × G microwave bridge and a continuous flow liquid helium cryostat (ESR900) coupled 
to an Oxford Instruments TC503 temperature controller. Spectra were obtained at 10 K 
under non-saturating microwave power conditions (ν = 9.428 GHz, microwave power = 
0.201 mW, modulation amplitude = 10 G, microwave frequency = 100 kHz, and receiver 
gain = 5.02 × 103).  
The compounds (F8)Fe
II, and the pyrrole deuterated derivative d8-(F8)Fe
II were 
synthesized as previously described.61,115,116  
 
4.4.2 UV-vis spectroscopy 
4.4.2.1 Generation of [(F8)FeIII-(OOH)] (HP) 
After generating complex [(F8)Fe
III-(O2
2–)]– (P),60 1 equiv [(LutH+)](OTf) or 
[(H)DMF](OTf) was added to the solution of P to form [(F8)Fe
III-(OOH)] (HP) in THF at 
–80 ℃. UV-vis: λmax = 418 (ԑ = 157048 M
–1 cm–1), 536 (ԑ = 9782.5 M–1 cm–1) and 558 (ԑ 





4.4.2.2 H2O2 quantification by horseradish peroxidase (HRP) test 
The spectrophotometric quantification of hydrogen peroxide was carried out by 
analyzing the intensity of the diammonium 2,2′-azino-bis(3-ethylbenzothiazoline-6-
sulfonate)(AzBTS-(NH4)2) peaks (at different wavelengths to minimize error, Figure 4.5), 
which was oxidized by horseradish peroxidase (HRP); this was adapted from published 
procedures.72,73 Three stock solutions were prepared: 300 mM sodium phosphate buffer pH 
7.0 (solution A), 1 mg/mL AzBTS-(NH4)2 (solution B) and 4 mg of HRP (type II salt free 
(Sigma)) with 6.5 mg of sodium azide in 50 mL of water (solution C). 3.0 mL of the desired 
[(F8)Fe
III-(O2
2–)]– (P) or [(F8)Fe
III-(OOH)] (HP) solution were generated in THF at –80 ℃, 
as previously described. The reaction which is before and after being quenched by adding 
100μL of triflic acid (HOTf) solution (2.5 equiv) is subject to the H2O2 analysis. 
Subsequently 100 μL of the cold THF sample solution was removed via a syringe and 
quickly added to a cuvette containing 1.3 mL of water, 500 μL of solution A, 100 μL of 
solution B, and 50 μL of solution C (all chilled in an ice bath prior to use). After mixing 
for 15s, the samples were allowed to sit at room temperature for ~2 min until full formation 
of the 418 nm band was observed (Figure 4.5).   
 
4.4.2.3 Determination of the reduction potential of [(F8)FeIII-(O2•–)] (S) 
[(F8)Fe
III-(O2
•–)] (S) generated as previously published61,62 was titrated with 0.25-2 
equiv Cr(η-C6H6)2 in THF at –80 ℃. For each equilibrium mixture, the concentration of 
each species in solution was measured using the absorption at 434 nm (Table 4.2). From 
these equilibrium constants, corresponding reduction potentials were calculated by using 
the Nernst equation.  
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4.4.2.4 Reversibility of [(F8)FeIII-(O2•–)] (S) and [(F8)FeIII-(O22–)]– (P) 
In a Schlenk cuvette, the addition of 1 equiv Magic Blue to a solution of [(F8)Fe
III-
(O2
2–)]– (P) generated from [(F8)Fe
III-(O2
•–)] (S) with 2 equiv Cr(η-C6H6)2 in THF at –80 ℃ 
leads to the formation of [(F8)Fe
III-(O2
•–)] (S) and again, the addition of 5 equiv Cr(η-
C6H6)2 gives back [(F8)Fe
III-(O2
2–)]– (P) (Figure 4.11). 
 
4.4.2.5 Determination of the pKa of [(F8)FeIII-(OOH)] (HP) 
In a Schlenk cuvette, [(F8)Fe
III-(OOH)] (HP) generated as described above, was 
titrated by 0.75-3 equiv EtP2(dma) in THF at –80 ℃. For each equilibrium mixture, the 
concentration of each species in solution was measured using the absorption at 434 nm 
(Table 4.4). From these equilibrium constants, the pKa was calculated. 
 
4.4.2.6 Reversibility of [(F8)FeIII-(O22–)]– (P) and [(F8)FeIII-(OOH)] (HP) 
In a Schlenk cuvette, the addition of 3 equiv EtP2(dma) to solution of [(F8)Fe
III-
(OOH)] (HP) generated as described above, results in the formation of [(F8)Fe
III-(O2
2–)]– 
(P) in THF at –80 ℃ and again, the addition of 3 equiv [(LutH+)](OTf) gives [(F8)Fe
III-
(OOH)] (HP) (Figure 4.14). 
 
4.4.2.7 Reactivity study of [(F8)FeIII-(O2•–)] (S) with TEMPO–H 
Excess amount of TEMPO–H (0.4-3.6 mM) was added to the solution of [(F8)Fe
III-
(O2





4.4.2.8 Kinetic studies of [(F8)FeIII-(O2•–)] (S) with TEMPO–H(D) 
The substrates TEMPO–H(D) (10, 30, 50, 70, 90 equiv) were added via syringe to 
a 0.04 mM solution of [(F8)Fe
III-(O2
•–)] (S) and the following UV-vis spectra were recorded 
(Figure 4.16). The hydroperoxide band at 418 nm appeared with time and the pseudo-first-
order rate plots were observed. The values of kobs were calculated from plots of log[(At-
Af)/(Ai-Af)] vs time (s) (Figure 4.18, 4.20). According to this plot of kobs vs [TEMPO–
H(D)], the second order rate constant k2 was obtained in THF at –80 ℃ (Figure 4.19).  
 
4.4.3 resonance Raman spectroscopy  
In the glovebox, 1 mM solutions of (F8)Fe
II in THF were prepared and transferred 
to rR tube and capped with tightfitting septa. The sample tubes were placed in a cold bath 
(dry ice/acetone) and oxygenated using 16O2 or 
18O2 gases. The oxygenated samples were 
set in a cold bath for 10 min and to the cold THF solution of [(F8)Fe
III-(O2
•–)] (S) was added 
1 equiv CoCp2 for complex [(F8)Fe
III-(O2
2–)]– (P). Subsequently, 1 equiv [(LutH+)](OTf) 
was added for complex [(F8)Fe
III-(OOH)] (HP). Then, the sample tubes were frozen in 
liquid N2 and sealed by flame. Resonance Raman samples were excited at 413 nm, using a 
Coherent I90C-K Kr+ ion laser while the sample was immersed in a liquid nitrogen cooled 
(77 K) EPR finger Dewar (Wilmad). Power was ~2 mW at the sample, which was 
continuously rotated to minimize photodecomposition. The spectra were recorded using a 






4.4.4 EPR spectroscopy 
In a glovebox, 1 mM solutions of (F8)Fe
II in THF were prepared and transferred to 
EPR tube and capped with tightfitting septa. The sample tubes were placed in a cold bath 
(dry ice/acetone) and oxygenated. The oxygenated samples were set in a cold bath for 10 
min and to the cold THF solution of [(F8)Fe
III-(O2
•–)] (S) was added 1 equiv CoCp2 for 
complex [(F8)Fe
III-(O2
2–)]– (P). Subsequently, 1 equiv [(LutH+)](OTf) was added for 
complex [(F8)Fe
III-(OOH)] (HP). Then, the sample tubes were frozen in liquid N2. For EPR 
data for the reaction of [(F8)Fe
III-(O2
•–)] (S) with TEMPO–H, 10 equiv TEMPO–H was 
added to the 1mM solution of S generated as described above. The tube was left at –80 ℃ 
for 1 hour 30 minutes and then frozen in liquid nitrogen. 
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Heme-containing enzymes show diverse biological functions such as substrate 
monooxygenation, oxygen reduction in the respiratory chain, nitric oxide synthesis, 
oxygen storage and delivery, electron transfer, and H2O2 activation and dismutation.
1–5 
Heme enzyme active sites contain a proximal ligand; cytochrome P450s (CYP450s) as well 
as NO synthase and chloroperoxidase utilize a cysteinate residue, whereas other 
peroxidases include a histidyl proximal ligand and catalases possess a tyrosinate ligand. 
The identity and nature of the axial ligand contributes to or defines spectroscopic properties, 
coordination, iron reduction potentials and thus the reactivity. These proximal ligand 
donors contribute the so-called “push effect”, due to their electron donation.1–5 In particular, 
the “push effect” of the anionic thiolate ligand in CYP450s leads to a much more negative 
FeIII/II reduction potential6 and helps effect the heterolytic O–O bond cleavage of a 
hydroperoxide species, forming Compound I (Cmpd I, (P•+)FeIV=O) as the reactive species 
which hydroxylates substrates.1–5  
CYP450s act as monooxygenases transferring one atom of molecular oxygen 
to a substrate, which is either hydroxylated, epoxidized, or sulfoxidized through its 
catalytic cycle.1–5  The latter involves formation of heme FeIII–superoxide (i.e., the 
initial FeII/O2 adduct), with subsequent transformation to Fe
III–peroxide and FeIII–





Figure 5.1 Stepwise generation of superoxide, peroxide, and hydroperoxide heme 
analogues and relevant thermodynamic square scheme (E° as determined vs Fc+/0 
and pKa) and OO–H BDFE of ferric heme hydroperoxide. Ar
F = 2,6-difluorophenyl 






For the three initial FeIII CYP450 intermediates, radiolytic 
cryoreduction/spectroscopic studies and theoretical calculations lead to the 
conclusion that all of these species have an end-on binding geometry, with FeIII-
coordination only to the O2-derived proximal oxygen atom.
9–13 Synthetic 
bioinorganic groups have been interested in the generation and characterization of 
model compounds for the superoxide, peroxide, or hydroperoxide intermediates, as 
relevant to O2 or H2O2 activating heme enzymes. There are many known end-on 
ferric heme superoxide14–24 and hydroperoxide synthetic compounds.8,21,23–27 
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Valentine and co-workers28–30 originally synthesized and characterized a series of 
ferric heme peroxides possessing a side-on bound O2
2– ligand (i.e., η2, with both 
peroxide O-atoms equivalently bound to FeIII). To date, there has been only one 
report of an end-on (η1) bound low-spin peroxide synthetic complex, [(P)FeIII–
(η1:O2
2–)]– (P possesses an internal imidazolyl axial ligand), that by Naruta and co-
workers.21 Recently, our group8,18 reported on an end-on ferric heme superoxide, a 
corresponding hydroperoxide species, and the related ferric heme peroxide, where 
the O2-derived O2
2–  ligand is side-on bound (Figure 5.1, upper right); the chemistry 
was carried out in tetrahydrofuran (THF), which serves as an axial base ligand. In 
that work, thermodynamic parameters, the [(F8)Fe
III–(O2
•ˉ)] (S) reduction potential 
and [(F8)Fe
III–(OOH)] (HP) pKa, led to the determination of the ferric heme 
hydroperoxide BDFE to be 73.5 kcal/mol. 
Herein, the newly generated end-on low-spin peroxide, [(PIm)FeIII–(O2
2–)]– 
(PIm-P), and its subsequent conversion to hydroperoxide species, [(PIm)FeIII–
(OOH)] (PIm-HP) are described utilizing PIm as the porphyrinate; this possesses an 
appended axial base strongly donating imidazolyl group (Figure 5.1), which is the 
same as is suggested to form in CYP450s where the FeIII is bound to only one oxygen 
atom of the peroxide moiety. Also, a reduction potential for the [(PIm)FeIII–(O2
•ˉ)] 
(PIm-S)/ [(PIm)FeIII–(O2
2–)]– (PIm-P) couple and a pKa for the [(P
Im)FeIII–(OOH)] 
(PIm-HP) acid-base pair are established. These thermodynamic parameters and use 
of the Bordwell relationship square scheme (Figure 5.1) allow the determination of 
OO–H bond dissociation free energy (BDFE) for PIm-HP. We compare and contrast 
thermodynamic findings (reduction potential and pKa for P
Im and F8 porphyrinate 
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complex) and insights obtained for corresponding complexes with hydrogen atom 
transfer (HAT) reactions. 
 
5.2 Results and Discussion 
5.2.1 Generation and characterization of a ferric peroxide, [(PIm)FeIII–(O22–)]– (PIm-P) 
The ferric heme superoxide [(PIm)FeIII–(O2
•ˉ)] (PIm-S) generated by bubbling O2 to 
a solution of [(PIm)FeII] (Figure 5.1), was previously characterized (νO−O, 1180 (Δ
18O2, –
56) cm–1; νFe‑O, 575 (Δ
18O2, –23) cm
–1).22,31 Addition of cobaltocene (CoCp2) to PIm-S at –
80 ℃ in THF results in the formation of the ferric heme peroxide complex [(PIm)FeIII–
(O2
2–)]– (PIm-P); UV-vis spectral shifts occurring are 423 to 424 nm (Soret) and 532 to 535, 
567 nm (Figure 5.2A). These product electronic absorption spectra are very similar to those 
of Naruta’s end-on low-spin ferric heme peroxide, as mentioned the first of its kind.21 The 
UV-vis features of PIm-P and Naruta’s analog exhibit higher energy Soret λmax values than 
the side-on bound ferric heme peroxides (also lacking a trans axial base ligand), as in 
[(F8)Fe
III–(η2:O2
2–)]– (Figure 5.1, upper right).8,18,20,28–30 The low-spin end-on formulation 
is confirmed by the EPR spectra which display signals at g = 2.25, 2.14, and 1.95 (Figure 
5.2A), matching Naruta’s analog,21 as well as for those end-on ferric peroxide obtained by 
cryoreduction methods in heme enzymes.9–13 Such EPR signatures also are distinct from 






Figure 5.2 (A) Electronic absorption spectra of [(PIm)FeIII–(O2
•ˉ)] (PIm-S) (red) to 
[(PIm)FeIII–(O2
2–)]– (PIm-P) (blue) at –80 ℃ in THF. Inset: Frozen THF solution EPR 
(10 K) spectrum of PIm-P. The small feature (g = 1.99) corresponds to an excess of 
cobaltocene.18 (B) Resonance Raman spectra of [(PIm)FeIII–(O2
2–)]– (PIm-P) in 
frozen THF obtained at 77 K with 413 nm excitation. The 16O2−
18O2 difference 
spectrum is shown in blue. Also, see the text. 
 
Further, [(PIm)FeIII–(O2
2–)]– (PIm-P) was characterized using rR 
spectroscopy. Two 16O2/
18O2 isotopic sensitive shifts were observed for this end-on 
peroxide species PIm-P, at 810 (Δ18O2 = −34) cm
−1 and 578 (Δ18O2 = −26) cm
−1 
corresponding to the νO−O and νFe−O stretches, respectively (Figure 5.2B). This latter 
stretching frequency value matches the expected value (ΔFe‑O,calc (
16O2/
18O2) = −26 
cm−1) using the harmonic oscillator approximation. The magnitude of the isotope 




however, the same trend is found for Naruta’s complex [(P)FeIII–(η1:O2
2–)]– (νO−O, 
808 (Δ18O2, –37) cm
–1; νFe‑O, 585 (Δ
18O2, –25) cm
–1).21 It is notable that νFe−O in 
[(PIm)FeIII–(η1:O2
2–)]– (PIm-P), is much larger than that found for the side-on 
peroxide species which has no internally appended axial base imidazolyl, [(F8)Fe
III–
(η2:O2
2−)]− (Figure 5.1, upper right; νO−O, 806 (Δ
18O2, −46) cm
−1; νFe‑O, 466 (Δ
18O2, 
−19) cm−1).8 The increased Fe–O stretching frequency is likely a result of both the 
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monodentate coordination and the σ-symmetry O2 donation into the fully 
unoccupied low-spin Fe dz2 orbital which is stronger than the π-symmetry donation 
into the half-occupied Fe dxz/dyz orbital of the side-on peroxide complex. These 
effects would strengthen the Fe–O bond of PIm-P, and favor the end-on binding 
mode, giving a low-spin six-coordinate species [(PIm)FeIII–(η1:O2
2ˉ)]ˉ (PIm-P).  
 
5.2.2 Generation and characterization of [(PIm)FeIII–(OOH)] (PIm-HP) 
When excess triflic acid (HOTf) is added to [(PIm)FeIII–(O2
2ˉ)]ˉ (PIm-P), Fe–
O bond cleavage occurs, releasing H2O2 (89 % yield; horseradish peroxidase assay, 
see Figure 5.3), corroborating the complex’s peroxide formulation. PIm-P is singly 
protonated by adding 1 equiv of 2,6-lutidinium triflate [(LutH+)](OTf) at –80 ℃ in 
THF, giving [(PIm)FeIII–(OOH)] (PIm-HP) with absorptions at 423 and 533 nm 
(Figure 5.4A). EPR spectra of PIm-HP confirm an end-on low-spin ferric heme 
hydroperoxide structure (g = 2.25, 2.14, and 1.95) as shown in Figure 5.4B. These 
values correspond closely to those already  known for synthetically  derived end-on 
low-spin hydroperoxide complexes8,20,21,23–26 as well as for ferric heme 
hydroperoxides generated within hemoglobin and myoglobin.32,33 A high yield of 
H2O2 (90.1 %) is also obtained when PIm-HP is acidified using HOTf (see Figure 
5.3). Further, we performed rR spectroscopy; while only noisy spectra could be 
obtained (Figure 5.5), νO−O (808 (Δ
18O2, –48) cm
–1) and νFe−O (579 (Δ
18O2, –36) cm
–
1) resonances could be discerned. These parameters, for PIm-HP, are quite similar to 
those for the other synthetic or protein low-spin ferric heme hydroperoxide 





Figure 5.3 Calibration curve (adapted from ref 36) used for H2O2 quantification by 





Figure 5.4 (A) UV–vis spectra illustrating the conversion of [(PIm)FeIII–(O2
2ˉ)]ˉ 
(PIm-P) to [(PIm)FeIII–(OOH)] (PIm-HP) by addition of [(LutH+)](OTf) at –80 ℃ in 
THF. (B) EPR spectra (10 K) of PIm-HP. Note that there is g = 1.99 signal from 








Figure 5.5 Resonance Raman spectra of ferric heme hydroperoxide complex [(PIm)FeIII–
(OOH)] (PIm-HP) in frozen THF obtained at 77 K with 413 nm excitation. 
 
 
5.2.3 Reduction potential of the [(PIm)FeIII–(O2•–)] (PIm-S)/ [(PIm)FeIII–(O22–)]– (PIm-P) 
We find [(PIm)FeIII–(O2
•ˉ)] (PIm-S) and [(PIm)FeIII–(O2
2ˉ)]ˉ (PIm-P) are 
interconvertible (Figure 5.1) using redox reagents. Addition of a ferrocenium 
reagent (Fc+; E1/2 = 0 V vs Fc
+/0) to the solution of PIm-P leads to the reappearance 
of the optical bands (423 and 532 nm) associated with PIm-S (Figure 5.6). This 
oxidation is supported by the EPR silent known diamagnetic behavior of PIm-S 
solution generated (10 K, in THF frozen solution). Additionally, the addition of 
CoCp2 to this resulting solution led to re-reduction giving the peroxide species PIm-






Figure 5.6 UV–vis spectra demonstrating the oxidation of [(PIm)FeIII–(O2
2–)]– (PIm-
P) to form [(PIm)FeIII–(O2







Figure 5.7 Addition of 1 equivalent of ferrocenium to [(PIm)FeIII–(O2
2–)]– (PIm-P) (blue) 
regenerates the formation of [(PIm)FeIII–(O2
•–)] (PIm-S) (red) and again, upon addition of 
excess amount of CoCp2, to this resulting solution, [(P
Im)FeIII–(O2




Interestingly, titration of [(PIm)FeIII–(O2
•ˉ)] (PIm-S) with varying amounts of 
CoCp2 (E1/2 = –1.33 V vs Fc
+/0 in THF)37 at –80 ℃ in THF gives an equilibrium 
mixture; UV-vis monitoring (at either 423 or 567 nm)  (Figure 5.8A, Table 5.1, and 
Figure 5.9), allowed determination of Keq in each instance. From these results and 
utilizing the Nernst equation, the reduction potential for the couple, [(PIm)FeIII–
(O2
•ˉ)] (PIm-S)/ [(PIm)FeIII–(O2
2ˉ)]ˉ (PIm-P) is calculated to be –1.33 V ± 0.01 V vs 
Fc+/0. This value is more negative by ∼160 mV than that of previously reported 
[(F8)Fe
III–(O2
•ˉ)] (–1.17 V vs Fc+/0) (Figure 5.10) which has no internally appended 
axial base in the porphyrinate complex.8 Consistent with this finding is the 
observation that in order to fully reduce [(F8)Fe
III–(O2
•ˉ)] to its peroxide product, 
one equivalent of CoCp2 was used, while multiple equivalents of the cobaltocene 
are required to fully reduce the presently described superoxide complex PIm-S. 
These findings suggest a “push effect” due to the axial imidazolyl ligand which is 




Figure 5.8 UV-vis spectroscopic monitoring of the incremental addition of (A) 
CoCp2 to a solution of [(P
Im)FeIII–(O2
•ˉ)] (PIm-S) (red). Inset:  monitoring of the 
absorbance at 567 nm (blue). (B) EtP2(dma) addition to a solution of [(P
Im)FeIII–




Table 5.1 Equilibrium concentrations for the titration of CoCp2 into a solution of 
[(PIm)FeIII–(O2
•–)] (PIm-S) in THF at –80 °C 
 
At 567 nm 
 
[CoCp2]added [CoCp2]eq [Peroxide]eq [Superoxide]eq [CoCp2]+eq Keq Es (mV) 
4.98 x 10–5 3.00 x 10–5 1.98 x 10–5 8.02 x 10–5 1.98 x 10–5 1.63 x 10–1 –1.36 
9.88 x 10–5 3.98 x 10–5 5.90 x 10–5 4.10 x 10–5 5.90 x 10–5 2.13 –1.32 
1.47 x 10–4 7.30 x 10–5 7.41 x 10–5 2.59 x 10–5 7.41 x 10–5 2.90 –1.31 
1.95 x 10–4 1.09 x 10–4 8.51 x 10–5 1.49 x 10–5 8.51 x 10–5 4.46 –1.31 
2.41 x 10–4 1.51 x 10–4 9.07 x 10–5 9.29 x 10–6 9.07 x 10–5 5.88 –1.30 
 
At 423 nm 
 
[CoCp2]added [CoCp2]eq [Peroxide]eq [Superoxide]eq [CoCp2]+eq Keq Es (mV) 
5.00 x 10–5 4.04 x 10–5 9.64 x 10–6 4.04 x 10–5 9.64 x 10–5 5.71 x 10–2 –1.38 
9.95 x 10–5 8.23 x 10–5 1.72 x 10–5 3.28 x 10–5 1.72 x 10–5 1.09 x 10–1 –1.37 
1.48 x 10–4 1.20 x 10–5 2.87 x 10–5 2.13 x 10–5 2.87 x 10–5 3.24 x 10–1 –1.35 
2.45 x 10–4 1.57 x 10–4 3.97 x 10–5 1.03 x 10–5 3.97 x 10–5 9.78 x 10–1 –1.33 




Figure 5.9 UV-vis spectroscopic monitoring of the incremental addition of CoCp2 to a 
solution of [(PIm)FeIII–(O2









couple was calculated to be –1.17 V vs Fc+/0 in THF.8 
 
Dey and co-workers6 reported the reduction potentials of iron-porphyrinate 
complexes (FeIII/II) which have thiolate and imidazolyl linkers bound to the iron 
center of porphyrinate complexes. The thiolate ligated porphyrin complex shows 
500 mV more negative FeIII/II reduction potential compared to an imidazolyl ligated 
porphyrinate analogue; the thiolate is a much better donor than imidazolyl. Thus, in 
our case, the greater covalent charge donation by an axial imidazolyl ligand in PIm 
reduces the reduction potential of [(PIm)FeIII–(O2





5.2.4 Determination of the pKa Value of [(PIm)FeIII–(OOH)] (PIm-HP) 
To complete the thermodynamic square scheme analysis (Figure 5.1),38 the 
pKa value of ferric heme hydroperoxide [(P
Im)FeIII–(OOH)] (PIm-HP) was evaluated 
at –80 ℃ in THF. Full deprotonation of PIm-HP was accomplished by spectral 
titration using the derivatized phosphazene base EtP2(dma) (pKa = 28.1 for the 
conjugate acid; THF solvent, room temperature).39 The concentrations of each 
species (PIm-P, PIm-HP, EtP2(dma), and EtP2(dma)H
+) were evaluated by 
examination of the observed absorbance at either 423 or 567 nm in the UV-vis 
spectra (Figure 5.8B, Table 5.2, and Figure 5.11). Such titration experiments lead to 
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the establishment of an equilibrium constant for the protonation of PIm-P to give 
PIm-HP, allowing the calculation of the pKa of the ferric heme hydroperoxide to be 
28.6 ± 0.5 (–80 ℃, THF). The reversibility of acid-base reaction was further 
demonstrated by adding [(LutH+)](OTf) to the solution generated in this titration, 
which gives back to hydroperoxide complex (Figure 5.12).  
 
Table 5.2 Equilibrium concentrations for the titration of EtP2(dma) into a solution of 
[(PIm)FeIII–(OOH)] (PIm-HP) in THF at –80 °C 
At 567 nm 
[EtP2(dma)]added [Peroxide]eq [EtP2(dma)]eq [Hydroperoxide]eq [EtP2(dma)H+]eq Keq 
2.41 x 10–5 1.05 x 10–5 1.35 x 10–5 8.61 x 10–5 1.05 x 10–5 0.09 
4.79 x 10–5 3.81 x 10–5 9.79 x 10–6 5.84 x 10–5 3.81 x 10–5 2.54 
7.16 x 10–5 6.08 x 10–5 1.08 x 10–5 3.58 x 10–5 6.07 x 10–5 9.48 
9.51 x 10–5 7.52 x 10–5 1.99 x 10–5 2.14 x 10–5 7.52 x 10–5 13.2 








At 423 nm 
[EtP2(dma)]added [Peroxide]eq [EtP2(dma)]eq [Hydroperoxide]eq [EtP2(dma)H+]eq Keq 
2.5 x 10–5 1.06 x 10–5 1.43 x 10–5 3.74 x 10–5 1.06 x 10–5 0.21 
4.95 x 10–5 1.81 x 10–5 3.14 x 10–5 2.99 x 10–5 1.81 x 10–5 0.34 
7.35 x 10–5 3.13 x 10–5 4.21 x 10–5 1.67 x 10–5 3.13 x 10–5 1.39 











Figure 5.11 Conversion of [(PIm)FeIII–(OOH)] (PIm-HP) (pink) to [(PIm)FeIII–(O2
2‒
)]– (PIm-P) (blue) upon addition of EtP2(dma) at –80 °C in THF, resulting in the 





Figure 5.12 Addition of EtP2(dma) to the solution of [(P
Im)FeIII–(OOH)] (PIm-HP) (pink) 
regenerates complex [(PIm)FeIII–(O2
2–)]– (PIm-P) (blue). This resulting solution can be 
protonated again to form complex PIm-HP (purple) by adding [(LutH+)](OTf). 
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5.2.5 Determination of the OO–H BDFE of [(PIm)FeIII–(OOH)] (PIm-HP) 
This allows the completion of the thermodynamic square scheme for electron 
and proton transfer reactions (Figure 5.1) using the presently determined 
thermodynamic parameters, E°’ (–1.33 V vs. Fc+/0, vide supra) and pKa (28.6, vide 
supra), and determination of the BDFE of the OO–H in the ferric heme 
hydroperoxide complex [(PIm)FeIII–(OOH)] (PIm-HP). According to eq. 1 (Bordwell 
relationship, CG stands for the H
+/H• standard reduction potential in a particular 
solvent),38 where CG = 61 kcal/mol in THF, the PIm-HP BDFE is calculated to be 
69.5 kcal/mol (eq. 2). 
 
BDFE = 1.37(pKa) + 23.06E
o + CG,solv                                            (1) 
 
BDFEOO–H = 1.37(28.6) + 23.06(–1.33) + 61 = 69.5 kcal/mol       (2)      
 
Our own previous report is the only other experimental evaluation of the 
thermodynamics and use of the square scheme as applied to ferric heme superoxide, 
peroxide (Figure 5.1, upper right) and hydroperoxide relatives, i.e., for the F8 heme 
containing superoxide, (side-on) peroxide and hydroperoxide, [(F8)Fe
III–(OOH)], 
BDFEOO–H = 73.5 kcal/mol.
8 Our OO–H BDFE value presented here with PIm is shown to 
be ~ 4 kcal/mol less, and the difference resides primarily in the variation in the 
superoxide/peroxide redox couple (Figure 5.13). The pKa values for [(F8)Fe
III–(OOH)] vs 
[(PIm)FeIII–(OOH)] (PIm-HP) are essentially identical, but the E°’ reduction potential is 
measurably more negative for the (PIm-S) / (PIm-P) couple (Figure 5.13). This makes 
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chemical sense as the PIm system possesses the strong imidazolyl axial base ligand donor, 
that not present in the F8 heme system. Also, the dissimilarity of BDFE values ([(PIm)FeIII–
(OOH)] BDFEOO–H = 69.5 kcal/mol and [(F8)Fe
III–(OOH)] BDFEOO–H = 73.5 kcal/mol) is 
supported by their hydrogen atom transfer (HAT) reactivities toward H atom donors (vide 
infra). As we noted previously8 our BDFE results are also in accord with computationally 
calculated ferric heme hydroperoxides (those modeling proteins), where a proximal ligand 
is either an imidazolyl or thiolate group, BDEs (64‒66 kcal/mol).40 
 
 
Figure 5.13 Comparison of PIm and F8 iron-porphyrinate complex for thermodynamic 
parameters and the geometry of peroxide species. 
 
 
5.2.6 Reactivity Studies of [(PIm)FeIII–(O2•–)] (PIm-S) with O–H and C–H substrates 
HAT reactivity (shown in the diagonal of Figure 5.1) studies were performed with 
[(PIm)FeIII–(O2
•‒)] (PIm-S) toward external substrates to support our experimentally 
determined BDFE value. Addition of an excess of substrates such as 9,10-
dihydroanthracene (76 kcal/mol in DMSO)38 and xanthene (72.2 kcal/mol in THF)39 to the 
solutions of PIm-S at –80 ℃ in THF led to no reaction. These observations are consistent 
175 
 
with our BDFE determination of 69.5 kcal/mol for [(PIm)FeIII–(OOH)] PIm-HP. In contrast, 
TEMPO-H (66.5 kcal/mol in THF, 72.6 kcal/mol in buffered aqueous solution and 69.6 
kcal/mol in benzene)39,41 does react with complex PIm-S. The final spectra (UV-vis and 
EPR; Scheme 5.1, Figure 5.14 and Figure 5.15) reveal a high yield of TEMPO•, while 
[(PIm)FeIII–(OOH)] (PIm-HP) seems to only form in small amounts (~20% yield), probably 
due to side-reactions. The results support the conclusion that an initial H-atom abstraction 
from TEMPO-H to give PIm-HP occurred. Based on these reactivity studies, the BDFE of 
[(PIm)FeIII–(OOH)] (PIm-HP) can be bracketed to be, 66.5 < BDFEOO–H < 72 kcal/mol, 
which is consistent with our experimentally determined BDFE value, 69.5 kcal/mol. 
Scheme 5.1 Hydrogen atom transfer (HAT) of [(PIm)FeIII–(O2
•ˉ)] (PIm-S) from TEMPO-H 





Figure 5.14 UV-vis spectra monitoring the reaction of [(PIm)FeIII–(O2
•–)] (PIm-S) with 




Figure 5.15 EPR spectrum of the reaction of [(PIm)FeIII–(O2
•‒)] (PIm-S) with TEMPO-H in 
frozen THF. 
 
As we previously showed that [(F8)Fe
III–(O2
•‒)] (S) reacts with TEMPO-H to 
cleanly give the TEMPO• and corresponding hydroperoxide complex [(F8)Fe
III–(OOH)] 
(HP), we now see that S and [(PIm)FeIII–(O2
•‒)] (PIm-S) reactions toward TEMPO-H are 
comparable. Thus, we sought to find a different substrate that might differentiate between 
the oxidizing capabilities of the two superoxide complexes, which is what we have found 
here based on our thermodynamic parameter analysis. The superoxide complex S should 
be a somewhat stronger oxidant for HAT chemistry as based on our finding of the ~ 4 







Figure 5.16 Reactivity comparison of PIm and F8 superoxide complex toward ABNO-H at 
–80 ℃ in THF. 
 
Thus, we turned to the use of another hydroxylamine substrate, ABNO-H (9-
azabicyclo[3.3.1]nonane-N-hydroxide, BDFE = 76.0 kcal/mol in buffered aqueous solution, 
76.2 kcal/mol in benzene)41 whose BDFE value is in the range 3.4-to-6.6 kcal/mol higher 
than that of TEMPO-H.  As summarized in Figure 5.16, there was no reaction between 
PIm-S and ABNO-H (Figure 5.16 and Figure 5.17), while spectroscopic monitoring (UV-
vis and EPR) of the corresponding [(F8)Fe
III–(O2
•‒)] (S) plus ABNO-H reaction (Figure 
5.16 and Figure 5.18) revealed both the generation of the organic radical product (ABNO•) 
along with the formation of the low-spin end-on hydroperoxide species, HP (See Figure 
5.18 for further details). The HAT reaction of ABNO-H with PIm-S is thermodynamically 
uphill. In contrast, the oxidizing ability of S via HAT from ABNO-H is thermodynamically 
downhill, thus favored. ABNO-H is a borderline substrate which enables us to discern the 
clear difference in the reactivities between [(PIm)FeIII–(O2
•‒)] (PIm-S) and [(F8)Fe
III–(O2
•‒)] 
(S); the results are fully consistent with our findings of heme-hydroperoxide OO–H 




Figure 5.17 UV-vis spectroscopy following the addition of ABNO-H to the solution of 
[(PIm)FeIII–(O2




Figure 5.18 UV−vis spectroscopic monitoring the reaction of [(F8)Fe
III–(O2
•‒)] (S) (red) 
with ABNO-H in THF at −80 °C to yield [(F8)Fe
III–(OOH)] (HP) (pink). Inset: 10 K EPR 
spectrum of the final products of ABNO-H HAT by S in frozen THF. Spin quantification 
reveals that the EPR signal corresponds to ~68% yield of S, but the yield of ABNO radical 
is low probably due to side-reactions, yet showing the expected triplet features (at g = 2; 




In conclusion, using the PIm iron-porphyrinate which includes an imidazolyl moiety 
appended to the periphery of a fluorinated tetraphenylporphyrin, we here generated a new 
(only the second one known) end-on low-spin ferric heme peroxide [(PIm)FeIII–(O2
2–)]– 
(PIm-P) and also a hydroperoxide [(PIm)FeIII–(OOH)] (PIm-HP) species which are relevant 
to the catalytic cycle of CYP450s and many other heme enzymes which activate O2 or 
H2O2. The end-on peroxide binding mode with the P
Im heme contrasts with that of the F8 
heme (without the appended axial imidazolyl ligand) which forms a side-on peroxide 
species. The reversibility of the [(PIm)FeIII–(O2
•‒)] (PIm-S)/ [(PIm)FeIII–(O2
2–)]– (PIm-P) 
redox process and the [(PIm)FeIII–(O2
2–)]– (PIm-P)/ [(PIm)FeIII–(OOH)] (PIm-HP) acid-base 
equilibrium allowed for the calculation of reduction potential and pKa, respectively. With 
the measured thermodynamic parameters, the ferric heme OO–H BDFE was determined to 
be 69.5 kcal/mol, contrasting with the value of 73.5 kcal/mol found for [(F8)Fe
III–(OOH)] 
(HP).  
This difference is a result of the existence of the appended axial imidazolyl ligand 
in the PIm system. Its “push effect” appears to contribute significantly to the lower reduction 
potential found for (PIm-S)/(PIm-P) compared to that measured for the (S)/(P) couple with 
F8-heme. Confirmation of our thermodynamically derived parameters comes from 
comparison of the [(PIm)FeIII–(O2
•‒)] (PIm-S) versus [(F8)Fe
III–(O2
•‒)] (S) reactivity results 
employing the hydroxylamine substrates TEMPO-H and/or ABNO-H. Future studies will 
explore further similar thermodynamic relationships to determine how ligand effects may 




5.4 Experimental section 
5.4.1 Materials and methods 
All reagents and solvents purchased and used were of commercially available 
quality except as noted. Inhibitor-free Tetrahydrofuran (THF) was distilled over 
Na/benzophenone under argon and deoxygenated with argon before use. Butyronitrile was 
distilled over sodium carbonate and potassium permanganate and deoxygenated with Ar 
before use. Cobaltocene was obtained from Sigma Aldrich, sublimed at 75°C, and stored 
under nitrogen in the glovebox freezer at –30 °C. The 2,6-lutidinium Triflate 
[(Lu)(H)](OTf), TEMPO-H, and ABNO-H were synthesized according to previously 
published literature procedures.42–44 
The preparation and handling of air-sensitive compounds were performed under a 
MBraun Labmaster 130 inert atmosphere (< 1 ppm O2 and < 1 ppm H2O) glovebox filled 
with nitrogen. Dioxygen gas purchased from Airgas and dried through Drierite. 18O2 gas 
was purchased from ICON, Summit, NJ, and 16O2 gas was purchased from BOC gases, 
Murray Hill, NJ. 
All UV−vis measurements were carried out as previously described22,31 using a 
Hewlett-Packard 8453 diode array spectrophotometer with HP Chemstation software and 
a Unisoku thermostated cell holder for low-temperature experiments. A 10 mm path length 
quartz cell cuvette modified with an extended glass neck with a female 14/19 joint, and 
stopcock was used to perform all UV–vis experiments, as previously described.31,45,46 1H 
NMR spectra were measured on a Bruker 300-MHz NMR spectrometer at ambient or low 
temperatures. Chemical shifts were reported as δ (ppm) values relative to an internal 
standard (tetramethylsilane) and the residual solvent proton peaks. Electron paramagnetic 
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resonance (EPR) spectra were recorded with a Bruker EMX spectrometer equipped with a 
Bruker ER 041 × G microwave bridge and a continuous flow liquid helium cryostat 
(ESR900) coupled to an Oxford Instruments TC503 temperature controller. Spectra were 
obtained at 10 K under non-saturating microwave power conditions (ν = 9.428 GHz, 
microwave power = 0.201 mW, modulation amplitude = 10 G, microwave frequency = 100 
kHz, and receiver gain = 5.02 × 103).  
The compound (PIm)FeII was synthesized as previously described.22 
 
5.4.2 UV-vis Spectroscopy 
5.4.2.1 Generation of [(PIm)FeIII–(O22–)] (PIm-P) 
In an inert atmosphere glovebox, a 0.05 mM solution of [(PIm)FeII] was prepared in 
THF in a 2 mm path length quartz Schlenk cuvette capped with a rubber septum. The 
cuvette was cooled in the cryostat chamber to –80 ℃. Dioxygen was bubbled through the 
solution, and excess O2 was purged out of the tubes by bubbling with Ar. Then, 15 μL (3 
equiv) of a 10 mM solution of CoCp2 dissolved in butyronitrile were added via gastight 
syringe to the solution of [(PIm)FeIII–(O2
•‒)] (PIm-S) and mixed by bubbling with Ar in THF 
at –80 ℃. UV-vis: λmax = 424, 535, and 567 nm. 
 
5.4.2.2 Generation of [(PIm)FeIII‒(OOH)] (PIm-HP) 
After generating complex [(PIm)FeIII‒(O2
2–)]– (PIm-P) as described above, 10 μL (1 
equiv) of a 5 mM solution of [(LutH+)](OTf) dissolved in THF was added via gastight 
syringe to the solution of PIm-P and mixed by bubbling with Ar in THF at –80 ℃. UV-vis: 
λmax = 423 and 533 nm. 
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5.4.2.3 H2O2 Quantification by Horseradish Peroxidase (HRP) Test  
The spectrophotometric quantification of hydrogen peroxide was carried out by 
analyzing the intensity of the diammonium 2,2′-azino-bis(3-ethylbenzothiazoline-6-
sulfonate)(AzBTS-(NH4)2) peaks (at different wavelengths to minimize error, Figure 5.3), 
which was oxidized by horseradish peroxidase (HRP); this was adapted from published 
procedures.36,47 Three stock solutions were prepared: 300 mM sodium phosphate buffer pH 
7.0 (solution A), 1 mg/mL AzBTS-(NH4)2 (solution B) and 4 mg of HRP (type II salt free 
(Sigma)) with 6.5 mg of sodium azide in 50 mL of water (solution C). 3.0 mL of the desired 
[(PIm)FeIII‒(O2
2–)] (PIm-P) or [(PIm)FeIII‒(OOH)] (PIm-HP) solution were generated in THF 
at –80 ℃, as previously described. The reaction which is before and after being quenched 
by adding 100μL of triflic acid (HOTf) solution (2.5 equiv) is subject to the H2O2 analysis. 
Subsequently 100 μL of the cold THF sample solution was removed via a syringe and 
quickly added to a cuvette containing 1.3 mL of water, 500 μL of solution A, 100 μL of 
solution B, and 50 μL of solution C (all chilled in an ice bath prior to use). After mixing 
for 15s, the samples were allowed to sit at room temperature for ~2 min until full formation 
of the 418 nm band was observed (Figure 5.3).  
 
5.4.2.4 Determination of the reduction potential of [(PIm)FeIII‒(O22–)] (PIm-P)  
In a 2mm path length quartz Schlenk cuvette, [(PIm)FeIII‒(O2
•–)] (PIm-S) was 
generated as previously published.22 Titrations of 0.25–3 equiv CoCp2 dissolved in 
butyronitrile were carried out in THF at –80 ℃. For each equilibrium mixture, the 
concentration of each species in solution was measured using the absorption at either 423 
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or 567 nm (Table 5.1). From these equilibrium constants, corresponding reduction 
potentials were calculated by using the Nernst equation.  
 
5.4.2.5 Reversibility of [(PIm)FeIII‒(O2•–)] (PIm-S) and [(PIm)FeIII‒(O22–)] (PIm-P)  
In a 2 mm path length quartz Schlenk cuvette, 1 equiv ferrocenium prepared in a 
glovebox was added via gastight syringe to a solution of [(PIm)FeIII‒(O2
2–)] (PIm-P) 
generated from [(PIm)FeIII‒(O2
•–)] (PIm-S) with 3 equiv CoCp2 in THF at –80 ℃. Then, 
excess amount of CoCp2 was added to this resulting solution via gastight syringe (Figure 
5.7). 
 
5.4.2.6 Determination of the pKa of [(PIm)FeIII‒(OOH)] (PIm-HP)  
In a 2 mm path length quartz Schlenk cuvette, [(PIm)FeIII‒(OOH)] (PIm-HP) was 
generated as described above. Titrations of 0.25–2 equiv EtP2(dma) prepared in a glovebox 
were carried out in THF at –80 ℃. For each equilibrium mixture, the concentration of each 
species in solution was measured using the absorption at either 423 or 567 nm (Table 5.2). 
From these equilibrium constants, the pKa was calculated.  
 
5.4.2.7 Reversibility of [(PIm)FeIII‒(O22–)]– (PIm-P) and [(PIm)FeIII‒(OOH)] (PIm-HP)  
In a 2 mm path length quartz Schlenk cuvette, 2 equiv EtP2(dma) prepared in a 
glovebox was added via gastight syringe to a solution of [(PIm)FeIII‒(OOH)] (PIm-HP) 
generated as described above. Then, 3 equiv [(LutH+)](OTf) was added to this resulting 




5.4.3 Electron Paramagnetic Resonance (EPR) Spectroscopy 
 In a glovebox, 1 mM solutions of (PIm)FeII in THF were prepared and transferred 
to EPR tube and capped with tightfitting septum. The sample tubes were placed in a cold 
bath (dry ice/acetone) and then O2 was bubbled through the solution. The excess O2 was 
purged out of the tubes by bubbling with Ar, and then the oxygenated samples were set in 
a cold bath for 10 min. The solution of CoCp2 dissolved in butyronitrile in a glovebox was 
added via gastight syringe to the solution of [(PIm)FeIII‒(O2
•–)] (PIm-S). Subsequently, 1 
equiv [(LutH+)](OTf) was added via gastight syringe, followed by mixing of the solution 
by bubbling Ar, for complex [(PIm)FeIII‒(OOH)] (PIm-HP). Then, the sample tubes were 
frozen in liquid N2. 
For EPR data for the reaction of [(PIm)FeIII‒(O2
•–)] (PIm-S) with TEMPO–H, 10 
equiv TEMPO–H prepared in a glovebox was added via gastight syringe to the 1mM 
solution of PIm-S generated as described above. The tube was left at –80 ℃ for 1 hour 30 
minutes and then frozen in liquid nitrogen and sealed by flame. 
 
5.4.4 Resonance Raman Spectroscopy 
In the glovebox, 1 mM solutions of (PIm)FeII in THF were prepared and transferred 
to rR tube and capped with tightfitting septum. The sample tubes were placed in a cold bath 
(dry ice/acetone) and then either 16O2 or 
18O2 gas was bubbled through the solution. The 
excess either 16O2 or 
18O2 was purged out of the tubes by bubbling with Ar, and then the 
oxygenated samples were set in a cold bath for 10 min. The solution of CoCp2 dissolved in 
butyronitrile in a glovebox was added via gastight syringe to the solution of [(PIm)FeIII‒
(O2
•–)] (PIm-S). Subsequently, 1 equiv [(LutH+)](OTf) was added via gastight syringe, 
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followed by mixing of the solution by bubbling Ar, for complex [(PIm)FeIII‒(OOH)] (PIm-
HP). Then, the sample tubes were frozen in liquid N2. Resonance Raman samples were 
excited at 413 nm, using a Coherent I90C-K Kr+ ion laser while the sample was immersed 
in a liquid nitrogen cooled (77 K) EPR finger Dewar (Wilmad). Power was ~2 mW at the 
sample, which was continuously rotated to minimize photodecomposition. The spectra 
were recorded using a Spex 1877 CP triple monochromator, and detected by an Andor 
Newton CCD cooled to –80 °C. 
 
5.5 References 
(1) Sono, M.; Roach, M. P.; Coulter, E. D.; Dawson, J. H. Heme-Containing Oxygenases. 
Chem. Rev. 1996, 96, 2841–2887. 
(2) Denisov, I. G.; Makris, T. M.; Sligar, S. G.; Schlichting, I. Structure and Chemistry of 
Cytochrome P450. Chem. Rev. 2005, 105, 2253–2277. 
(3) Ortiz de Montellano, P. R. Hydrocarbon Hydroxylation by Cytochrome P450 Enzymes. 
Chem. Rev. 2010, 110, 932–948. 
(4) Huang, X.; Groves, J. T. Oxygen Activation and Radical Transformations in Heme 
Proteins and Metalloporphyrins. Chem. Rev. 2018, 118, 2491–2553. 
(5) Adam, S. M.; Wijeratne, G. B.; Rogler, P. J.; Diaz, D. E.; Quist, D. A.; Liu, J. J.; Karlin, 
K. D. Synthetic Fe/Cu Complexes: Toward Understanding Heme-Copper Oxidase 
Structure and Function. Chem. Rev. 2018, 118, 10840–11022. 
(6) Das, P. K.; Chatterjee, S.; Samanta, S.; Dey, A. EPR, Resonance Raman, and DFT 
Calculations on Thiolate- and Imidazole-Bound Iron(III) Porphyrin Complexes: Role of 
the Axial Ligand in Tuning the Electronic Structure. Inorg. Chem. 2012, 51, 10704–10714. 
186 
 
(7) Dubey, K. D.; Shaik, S. Cytochrome P450-The Wonderful Nanomachine Revealed 
through Dynamic Simulations of the Catalytic Cycle. Acc. Chem. Res. 2019, 52, 389–399. 
(8) Kim, H.; Rogler, P. J.; Sharma, S. K.; Schaefer, A. W.; Solomon, E. I.; Karlin, K. D. 
Superoxide, Peroxide and Hydroperoxide Thermodynamic Relationships: FeIII-O2
•− 
Complex H‑Atom Abstraction Reactivity. J . Am. Chem. Soc. 2020, 142, 3104–3116. 
(9) Davydov, R.; Macdonald, I. D. G.; Makris, T. M.; Sligar, S. G.; Hoffman, B. M. EPR 
and ENDOR of Catalytic Intermediates in Cryoreduced Native and Mutant Oxy-
Cytochromes P450cam: Mutation-Induced Changes in the Proton Delivery System. J. Am. 
Chem. Soc. 1999, 121, 10654–10655. 
(10) Davydov, R.; Makris, T. M.; Kofman, V.; Werst, D. E.; Sligar, S. G.; Hoffman, B. M. 
Hydroxylation of Camphor by Reduced Oxy-Cytochrome P450cam : Mechanistic 
Implications of EPR and ENDOR Studies of Catalytic Intermediates in Native and Mutant 
Enzymes. J. Am. Chem. Soc. 2001, 123, 1403–1415. 
(11) Davydov, R.; Satterlee, J. D.; Fujii, H.; Sauer-Masarwa, A.; Busch, D. H.; Hoffman, 
B. M. A Superoxo-Ferrous State in a Reduced Oxy-Ferrous Hemoprotein and Model 
Compounds. J. Am. Chem. Soc. 2003, 125, 16340–16346. 
(12) Garcia-Serres, R.; Davydov, R. M.; Matsui, T.; Ikeda-Saito, M.; Hoffman, B. M.; 
Huynh, B. H. Distinct Reaction Pathways Followed upon Reduction of Oxy-Heme 
Oxygenase and Oxy-Myoglobin as Characterized by Mössbauer Spectroscopy. J. Am. 
Chem. Soc. 2007, 129, 1402–1412. 
(13) Shaik, S.; Cohen, S.; Wang, Y.; Chen, H.; Kumar, D.; Thiel, W. P450 Enzymes: Their 




(14) Collman, J. P.; Gagnet, R. R.; Christopher, A.; Robinson, W. T. Structure of an Iron(II) 
Dioxygen Complex ; A Model for Oxygen Carrying Hemeproteins. Proc. Natl. Acad. Sci. 
U. S. A. 1974, 71, 1326–1329. 
(15) Momenteau, M.; Reed, C. A. Synthetic Heme Dioxygen Complexes. Chem. Rev. 1994, 
94, 659–698. 
(16) Kim, H.; Sharma, S. K.; Schaefer, A. W.; Solomon, E. I.; Karlin, K. D. Heme−Cu 
Binucleating Ligand Supports Heme/O2 and Fe
II−CuI/O2 Reactivity Providing High- and 
Low-Spin FeIII−Peroxo−CuII Complexes. Inorg. Chem. 2019, 58, 15423–15432. 
(17) Collman, J. P.; Sunderland, C. J.; Berg, K. E.; Vance, M. A.; Solomon, E. I. 
Spectroscopic Evidence for a Heme-Superoxide/Cu(I) Intermediate in a Functional Model 
of Cytochrome c Oxidase. J. Am. Chem. Soc. 2003, 125, 6648–6649. 
(18) Chufan, E. E.; Karlin, K. D. An Iron-Peroxo Porphyrin Complex : New Synthesis and 
Reactivity Toward a Cu(II) Complex Giving a Heme-Peroxo-Copper Adduct. J. Am. Chem. 
Soc. 2003, 125, 16160–16161. 
(19) Liu, J. G.; Naruta, Y.; Tani, F. A Functional Model of the Cytochrome c Oxidase 
Active Site: Unique Conversion of a Heme–μ-Peroxo–CuII Intermediate into Heme– 
Superoxo/CuI. Angew. Chem. Int. Ed. 2005, 44, 1836–1840. 
(20) Liu, J.-G.; Ohta, T.; Yamaguchi, S.; Ogura, T.; Sakamoto, S.; Maeda, Y.; Naruta, Y. 
Spectroscopic Characterization of a Hydroperoxo-Heme Intermediate: Conversion of a 
Side-on Peroxo to an End-on Hydroperoxo Complex. Angew. Chem. Int. Ed. Engl. 2009, 
48, 9262–9267. 
(21) Liu, J. G.; Shimizu, Y.; Ohta, T.; Naruta, Y. Formation of an End-on Ferric Peroxo 
Intermediate upon One-Electron Reduction of a Ferric Superoxo Heme. J. Am. Chem. Soc. 
188 
 
2010, 132, 3672–3673. 
(22) Li, Y.; Sharma, S. K.; Karlin, K. D. New Heme-Dioxygen and Carbon Monoxide 
Adducts Using Pyridyl or Imidazolyl Tailed Porphyrins. Polyhedron 2013, 58, 190–196. 
(23) Nagaraju, P.; Ohta, T.; Liu, J.-G.; Ogura, T.; Naruta, Y. The Secondary Coordination 
Sphere Controlled Reactivity of a Ferric-Superoxo Heme: Unexpected Conversion to a 
Ferric Hydroperoxo Intermediate by Reaction with a High-Spin Ferrous Heme. Chem. 
Commun. 2016, 52, 7213–7216. 
(24) Singha, A.; Dey, A. Hydrogen Atom Abstraction by Synthetic Heme Ferric 
Superoxide and Hydroperoxide Species. Chem. Commun. 2019, 55, 5591–5594. 
(25) Tajima, K.; Oka, S.; Edo, T.; Miyake, S.; Mano, H.; Mukai, K.; Sakurai, H.; Ishizu, 
K. Optical Absorption and EPR Studies on a Six-Coordinate Iron(III)-
Tetramesitylporphyrin-Hydrogen Peroxide Complex Having a Nitrogenous Axial Ligand. 
J. Chem. Soc., Chem. Commun., 1995, 1507–1508. 
(26) Oliveira, R.; Zouari, W.; Herrero, C.; Banse, F.; Schöllhorn, B.; Fave, C.; 
Anxolabéhère-Mallart, E. Characterization and Subsequent Reactivity of an Fe-Peroxo 
Porphyrin Generated by Electrochemical Reductive Activation of O2. Inorg. Chem. 2016, 
55, 12204–12210. 
(27) Sengupta, K.; Chatterjee, S.; Samanta, S.; Dey, A. Direct Observation of Intermediates 
Formed during Steady-State Electrocatalytic O2 Reduction by Iron Porphyrins. Proc. Natl. 
Acad. Sci. U. S. A. 2013, 110, 8431–8436. 
(28) Elizabeth McCandlish, A. R. M.; Mario Nappa, Alice Q. Sprenger, J. S. V. Reactions 
of Superoxide with Iron Porphyrins in Aprotic Solvents. A High Spin Ferric Porphyrin 
Peroxo Complex. J. Am. Chem. Soc. 1980, 102, 4268–4271. 
189 
 
(29) Selke, M.; Sisemore, M. F.; Valentine, J. S. The Diverse Reactivity of Peroxy Ferric 
Porphyrin Complexes of Electron-Rich and Electron-Poor Porphyrins. J. Am. Chem. Soc. 
1996, 118, 2008–2012. 
(30) D. L. Wertz, J. S. Valentine, Struct. Bonding (Berlin) 2000, 97, 37–60. 
(31) Sharma, S. K.; Schaefer, A. W.; Lim, H.; Matsumura, H.; Moënne-Loccoz, P.; 
Hedman, B.; Hodgson, K. O.; Solomon, E. I.; Karlin, K. D. A Six-Coordinate Peroxynitrite 
Low-Spin Iron(III) Porphyrinate Complex - The Product of the Reaction of Nitrogen 
Monoxide (·NO(g)) with a Ferric-Superoxide Species. J. Am. Chem. Soc. 2017, 139, 
17421–17430. 
(32) Mak, P. J.; Denisov, I. G.; Victoria, D.; Makris, T. M.; Deng, T.; Sligar, S. G.; Kincaid, 
J. R. Resonance Raman Detection of the Hydroperoxo Intermediate in the Cytochrome 
P450 Enzymatic Cycle. J. Am. Chem. Soc. 2007, 129, 6382–6383. 
(33) Denisov, I. G.; Mak, P. J.; Makris, T. M.; Sligar, S. G.; Kincaid, J. R. Resonance 
Raman Characterization of the Peroxo and Hydroperoxo Intermediates in Cytochrome 
P450. J. Phys. Chem. A 2008, 112, 13172–13179. 
(34) Davydov, R. M.; Yoshida, T.; Ikeda-Saito, M.; Hoffman, B. M. Hydroperoxy-Heme 
Oxygenase Generated by Cryoreduction Catalyzes the Formation of α-Meso-
Hydroxyheme as Detected by EPR and ENDOR. J. Am. Chem. Soc. 1999, 121, 10656–
10657. 
(35) Ibrahim, M.; Denisov, I. G.; Makris, T. M.; Kincaid, J. R.; Sligar, S. G. Resonance 
Raman Spectroscopic Studies of Hydroperoxo-Myoglobin at Cryogenic Temperatures. J. 
Am. Chem. Soc. 2003, 125, 13714–13718. 
(36) Adam, S. M.; Garcia-Bosch, I.; Schaefer, A. W.; Sharma, S. K.; Siegler, M. A.; 
190 
 
Solomon, E. I.; Karlin, K. D. Critical Aspects of Heme–Peroxo–Cu Complex Structure and 
Nature of Proton Source Dictate Metal–Operoxo Breakage versus Reductive O–O 
Cleavage Chemistry. J . Am. Chem. Soc. 2017, 139, 472–481. 
(37) Yandulov, D. V.; Schrock, R. R. Erratum: Studies Relevant to Catalytic Reduction of 
Dinitrogen to Ammonia by Molybdenum Triamidoamine Complexes. Inorg. Chem. 2005, 
44, 1103–1117. 
(38) Warren, J. J.; Tronic, T. A.; Mayer, J. M. Thermochemistry of Proton-Coupled 
Electron Transfer Reagents and Its Implications. Chem. Rev. 2010, 110, 6961–7001. 
(39) Quist, D. A.; Ehudin, M. A.; Schaefer, A. W.; Schneider, G. L.; Solomon, E. I.; Karlin, 
K. D. Ligand Identity-Induced Generation of Enhanced Oxidative Hydrogen Atom 
Transfer Reactivity for a CuII2(O2
•–) Complex Driven by Formation of a CuII2(−OOH) 
Compound with a Strong O–H Bond. J. Am. Chem. Soc. 2019, 141, 12682–12696. 
(40) Chung, L. W.; Li, X.; Hirao, H.; Morokuma, K. Comparative Reactivity of Ferric-
Superoxo and Ferryl-Oxo Species in Heme and Non-Heme Complexes. J. Am. Chem. Soc. 
2011, 133, 20076–20079. 
(41) Gerken, J. B.; Pang, Y. Q.; Lauber, M. B.; Stahl, S. S. Structural Effects on the PH-
Dependent Redox Properties of Organic Nitroxyls: Pourbaix Diagrams for TEMPO, 
ABNO, and Three TEMPO Analogs. J. Org. Chem. 2018, 83, 7323–7330. 
(42) Curley, J. J.; Bergman, R. G.; Tilley, T. D. Preparation and Physical Properties of 
Early-Late Heterobimetallic Compounds Featuring Ir-M Bonds (M = Ti, Zr, Hf). Dalt. 
Trans. 2012, 41, 192–200. 
(43) Mader, E. A.; Davidson, E. R.; Mayer, J. M. Large Ground-State Entropy Changes for 




(44) Porter, T. R.; Capitao, D.; Kaminsky, W.; Qian, Z.; Mayer, J. M. Synthesis, Radical 
Reactivity, and Thermochemistry of Monomeric Cu(II) Alkoxide Complexes Relevant to 
Cu/Radical Alcohol Oxidation Catalysis. Inorg. Chem. 2016, 55, 5467–5475. 
(45) Ghiladi, R. a; Huang, H.; Moënne-Loccoz, P.; Stasser, J.; Blackburn, N. J.; Woods, A. 
S.; Cotter, R. J.; Incarvito, C. D.; Rheingold, A. L.; Karlin, K. D. Heme-Copper/Dioxygen 
Adduct Formation Relevant to Cytochrome c Oxidase: Spectroscopic Characterization of 
[(6L)FeIII-(O2(
2-))-CuII]+. J. Biol. Inorg. Chem. 2005, 10, 63–77. 
(46) Wasser, I. M.; Huang, H. W.; Moe, P.; Karlin, K. D. Heme / Non-Heme Diiron(II) 
Complexes and O2, CO, and NO Adducts as Reduced and Substrate-Bound Models for the 
Active Site of Bacterial Nitric Oxide Reductase. J. Am. Chem. Soc. 2005, 127, 3310–3320. 
(47) Peterson, R. L.; Ginsbach, J. W.; Cowley, R. E.; Qayyum, M. F.; Himes, R. A.; Siegler, 
M. A.; Moore, C. D.; Hedman, B.; Hodgson, K. O.; Fukuzumi, S.; Solomon, E. I.; Karlin, 
K. D. Stepwise Protonation and Electron-Transfer Reduction of a Primary Copper-













yuneagle@gmail.com • Baltimore, MD 21218, USA 
 
EDUCATION 
Johns Hopkins University                                                                           05/2018 – 12/2020 
Baltimore, MD, USA 
Ph.D. in Chemistry 
Advisor: Professor Kenneth D. Karlin  
Johns Hopkins University                                                                           08/2015 – 05/2018 
Baltimore, MD, USA 
M.A. in Chemistry 
Advisor: Professor Kenneth D. Karlin 
Seoul National University of Science and Technology                                03/2012 – 08/2015 
Seoul, Korea 
M.S. in Chemistry 
Advisor: Professor Cheal Kim 
Seoul National University of Science and Technology                                03/2008 – 02/2012 
Seoul, Korea 
B.S. in Chemistry 
Advisor: Professor Cheal Kim 
 
RESEARCH EXPERIENCE 
Graduate Research Assistant, Johns Hopkins University                        08/2015 – 12/2020 
Advisor: Professor Kenneth D. Karlin    
   •  Project 1: Synthesis of a new porphyrinate complex as a model for the imidazole-
phenol cross-coupling reaction implicated in His 240-Tyr 244 crosslink formation in 
Cytochrome c Oxidase (CcO). 
➢ Synthesized a new porphyrinate iron complex and characterized using 1H-NMR, 
2H-NMR, 19F-NMR, UV-vis and Electron Paramagnetic Resonance Spectroscopy 
(EPR).  
➢ Collaborative (team player), interpersonal communication skills. 
   •  Project 2: Investigated the coordination chemistry of heme/O2 and heme/Cu/O2 adducts 
with Cytochrome c Oxidase-inspired model complex. 
➢ Developed a strategy for generation of biomimetic small molecule model systems 
about peroxidic intermediates, characterized these species using variable 
temperature UV-visible Spectroscopy, variable temperature Nuclear Magnetic 
Resonance Spectroscopy, EPR and Resonance Raman spectroscopy (rR). 
➢ Productive independent research with excellent communication and team skills. 
193 
 
   •  Project 3: Studies on the thermodynamics of biomimetic model complexes relevant to 
Cytochrome P450s (CYP450). 
➢ Investigated the optimal redox chemicals for reduction/oxidation of model 
complexes, calculated the redox potential and pKa, conducted the reactivity and 
kinetic studies. 
➢ Self-directed, innovative, collaborative, able to balance multiple projects. 
Graduate Research Assistant                                                                    03/2012 – 08/2015 
Seoul National University of Science and Technology 
Advisor: Professor Cheal Kim 
   •  Thesis: Synthesis, application and analysis of chemosensors based on pyridine and 
phenol colorimetric and fluorometric sensor for metal ions. 
➢ Designed, synthesized and characterized novel optical chemosensors for detection 
of target ions (Al, Zn, Cu, Fe), investigated their unique optical properties using 
Fourier Transform Infrared Spectroscopy (FT-IR), UV-vis and Fluorescence 
Spectroscopies. 
➢ Calculated a detection limit of the target ions using the chemosensors, examined 
the practicability as a sensor. 
Undergraduate Research                                                                          03/2011 – 02/2012 
Seoul National University of Science and Technology 
Advisor: Professor Cheal Kim 
   •  Project: Synthesis and characterization of metal complexes with Saloph ligands. 
 
AWARDS and HONORS 
Honor Student Award, Seoul National University of Science and Technology                   2012 
 
TEACHING EXPERIENCE 
Teaching Assistant – Johns Hopkins University                                          01/2017 – 05/2017 
Class: Chemistry with Problem Solving 
Teaching Assistant – Johns Hopkins University                                          08/2015 – 12/2016 
Class: Introductory Chemistry Laboratory 
Teaching Assistant – Seoul National University of Science and Technology 
Class: Inorganic Chemistry Laboratory                                                       03/2013 – 06/2013      
Teaching Assistant – Seoul National University of Science and Technology          
Class: Introductory Chemistry Laboratory                                                   03/2012 – 12/2012 
 
TECHNICAL PROFICIENCIES 
Synthesis and purification of multi-step organic compounds 
Thin layer chromatography, column chromatography 
Synthesis of highly air-sensitive compounds 
194 
 
Schlenk/vacuum line techniques, inert atmosphere glovebox (dry-box) maintenance 
and usage 
Crystallization with complexes for X-ray crystallography analysis 
Analysis of compounds 
Fourier Transform Infrared Spectroscopy, variable temperature UV-visible 
Spectroscopy, Fluorescence Spectroscopy, variable temperature Nuclear Magnetic 
Resonance Spectroscopy, Electrospray Ionization Mass Spectrometry, Electron 
Paramagnetic Resonance Spectroscopy, Gas Chromatography, Gas Chromatography-
Mass Spectrometry, Cyclic Voltammetry 
Solvent distillation techniques, Nitric Oxide (NO(g)) purification 
Air-free and low-temperature sample preparation for UV-vis, resonance Raman 
spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Electron Paramagnetic 
Resonance Spectroscopy 
Expertise in Microsoft Office: Word, Excel, PowerPoint 
 
SCIENTIFIC SOCIETY MEMBERSHIPS 
American Chemical Society (Inorganic Chemistry Division)                          2017 – present 
Korean Chemical Society                                                                                    2012 – 2013 
 
ORAL PRESENTATIONS 
Kim, Hyun; Rogler, Patrick J.; Sharma, Savita K.; Karlin, Kenneth D. Contributed Lecture 
to the Division of Inorganic Chemistry: Creative Advances in Synthetic and Biological 
Coordination Chemistry (invited): “Thermochemistry of a ferric heme hydroperoxide 
complex: hydrogen atom abstraction reactivity of the superoxide partner complex”, 259th 
American Chemical Society National Meeting, Philadelphia, PA, USA, March 24, 2020. 
INOR 549. Unable to deliver, meeting canceled due to COVID-19 outbreak.  
Kim, Hyun; Sharma, Savita K.; Karlin, Kenneth D. Contributed Lecture to the Division of 
Inorganic Chemistry: Many Colors of Copper: “Binding and activation of small molecules 
(NO, O2) by a biomimetic heme-Cu ligand scaffold”, 254
th American Chemical Society 
National Meeting, Washington, DC, USA, August 23, 2017. INOR 720. 
 
POSTER PRESENTATIONS 
Bhadra, Mayukh; Kim, Hyun; Herzog, Austin; Karlin, Kenneth D. “Different Projects of 
the Karlin Lab: A Brief Overview”, Johns Hopkins University Chemistry Department 
Graduate Student Recruitment Session, Johns Hopkins University, Baltimore, MD, USA, 
March 8, 2019. 
Kim, Hyun; Sharma, Savita K.; Karlin, Kenneth D. “Characterization and Reactivity of a 
New Porphyrinate as a Model for the Imidazole-Phenol Cross-Coupling Reaction 
Implicated in His-Tyr Crosslink Formation in Cytochrome c Oxidase”, Frontiers in 
195 
 
Metallobiochemistry Symposium, 37th Summer Symposium in Molecular Biology, State 
College, PA, USA, June 6–8, 2018. 
Kim, Hyun; Sharma, Savita K.; Karlin, Kenneth D. “The Synthesis of a New Porphyrin as 
a Model System for Cytochrome c Oxidase”, Mid-Atlantic Seaboard Inorganic Symposium, 
Philadelphia, PA, USA, July 20, 2016. 
 
PUBLICATIONS 
1. Kim, Hyun; Rogler, Patrick J.; Sharma, Savita K.; Schaefer, Andrew W.; Solomon, 
Edward I.; Karlin, Kenneth D “Ferric Heme Superoxide Reductive Transformations to 
Ferric Heme (Hydro)Peroxide Species: Spectroscopic Characterization and 
Thermodynamic Implications for H-atom transfer (HAT)”, Angew. Chem., DOI: 
10.1002/anie.202013791 and 10.1002/ange.202013791. 
2. Kim, Hyun; Rogler, Patrick J.; Sharma, Savita K.; Schaefer, Andrew W.; Solomon, 
Edward I.; Karlin, Kenneth D. “Heme-FeIII Superoxide, Peroxide and Hydroperoxide 
Thermodynamic Relationships: FeIII-O2
•– Complex H-Atom Abstraction Reactivity”, J. Am. 
Chem. Soc., 2020, 142, 3104–3116.   
3. Kim, Hyun; Sharma, Savita K.; Schaefer, Andrew W.; Solomon, Edward I.; Karlin, 
Kenneth D. “New Heme–Cu Binucleating Ligand Supports Heme/O2 and Fe
II–CuI/O2 
Reactivity Providing High- and Low-Spin FeIII–Peroxo–CuII Complexes”, Inorg. Chem., 
2019, 58, 15423–15432. 
4. Sharma, Savita K.; Kim, Hyun; Rogler, Patrick J.; Karlin, Kenneth D. “Isocyanide or 
nitrosyl complexation to hemes with varying tethered axial base ligand donors: synthesis 
and characterization”, J. Biol. Inorg. Chem., 2016, 21, 729–743. 
5. Lee, Jae Jun; Lee, Seul Ah; Kim, Hyun; Nguyen, LeTuyen; Noh, Insup; Kim, Cheal “A 
highly selective CHEF-type chemosensor for monitoring Zn2+ in aqueous solution and 
living cells”, RSC Adv., 2015, 5, 41905–41913. 
6. Park, Gyeong Jin; Kim, Hyun; Lee, Jae Jun; Kim, Yong Sung; Lee, Sun Young; Lee, 
Suyeon; Noh, Insup; Kim, Cheal “A highly selective turn-on chemosensor capable of 
monitoring Zn2+ concentrations in living cells and aqueous solution” Sensors and Actuators 
B, 2015, 215, 568–576. 
7. Kim, Hyun; You, Ga Rim; Park, Gyeong Jin; Choi, Ji Young; Noh, Insup; Kim, 
Youngmee; Kim, Sung-Jin; Kim, Cheal; Harrison, Roger G. “Selective zinc sensor based 
on pyrazoles and quinoline used to image cells”, dyes and pigments, 2015, 113, 723–729. 
8. Song, Eun Joo; Kim, Hyun; Hwang, In Hong;  Kim, Kyung Beom; Kim, Ah Ram; Noh, 
Insup; Kim, Cheal “A single fluorescent chemosensor for multiple target ions: Recognition 
of Zn2+ in 100% aqueous solution and F− in organic solvent”, Sensors and Actuators B, 
2014, 195, 36–43. 
9. Kim, Hyun; Na, Yu Jeong; Park, Gyeong Jin; Lee, Jae Jun; Kim, Yong Sung; Lee, Sun 
Young; Kim, Cheal “A novel selective colorimetric chemosensor for Cu2+ in aqueous 
solution” Inorg. Chem. Commun., 2014, 49, 68–71. 
196 
 
10. Kim, Kyung Beom; Park, Gyeong Jin; Kim, Hyun; Song, Eun Joo; Bae, Jeong Mi; 
Kim, Cheal “A novel colorimetric chemosensor for multiple target ions in aqueous solution: 
simultaneous detection of Mn(II) and Fe(II)”, Inorg. Chem. Commun., 2014, 46, 237–240. 
11. Kim, Hyun; Na, Yu Jeong; Song, Eun Joo; Kim, Kyung Beom; Bae, Jeong Mi; Kim, 
Cheal “A single colorimetric sensor for multiple target ions: the simultaneous detection of 
Fe2+ and Cu2+ in aqueous media”, RSC Adv., 2014, 4, 22463–22469. 
12. Kim, Dong Ha; Im, Ye Seo; Kim, Hyun; Kim, Cheal “Solvent-dependent selective 
fluorescence sensing of Al3+ and Zn2+ using a single Schiff base”, Inorg. Chem. Commun., 
2014, 45, 15–19. 
13. Kim, Hyun; Kang, Juhye; Kim, Kyung Beom; Song, Eun Joo; Kim, Cheal “A highly 
selective quinoline-based fluorescent sensor for Zn(II)”, Spectrochimica Acta Part A: 
Molecular and Biomolecular Spectroscopy, 2014, 118, 883–887. 
14. Park, Gyeong Jin; Hwang, In Hong; Song, Eun Joo; Kim, Hyun; Kim, Cheal “A 
colorimetric and fluorescent sensor for sequential detection of copper ion and cyanide”, 
Tetrahedron, 2014, 70, 2822–2828. 
15. Kim, Hyun; Kim, Kyung Beom; Song, Eun Joo; Hwang, In Hong; Noh, Jin Young; 
Kim, Pan Gi; Jeong, Kwang Duk; Kim, Cheal “Turn–on Selective Fluorescent Probe for 
Trivalent Cations” Inorg. Chem. Commun., 2013, 36, 72–76. 
16. Kim, Kyung Beom; Kim, Hyun; Song, Eun Joo; Kim, Sumi; Noh, Insup; Kim, Cheal 
“A Cap-Type Schiff Base Acting as Fluorescence Sensor for Zinc(II) and Colorimetric 
Sensor for Iron(II), Copper(II), and Zinc(II) in Aqueous Media”, Dalton Trans., 2013, 42, 
16569–16577. 
17. Noh, Jin Young; Hwang, In Hong; Kim, Hyun; Song, Eun Joo; Kim, Kyung Beom; 
Kim, Cheal “Salicylimine-Based Colorimetric and Fluorescent Chemosensor for Selective 
Detection of Cyanide in Aqueous Buffer”, Bull. Korean Chem. Soc., 2013, 34, 1985–1989. 
18. Kang, Juhye; Kang, Hee Kyung, Kim, Hyun; Lee, Jungha; Song, Eun Joo; Jeong, 
Kwang Duk; Kim, Cheal; Kim, Jinheung “Fluorescent chemosensor based on 
bispicolylamine for selective detection of magnesium ions”, Supramolecular Chemistry, 
2013, 25, 65–68. 
19. Hwang, In Hong; Jo, Young Dan, Kim, Hyun; Kim, Kyeong Beom; Jung, Kwang 
Deog; Kim, Cheal; Kim, Youngmee; Kim, Sung Jin “Catalytic transesterification reactions 
of one-dimensional coordination polymers containing paddle-wheel-type units connected 
by various bridging ligands”, Inorg. Chim. Acta, 2013, 402, 39–45. 
20. Hyun, Min Young; Hwang, In Hong; Lee, Myoung Mi; Kim, Hyun; Kim, Kyeong 
Beom; Kim, Cheal; Kim, Ha Yeoung; Kim, Youngmee; Kim, Sung Jin “ZnII coordination 
polymers constructed with malonate and bipyridyl ligands: Photoluminescence and 
heterogeneous catalytic reactivity”, Polyhedron, 2013, 53, 166–171. 
21. Kang, Jongmin; Song, Eun Joo; Kim, Hyun; Kim, Young Hee; Kim, Youngmee; Kim, 
Sung Jin; Kim, Cheal “Specific naked eye sensing of cyanide by chromogenic host: studies 
on the effect of solvents”, Tetrahedron Letters, 2013, 54, 1015–1019. 
197 
 
22. Lee, Jungha; Kim, Hyun; Kim, Soojin; Noh, Jin Young; Song, Eun Joo; Kim, Cheal; 
Kim, Jinheung “Fluorescent dye containing phenol-pyridyl for selective detection of 
aluminum ions”, Dyes and Pigments, 2013, 96, 590–594. 
 
REFERENCES 
Kenneth D. Karlin                 David P. Goldberg                     Alan T. Stone 
  karlin@jhu.edu                       dpg@jhu.edu                         astone@jhu.edu 
 1-410-516-8027                    1-410-516-6658                       1-410-516-8476 
 
                                                
 
 
 
 
 
 
 
 
 
